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ABSTRACT
An investigation was performed in vitro and in an animal model toward the
development of a collagen-glycosaminoglycan analog of extracellular matrix to
facilitate articular cartilage regeneration in vivo.
Highly porous, sponge-like matrices were fabricated via a freeze-drying process
from 1) type I collagen and chondroitin 6-sulfate, and 2) reconstituted porcine
hyaline cartilage extracellular matrix (containing predominantly type II
collagen). Specimens of varying pore diameter, degree of cross-linking, and
collagen type were seeded with adult canine chondrocytes and cultured for up
to six weeks. The phenotype and proliferative and biosynthetic activity of the
cells were assessed by histology, immunohistochemistry, DNA and
glycosaminoglycan analyses, and radiolabeled sulfate incorporation. Certain
characteristics of the matrix were found to affect the chondrocyte distribution
in the cell-seeded construct or the behavior of the chondrocytes.
A canine model of cartilage injury was developed and the baseline healing of
untreated full-thickness chondral defects was established. Distinct phases of
healing in this model were identified and described. The model was used to
test the regenerative effects of relevant clinical treatments (including
microfracture and autologous chondrocyte transplantation) and a specific
porous type II collagen matrix. A quantitative histomorphometric method of
evaluating the contribution to healing of distinct tissue types was developed
and employed. The various treatments yielded different amounts of
reparative tissue and percentages of specific tissue types after 15 weeks.
Autologous chondrocyte transplantation resulted in the most hyaline cartilage,
but only approximately 50% filling of the defect; by one year, this reparative
tissue displayed degenerative changes. Treatments with collagen-
glycosaminoglycan matrices resulted in greater filling at 15 weeks (up to
approximately 90%), but predominantly with fibrocartilage. Long-term follow-
up will be required to assess the fate of this tissue.
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Title: Lecturer in Health Sciences and Technology,
Professor of Orthopedic Surgery (Biomaterials), Harvard Medical School
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1 Introduction
1.1 Statement of the Problem
When injured, articular cartilage has limited capacity for self repair. A
method of regenerating articular cartilage to resurface damaged joints would
be of great clinical value.
1.2 Clinical Significance
Articular cartilage is a specialized connective tissue covering the ends of bones
in synovial joints. The articular surface is responsible for transmitting loads
across joints and for providing a very low-friction bearing surface, both of
which are critical to normal joint function. Failure of the articular surface
may lead directly to pain or dysfunction or to inflammation of the joint and
damage to the underlying bone that will eventually necessitate joint
replacement.
Articular cartilage is susceptible to both traumatic and degenerative injury,
and to disease. These processes may be closely related, with incidents of
trauma or degeneration inciting or accelerating a disease process. Traumatic
injuries such as tearing of the cartilage commonly occur in sports injuries,
accidents, and other situations where joints are subjected to unusual or severe
loading. Traumatic injuries may affect only the cartilage (chondral fractures
or lesions), or both the cartilage and underlying subchondral bone
(osteochondral fractures). Such lesions can vary significantly in size, location,
and complexity, including whether or not the opposing load-bearing surface of
the joint is also involved.
The most common primary disease of articular cartilage is osteoarthrosis (also
called degenerative joint disease or, improperly, osteorthritis). This disease,
which can also occur idiopathically or secondary to traumatic injury or other
abnormalities, may begin with subtle changes in the biochemical composition
of the cartilage, but eventually leads to mechanical breakdown of cartilage,
damage to the underlying bone, and loss of the entire articular surface. In
other situations, osteoarthrosis may cause isolated lesions. In another disorder
of the cartilage, osteochondritis dissecans, the cartilage separates cleanly from
the underlying bone, which is often damaged. Cartilage may also be damaged
by diseases affecting other parts of the joint. For example, in rheumatoid
arthritis, inflammation in the synovium of the joint can impair cartilage
function, while avascular necrosis may destroy cartilage due to pathology
arising from the underlying bone.
Regardless of the cause, damage to the cartilage is likely to cause pain and
dysfunction to the patient. Damage to the upper extremity can result in
inability to perform routine daily tasks, while damage to the lower extremity
15
can severely hamper mobility or activity level. Pain, then dysfunction, are the
basis for intervention.
If successfully developed, a collagen-GAG matrix, possibly seeded with cells,
might be used for the following types of lesions, all of which are localized to
some extent within a joint:
- isolated, small chondral lesions (< 2 cm diameter)
- more extensive chondral lesion (>2 cm diameter)
- isolated osteochondral lesions
- osteochondritis dissecans
It is possible that the performance of such a matrix could vary with the type of
lesion, as well as other variables involved in specific clinical cases. The
construct would not be designed to treat generalized destruction of cartilage, as
in advance osteoarthrosis.
The prevalence of these types of lesions is generally unknown because not all
cases are symptomatic or diagnosed. Only recently has there been an attempt
to understand the patient populations which would benefit from the latest
cartilage repair techniques including chondrocyte transplantation or
resurfacing techniques using porous matrices, both of which are studied in this
work.
It is generally accepted that the treatments to be discussed would be most
appropriate for the population of young patients (40 years of age or younger)
with isolated chondral lesions, erosion of the cartilage to the calcified layer,
and no associated joint pathologies (including osteoarthrosis, meniscal tears,
ligament insufficiencies, or malalignment of the joint). A recent study
investigating over 30,000 arthroscopies has suggested that the prevalence of
this very specific situation taken from all arthroscopic examinations is
approximately 1.5% [40]. Given approximately 1.4 million arthroscopic
procedures performed on the knee annually in the United States, this would
represent approximately 20,000 patients. In practice, cartilage repair
techniques are being used clinically in a much wider range of patients
including older patients and those with damaged bone, mild osteoarthrosis,
multiple lesions or insufficiency of other tissues. The prevalence of this defect
type in these more complicated cases totals approximately 20% of
arthroscopies [40]. As this work is in its infancy, many years of clinical and
basic research are needed to elicit the proper criteria for patient selection and
treatment.
1.3 Current clinical treatments for cartilage defects
Clinical treatments for articular cartilage injury will depend on the extent of
the injury, patient age, severity of symptoms, the desired result for the patient,
and willingness of the patient and surgeon to undertake risky or experimental
procedures. The primary goals are to relieve pain and to replace lost function
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to a level satisfactory to the patient. It is generally desired to achieve an
optimum combination of long-lasting relief from a minimally invasive
procedure, although normally it is not possible to achieve both
simultaneously. Depending on the situation, treatments currently
implemented clinically may focus on one or more of the following: correcting
conditions causing the damage, relieving symptoms, or resurfacing the
articular cartilage.
If acceptable to the patient, a first option is altering the patient's lifestyle in an
effort to relieve the symptoms. However, restriction of activity may be
impossible or undesirable, and invasive treatment may be indicated. In cases
where loose pieces or fibrillated cartilage cause swelling, inflammation, or
locking/catching of the joint, arthroscopy may bring relief. In arthroscopic
surgery, small instruments for removing loose pieces of tissue or shaving the
articular surface are introduced through tiny incisions (=1 cm). Such
minimally invasive surgery is preferable to any procedure which requires
opening of the joint through larger incisions (arthrotomy), typically 4 cm or
more. This method does not repair cartilage defects, but if the injury to the
cartilage is not serious, it may prevent the damage from progressing further. If
there is no damage to the bone, the surgeon will first attempt to bring relief
while keeping the bone intact.
Further intervention may be required due to excessive damage to the joint or
failure of arthroscopy. The primary options in treatment are resurfacing the
damaged area or altering joint loading. When damage is caused by excessive
forces stemming from abnormal joint anatomy, several methods may be used
to alter joint loading, including osteotomy, release of muscles or tendons
pulling abnormally on the joint, or other realignment surgery. These
procedures may either correct the underlying abnormality which has caused
the damage, and/or provide relief to the patient by shifting the load to a non-
damaged area. While this method leaves the joint intact, it may not correct
certain underlying disease processes. Success may be only temporary if the
new joint anatomy is also susceptible to degeneration. Realignment surgery is
often combined with methods of resurfacing.
Methods focused on resurfacing damaged articular cartilage seek either to
regenerate the damaged tissue or to replace it with a different tissue that will
carry enough load to allow the joint to function near normally, at least
temporarily. One set of alternatives deliberately penetrate the subchondral
bone to allow blood and marrow cells to fill the defect and form a reparative
tissue. In drilling, abrasion arthroplasty, and microfracture, only the extent
and nature of the penetration vary. All of these methods may be applied
arthroscopically. Because penetration of the subchondral bone has been found
to increase the incidence of pain and may introduce complications in the bone
[85], the consensus is to use the least invasive procedure. Currently, that
treatment is microfracture, which uses very sharp picks to puncture the
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surface, but leaves most of the bone intact. In microfracture, the defect is
filled through punctate bleeding and infiltration of marrow from the small
pick holes. The result of any of these procedures is a fibrocartilaginous repair
tissue that often provides at least temporary relief to the patient. However,
the long term success is variable and generally not considered satisfactory.
Break down of this tissue may cause more serious joint damage.
Alternatively, autografts or allografts may be used as a source of cells for
cartilage resurfacing. While allografts, especially if frozen, could be made
widely available, they have significant drawbacks due to the possibility of
immunologic rejection and disease transmission. The main drawbacks of
autografts are the need for additional surgical procedures and the limited
supply of donor tissue.
The simplest autograft materials are those in which a bulk piece of tissue
containing chondrogenic cells can be fixed to the defect site. Autologous
perichondrial grafts, isolated from the rib [74, 75, 171], and autologous
periosteal grafts, isolated from the tibia [73, 95, 133], have been used clinically.
Preliminary results with periosteal grafts have been mixed and require more
follow-up [121], while perichondrial grafts have shown a tendency to calcify or
delaminate [21, 121].
One recent technique uses a combination autograft to improve repair:
cultured autologous chondrocytes held in place by an autologous periosteum
cover. In this technique, chondrocytes are obtained from the patient via a
cartilage biopsy, isolated and proliferated in culture, and then returned to the
patient. This procedure has generated a great deal of interest and controversy
since publication in 1994 [22]. While preliminary results have been
encouraging, there has been no controlled trial including treatments of
periosteum alone. Thus, the efficacy of the cell transplantation has been
questioned. An additional question is raised by possible abnormal behavior of
chondrocytes due to possible alterations in the phenotype caused by culturing.
Each of the aforementioned autografts offer the advantage of being useful in
chondral defects or osteochondral defects. These methods can be applied
without causing additional damage to the bone. However, in defects where
there is already significant damage to the bone, the surgeon is more likely to
choose from more invasive techniques.
One choice has been that of osteochondral autografts, or in some cases
allografts [37, 61, 119]. Because autograft tissue can only be taken from the
non-articulating margins of cartilage surface, the size of a lesion to be treated
with an autograft is limited. However, a new technique seeks to extend the use
of osteochondral allograft procedures. In mosaicplasty, instead of one large
graft, small osteochondral cores are spread throughout the defect area, with
the gaps allowed to fill with clot from the underlying bone. Thus, a larger area
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can be resurfaced, and the smaller donor sites can be selected from a greater
range of the cartilage margins.
Ultimately, if all else fails, total joint replacement using metallic and
polymeric implants are performed. This procedure is undesirable due to the
invasive nature of the surgery and the limited lifespan of the implants and
difficulty of revision of the procedure.
1.4 Scope of the present research
The present laboratory and animal research seeks to evaluate the capability of
porous collagen analogs of extracellular matrix to facilitate regeneration of
articular cartilage in vivo. It was not intended to grow cartilage in vitro, but
rather to provide a construct to support in vivo regeneration of the tissue. The
in vivo strategy may have advantages over the in vitro approach because: 1)
the ability of natural biomechanical forces in the joint to influence and guide
regeneration, and 2) integration of the reparative tissue with adjacent
structures is likely to be facilitated and more complete when occurring in
parallel with new tissue synthesis.
In vitro work was used to study cell-matrix interactions in the process of
developing a cell-seeded construct for implantation in an animal model. Due
to the time and expense associated with experimentation with an animal
model, the in vitro work provided rationale for the choice of constructs to be
used in vivo. Certain matrix characteristics were varied in vitro to determine
how certain parameters in the design of the matrix might affect cell behavior.
The results in culture could be correlated with behavior in the animal model
and used to further engineer the material.
The in vivo work, performed in a canine model, was designed to evaluate the
effects of the matrices engineered in vitro on the healing of a specific type of
defect in articular cartilage. The matrix was studied alone and in conjunction
with or comparison to other clinically relevant treatments for cartilage repair.
An important component of the work was to assess the potential for
spontaneous regeneration in this type of lesion, and to ensure that the defect
was beyond the critical size at which healing could be expected to occur
without intervention. The defect chosen was limited to the articular layer
(chondral defect), and therefore resembles only a subset of clinical defects.
The performance of matrices in this type of defect may not reflect their
performance in other types of defects or related applications.
1.4.1. Specific aims
The specific aims of this thesis were to:
1) Synthesize and characterize analogs of extracellular matrix comprised of
both type I and type II collagen
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2) Evaluate in vitro the interaction of matrices and chondrocytes including:
- Developing methods of seeding matrices with chondrocytes
- Evaluating chondrocyte proliferation in matrices
- Evaluating biochemical activity of chondrocytes in matrices
- Engineering implantable chondrocyte-AECM composites
3) Develop an animal model for studying cartilage regeneration including:
- Establishing a well-defined surgical lesion
- Developing methods for quantitative analysis and characterization of
healing in the model
- Characterizing spontaneous healing
- Characterizing healing due to autologous cultured chondrocytes alone
4) Evaluate engineered matrices from (2) in the animal model.
1.4.2 Hypotheses
The following are hypotheses that were synthesized to direct the research in
the process of the achieving the specific aims:
* The chemical composition of a matrix, primarily the predominant collagen
type, will influence cell morphology and synthesis of DNA and
glycosaminoglycan in vitro.
* The pore structure of a matrix, primarily the pore diameter, will influence
cell morphology and synthesis of DNA and glycosaminoglycan in vitro.
* The application of cultured autolgous chondrocytes under a periosteal flap
to a chondral defect of articular cartilage will increase the amounts of
reparative tissue and hyaline cartilage found filling the defect relative to an
untreated control.
* The application of a cultured autolgous chondrocyte-seeded engineered
type II collagen matrix to a chondral defect of articular cartilage will
increase the amounts of reparative tissue and hyaline cartilage found filling
the defect relative to a defect treated with cultured autologous chondrocyte
transplantation.
* Chondrocyte-seeded collagen matrices implanted in chondral defects will
form more reparative tissue and hyaline cartilage than identical treatments
using unseeded matrices.
* The implantation of a porous collagen matrix in a microfracture-treated
chondral defect will increase the amounts of reparative tissue and hyaline
cartilage filling the defect.
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2 Background
2.1 Articular cartilage
2.1.1 Articular cartilage structure and function
Articular cartilage is a load-bearing connective tissue covering the ends of
bones in synovial joints. It has a unique structure which gives rise to its
equally unique mechanical and functional properties. Its main functions
include transmitting loads across the joint and providing a smooth, low
friction surface to facilitate articulation. No other material, natural or
synthetic has been found to reproduce these specialized functions.
Composed predominantly of water (65-80 percent by weight), articular
cartilage is basically avascular, aneural, and alymphatic. Articular cartilage is
also relatively acellular, but the few chondrocytes synthesize and maintain a
complex extracellular matrix. Structural materials in the matrix include
collagens (10-30 wt%) and proteoglycans (5-10 wt%). Chondrocytes account
for less than 5% of the dry weight, and occupy 2 to 10 percent of the tissue
volume. The balance of the tissue consists of numerous non-collagenous
proteins and lipids such as fibronectin, anchorin, cartilage oligomeric matrix
protein (COMP), and chondrocalcin.
Collagens provide the primary three dimensional structure of articular
cartilage, giving the tissue tensile strength. Normal articular cartilage contains
predominantly type II collagen (90%), but also includes small amounts of
types VI, IX, X, and XI collagen. Type II collagen is normally found only
specialized tissues such as hyaline cartilage and the nucleus pulposis of the
intervertebral disc. The collagens are arranged in fibrils and are cross-linked to
each other and entrap the network of proteoglycans. Type IX collagen is
thought to be an important component of cross-linking the type II network.
Type X is found in calcifying regions, type XI within type II fibrils, and type VI
surrounding chondrocytes. The majority of the large proteoglycan molecules
(aggrecan) attach to hyaluronic acid molecules to form proteoglycan
aggregates. A special protein specific to articular cartilage, link protein,
stabilizes this attachment. Each aggrecan molecule consists of a core protein
which is divided into a hyaluronic acid binding region and glycosaminoglycan
(GAG) rich regions. GAGs are linear, negatively charged polysaccharides. The
high density of hydrophilic negative charges on GAGs creates a large swelling
pressure within the cartilage and provides compressive strength. The
predominant GAGs in human articular cartilage are chondroitin 6-sulfate,
keratan 6-sulfate, and chondroitin 4-sulfate.
In the light microscope, chondrocytes appear surrounded by distinct spherical
matrix structures known as lacunae. The extracellular matrix structure varies
with proximity to chondrocytes. In the pericellular region, surrounding the
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chondrocytes, the matrix consists predominantly of proteoglycans, non-
collagenous proteins, and glycoproteins. This matrix provides a means of
cellular attachment to the extracellular matrix as a whole. A territorial matrix
surrounds the pericellular matrix. It consists of thin fibrils and serves to link
the chondrocyte to the main interterritorial matrix. The interterritorial
matrix, as described above, occupies most of the volume in cartilage and is
responsible for the bulk of the mechanical properties of the tissue as a whole.
Articular cartilage is divided into zones based on the horizontal plane level
relative to the smooth surface. Many structural and biochemical
characteristics change from zone to zone including collagen structure,
chondrocyte appearance and metabolism, proteoglycan content, etc. It has
been shown that collagen forms arching leaf-like structures which emanate
from the subchondral bone and bend over when they reach the articular
surface. Thus, the leaves display a different orientation in each zone. The
thin superficial zone found at the articular surface of the cartilage lies furthest
from the bone. In this zone, the collagen leaves are closely packed, oriented
basically parallel to the surface, and consist of a fine mesh. The most
superficial layer is bare of chondrocytes. Deeper in the layer, elongated,
relatively inactive chondrocytes lie parallel to the surface. Since there is very
little hyaluronic acid here, proteoglycan monomers may exist and may react
directly with collagen fibrils. Below the superficial layer lies the intermediate
or transitional zone. This zone provides a bridge to the deep zone and exhibits
larger collagen fibrils and more rounded chondrocytes.
The large region of cartilage adjacent to the subchondral bone includes the
deep zone or radiate zone, the calcified zone, and the tide mark, a distinct line
separating the two zones. The calcified zone consists of a layer of calcified
cartilage attached to the subchondral bone and may contain blood vessels.
Collagen leaves emanate from the calcified zone normal to the joint surface
and stretch vertically through the deep zone. The fibrils are largest in the
deep zone and increased proteoglycan content is also found In addition,
chondrocytes in the deep zone are typically rounded and arranged in vertical
columns.
As mentioned above, cartilage function depends on this specialized structure.
This pattern may be altered either by abnormal changes to the grossly intact
articular structure, or, in the case of removal of large pieces of cartilage,
complete replacement by a very different reparative tissue (see below, 2.1.3).
The resulting tissues can be distinguished from articular cartilage based on
changes in the matrix and cells populating the tissue. Other tissue types
(characteristic of damaged cartilage or reparative responses) include fibrous
tissue, fibrocartilage, or hyaline cartilage. Fibrous tissue consists of fibrous
bundles of type I collagen easily distinguishable through low power light
microscopy and elongated, fibroblastic cells. A fibrocartilaginous tissue would
have characteristics intermediate between fibrous and hyaline tissue. Often
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this appearance includes macroscopically visible collagen fibers interspersed
with chondrocyte-like cells in lacunae. Typically, the end result of cartilage
injury will be described as fibrocartilage, making it the articular cartilage
equivalent of scar tissue in skin. The term hyaline refers to the ground-glass
appearance of cartilage matrix and is generally used to refer to a material that
grossly resembles articular cartilage. However, hyaline tissue may lack certain
elements of the highly specialized articular structure described above, and
therefore must be distinguished.
The relationship between articular cartilage structure and function by
measuring mechanical or electromechanical properties of modified articular
cartilage has been well-studied and reviewed [128]. Experiments have included
studies of cartilage in which damage occurs naturally (as in osteoarthrosis) or
is induced by experimental enzyme treatment or joint destabilization [6, 17,
31, 49, 71, 153, 165], as well as studies of reparative and surrounding tissues in
healing of cartilage defects [7, 92, 117, 131, 154, 188, 195, 196]. It is clear from
this work that altering the collagen and or proteoglycan structure of normal
cartilage will alter its mechanical function.
2.1.2 Mechanisms of injury and disease in articular cartilage
As introduced in section 1.2, articular cartilage can fail when it is subject to
disease or injury. Under normal conditions, chondrocytes are responsible for
maintaining the cartilage structure needed for proper function. Thus, all
injury can be described as the inability of the chondrocytes to maintain the
normal articular cartilage extracellular matrix structure. This may be due to
abnormalities in the chondrocytes themselves (such as genetic abnormalities or
direct damage or death of chondrocytes), or simply the inability of normal
chondrocytes to repair damage to the matrix caused by external factors (such
as repeated mechanical injury or excesses of destructive enzymes). For
example, traumatic injuries may cause irreparable disruption of the matrix or
directly kill chondrocytes. In other cases, the problem may stem from a subtle
imbalance in chemical regulators of the chondrocytes.
2.1.3 Spontaneous healing of articular cartilage
Articular cartilage self-repair depends on the nature of the damage. This
discussion will be limited to the general type of defects studied in this thesis:
one in which a bulk quantity of cartilage tissue is removed, i.e. excisional
injury. The most relevant types include chondral (defects limited to the
thickness of the articular cartilage) and osteochondral defects (those
penetrating the subchondral bone). For these injuries, there is no critical sized
defect, defined as a defect that will spontaneously heal with normal articular
cartilage. This is the consensus of years of clinical observations [27, 111] and
animal experimentation. The majority of scientific work in this area, as
outlined below, has focused on the animal models of repair.
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In a chondral defect, repair is limited due to the avascularity and relative
acellularity in the tissue. Some authors have observed that chondral defects
display minimal healing (i.e. there is little filling with reparative tissue)[33, 42,
57, 59, 107, 125, 152]. In other cases investigators have described some fibrous
tissue or fibrocartilage as the end result of healing [13, 28, 74, 97, 155, 167].
Responses to these defects included cloning of chondrocytes and increased
synthesis of proteoglycans, but chondrocytes appeared trapped by their
extracellular matrix and did not migrate to adjacent regions to enact repair.
While the specific responses observed in chondral defects have varied due to
differences in animal models, surgical procedures, and the extent of the lesion,
there has been a consensus that reparative responses were incapable of fully
regenerating any significant portion of the damaged. There is some evidence
that synovial cells can migrate into the wound to participate in repair, but the
spontaneous effect was minimal [78]. While these lesions do not heal by
regeneration, there remains uncertainty about the clinical consequences, for
example the likelihood of progression to osteoarthrosis [13, 24, 28, 57, 59, 64,
89, 97, 109, 115, 125, 176].
Osteochondral defects, which violate the subchondral bone, introduce a second
repair mechanism. Cells and soluble factors from the bone marrow and
subchondral vessels may infiltrate the defect area and participate in a
reparative process. Unlike chondral defects, defect filling is always observed.
Numerous studies have reported the formation of a fibrous repair tissue during
early stages of healing [3, 4, 26, 38, 58, 60, 79, 82, 88, 89, 116, 124, 131, 146,
152, 161, 168]. Over time, the cells may undergo metaplasia into
chondrocytes, forming a fibrocartilage, and in some cases even a hyaline-like
tissue [38, 125, 152, 167]. However, this hyaline tissue was either a minor
component of healing, or at least could still be distinguished histologically
from normal articular cartilage. In addition, long term results in animal
models have suggested that fibrocartilage is the final product of healing, and
that this tissue may be susceptible to degeneration [125, 168]. The repair
response may vary significantly from animal to animal in a given experiment,
and especially across different models. Injury response may also depend on
defect size [38, 79]. Biochemical and mechanical studies have shown that the
fibrocartilage reparative tissue contains type I collagen [3, 58] and is less stiff
and more permeable than normal cartilage [195].
2.1.4 Summary
The structure and function of articular cartilage are intimately related.
Changes in the specialized structure, from injury or disease, will invariably
affect the mechanical properties of cartilage. The response of articular
cartilage to injury depends on many factors, most notably the type of defect.
For the excisional type defects studied in this thesis, the best controlled
observations of spontaneous healing have been performed in animal models.
It has not been shown that any cartilage defect can fully regenerate. In
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essence, there is no critical sized defect, although the reparative response is
much more effective in defects which penetrate the subchondral plate. Even
so, the reparative response results in a tissue which is easily distinguishable
from normal cartilage. This "scar" of articular cartilage is normally referred to
as fibrocartilage. Any effort to regenerate articular cartilage will have to
improve on the natural response to injury.
2.2 Chondrocyte-matrix interactions
2.2.1 Gross effects of extracellular matrix
It is clear from the literature that the environment of the chondrocyte,
specifically the extracellular matrix, can affect chondrocyte function and
phenotypic expression. Much work has focused on finding environments
which support expression of the chondrocytic phenotype in culture.
When placed in 2-dimensional culture, chondrocytes spread on their plastic
substrate, adopting a stellate or elongated morphology. This shape change
had been correlated with loss of expression of cartilage-specific molecules and
is therefore taken as a sign of loss of chondrocyte phenotype. However, it is
well established that chondrocytes cultured under special conditions regain
their rounded morphology or retain the ability to synthesize chondrocyte-
specific macromolecules. In 2-dimensional culture, conditions of high seeding
density [192, 203] or hydrogel coating of the culture surface [151] have been
found more favorable to chondrocytic expression.
A wide range of 3-dimensional systems have been found to support the
chondrocytic phenotype, including agarose [16, 25, 39, 169] collagen gels [90,
203], alginate [19], many porous or fibrous matrices, both natural and
synthetic [50, 105, 123], and microcarrier beads [56]. The ability of
chondrocytes to express their native phenotype in these and other matrices
has been the basis for current research focused on efforts to induce cartilage
regeneration.
One study of chondrocyte behavior in porous sponge-like matrices has shown
different chondrocyte expression in constructs made of collagen versus a
synthetic polymer [63]. This work was not able to determine the specific
factors which influence the chondrocyte behavior (i.e. chemical vs. physical).
2.2.2 Molecular level interactions
The extracellular matrix likely regulates cell function through two means: 1)
direct cell-matrix interaction, and 2) regulation of other (soluble) factors which
can affect the cells.
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On one hand, the ability of the extracellular matrix to modulate chondrocyte
phenotype and activity can be due to effects of chondrocyte-matrix
interactions through integrins. Recent studies have found at least three
different specific integrins (al13, a2 1, and a 3 1) are involved in chondrocyte
attachment to extracellular matrix [2, 46, 182]. The importance of these
integrins is suggested by a study showing integrin dependence of chondrocyte
shape and proliferation [47]. Alternatively, the extracellular matrix may affect
cells indirectly, through interaction with growth factors. The ability of the
matrix to bind and modulate growth factors has been studied in many systems
such as wound healing [113] and angiogenesis [81], however little work has
been performed to determine growth factor binding effects in chondrocyte
culture. One recent study showed that the collagen type of the extracellular
matrix was able to modulate chondrocyte response to one growth factor, TGF-
p1 [149]. Thus, while more work is needed to extend this knowledge to the
many other chondrocyte-matrix-growth factor systems of interest, it is clear
that the growth factor-binding properties of the matrix can exert considerable
influence over chondrocyte behavior.
2.2.3 Matrix contraction
One phenomena that is reflective of cell-matrix interactions is matrix
contraction. Several investigators have studied the ability of the extracellular
matrix to regulate cell contraction of that matrix [44, 66, 162]. If it occurs in
vivo, chondrocyte contraction of the matrix in which it is seeded has the
potential to affect the performance of the construct as an implant: 1) by
reducing the pore diameter and thus impairing cell proliferation and
migration; 2) by reducing the volume that the implant occupies in the defect;
and 3) by separating the implant from the adjacent tissue, thus impairing
integration of the newly forming reparative tissue.
2.2.4 Summary
Natural or artificial extracellular matrix can affect cellular function of most
cell types, including chondrocytes. Matrix components have been found to
regulate chondrocyte interactions with growth factors, integrin expression,
biosynthetic activity, morphology, and contractile properties. Attempts to
regenerate articular cartilage need consider the influence of a synthesized or
engineered matrix on this behavior.
2.3 Collagen-GAG analogs of extracellular matrix
2.3.1 Introduction
Collagen is one of the most versatile materials that can be used as a
biodegradable, implantable matrix material. It can be used in several forms,
including gelatin, gels or lattices, and sponges or scaffolds. Gelatin refers to the
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naturally occurring form of collagen consisting of randomly coiled individual
chains. Gels or lattices are hydrated networks of small fibrils (banded bundles
of collagen 50-500 nm in diameter) with interfiber spaces of "pores" of 1-10
jim. Sponges or scaffolds are made of large sheets or fibers of collagen with
pores from 5 to over 500 jim. The walls may be of varying thickness (on the
order of 10 Lm, and may display either banded or unbanded collagen
structure. A porous collagen-GAG cross-linked copolymer has not yet been
used in articular cartilage experimentation. Because it has been studied in
depth for other regenerative purposes, its effects in an articular cartilage model
would be of great interest. In addition, the above findings of differential effects
of collagen type on cell behavior suggest that culture of chondrocytes in
collagen-GAG matrices composed predominantly of different collagen types
would be of interest in searching for an optimal method of facilitating
regeneration.
2.3.2 Method of fabrication
In general, porous materials can be produced by a variety of methods
including woven or non-woven structures formed from fibers, polymerization
in the presence of sacrificial particles or other insoluble phase of solution, or
through a freeze-drying process. The method of freeze-drying, which involves
forming of a slurry of a predominantly hydrous solution, freezing to form ice
crystals, and lyophilization of the ice phase under vacuum has been used with
collagen materials. The structure of the pores of the collagen sponge are
negative replicas of the ice crystals formed in the freezing process. Thus, the
principles of heat transfer may be applied to alter the formation of the solid
phase, and thus, indirectly, the pore structure achieved.
2.3.3 Cross-linking of collagen matrices
Several methods are available for cross-linking collagen. The effect of cross-
linking can be to improve mechanical properties, decrease the rate of
degradation, or even to reduce antigenicity [187, 194]. Techniques include
dehydrothermal treatment, ultraviolet and gamma radiation, and chemical
cross-linking. All of these methods can offer the additional advantage of
sterilization of the collagen material during the course of treatment. Each
method introduces interchain bonds into the collagen structure through a
different mechanism. Dehydrothermal treatment removes water form the
environment of the matrix, thereby inducing condensation reactions between
neighboring amino acid residues-- likely carboxyl and amino groups [193, 198].
There will be a theoretical limit to the cross-linking induced by this method
based on the chemical makeup of the amino acid residues. Ultraviolet
radiation creates free radicals on adjacent collagen fibers (most likely aromatic
amino acid residues such as tyrosine and phenylalanine [193], which then
combine to form a covalent crosslink. There are several chemical methods of
cross-linking collagen, usually based on bifunctional compounds which can
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react with amino acid side chains on neighboring collagen fibers [68, 194].
Some commonly used chemical cross-linking agents include glutaraldehyde (or
other aldehydes), diamines, diisocyanates, imidoesters, and carbodiimides [68,
87, 194]. A potential disadvantage to this method is hydrolysis of the
chemical into toxic byproducts. Finally, ethanol, which is often used as a
tissue fixative, was used as a pre-wetting and sterilization agent in this work.
Previous work has noted less shrinkage in collagen matrices treated with
ethanol versus aqueous solutions, suggesting a slight cross-linking effect [41].
However, the effect of ethanol as a cross-linking agent on the collagen
biomaterials used in this work is unknown.
For this work, cross-linking was used primarily as a means to control the rate of
degradation of the matrix and mechanical properties after periods in culture.
It was desired that the matrices remain intact throughout in vitro experiments
to allow proper assays. In addition, it was desired that constructs seeded in
vitro and transplanted to an animal model be easily handled by the surgeon.
2.3.4 Previous use in tissue engineering
The use of collagen-GAG copolymer matrices to regenerate articular cartilage
follows logically from previous work using engineered collagen-based materials
in hard and soft tissue regeneration or repair. Collagen-GAG matrices were first
used by Yannas in 1977 to facilitate regeneration of skin in guinea pigs and
subsequently humans [199]. These matrices were formed from a homogenized
acetic acid solution of reconstituted bovine type I collagen and chondroitin 6-
sulfate (isolated from shark) by various freeze-drying methods. The GAGs and
collagen were cross-linked by a combination of vacuum drying treatment and
soaking in acidic glutaraldehyde solution to provide mechanical strength and
to prevent the elution of GAGs in vivo.
Attention was paid to engineering the copolymers for optimum regenerative
capabilities. Variation of cross-linking technique controlled the degradation
rate of the material in vivo [200, 201]. Pore characteristics (percent porosity,
pore size, and pore orientation) were controlled by varying the freeze-drying
techniques [41]. These effects were studied in depth, and it was found that a
limited range of pore characteristics and degradation rates provided optimum
activity in delaying wound contraction of skin lesions [202]. It was later found
that seeding of the matrices with cultured cells could improve the performance
of the construct by arresting contraction and supporting the regeneration of
dermis instead of formation of scar [199]. Finally, it was more recently
suggested that the chemical composition of the matrix, specifically the nature
of the GAG component, may affect the biological activity of the construct
[166].
In subsequent work, similar materials were used to treat peripheral nerve
defects. These experiments found that different parameters were required in
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engineering matrices appropriate for nerve regeneration [29, 30]. Optimally
regenerated nerve resulted from implants with smaller pore sizes (5-10g versus
20-125g for skin) and quicker degradation rates (180 assay units versus less
than 140 assay units for skin). In addition, it was found that nerve grafts
performed better with the pores oriented axially along the length of the severed
nerve. Presently, collagen-GAG copolymers are being investigated in treating
spinal cord, tendon, and ligament defects.
Stone has investigated the use of collagen-GAG copolymers in meniscus
regeneration in pig and dog models [173, 174]. Using the same basic sources of
material and synthesis procedures as Yannas, he included dermatan sulfate
and hyaluronic acid in the copolymer. In vitro experiments indicated that the
matrix could be seeded with chemotactic factors, specifically fibronectin, to
improve cell migration through the matrix in culture. Stone reported that the
matrix did not impair meniscal healing in the pig, and may have improved
healing in the dog. Meniscus differs from articular cartilage in that it is a
fibrocartilage and contains areas of vasculature, thus improving its self
regenerative capabilities. Although Stone mentions the possibility of
optimizing his matrix through control of pore characteristics, degradation rate,
he reports no experiments where he actually changes matrix characteristics.
Recently, this technique has been introduced into the clinic in ongoing human
trials [175].
2.3.5 Summary
The history of the use of collagen-GAG copolymers has demonstrated success in
tissue engineering of several different tissue types. The chemical and physical
properties of the matrix have proven to be important variables in optimizing
regeneration. Because the nature of cell-matrix interactions are cell- and
tissue- specific, a construct designed to facilitate articular cartilage
regeneration will likely have different properties from those used in other
tissues. Specifically, based on results in skin and nerve, pore size is expected to
be an important variable. In addition, because the natural collagen type of
articular cartilage differs from that in skin and nerve, the nature of the
collagen component of the matrix is likely to be important. Finally, because
of the limited reparative response inherent in cartilage, it is anticipated that
addition of an exogenous cell source to the matrix may improve its activity as
it does in skin.
2.4 Animal models of cartilage injury
2.4.1 Animal species
Studies of healing of cartilage defects have been carried out in many animal
models. Specifically, work in regeneration has utilized rooster, rabbit, and dog
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models as well as clinical trials on humans. The most common animal model,
the rabbit, however, has several problems. First, the rabbit knee experiences
considerably different loading and stresses on the articulating surface
compared to a human knee. In addition the defect depth is limited by the
thickness of the articular cartilage in the rabbit knee joint (generally 0.5 mm
or less). The thicker articular cartilage layer (approximately 0.5 to 1.0 mm) in
the dog improves this condition, and the activity level and loading more
closely resemble human conditions.
2.4.2 Animal age
Healing may be affected by animal age, as studies performed in adolescent
species have reported very good healing compared to other studies [26, 89].
While it has been known for many years that chondrocyte response to injury
may be age dependent [108] only recently has a study conclusively shown age
dependent differences in repair in the rabbit [195]. Because a treatment
modality that would work only in young patients (prior to skeletal maturity)
would be very limited in applications, adult models are generally preferred to
provide more clinically applicable tests of efficacy.
2.4.3 Defect depth
Although there is no critical defect size in articular cartilage for regeneration
(section 2.4.4), the depth of a defect determines the process of repair. In
intact cartilage, the calcified layer prevents direct transfer of large molecules
between bone and cartilage. Thus, it is convenient to classify defects as either
limited to the non-calcified articular layers (chondral defects) or penetrating
to the subchondral bone (osteochondral defects). It is unclear in the adult
whether defects extending into, but not through the calcified cartilage should
be considered chondral or osteochondral. The vascular supply to the calcified
layer is extremely limited or absent in the adult, thus penetration into the
calcified cartilage may bring no visible response. However, if vessels are
penetrated, communication extends to the subchondral bone, albeit on a
much smaller scale than occurs with fracture or intentional drilling into bone.
The terminology used for defects in this work is depicted in Figure 2-1.
The filling of osteochondral defects was discussed in section 2.1.3. In fact, this
filling by reparative tissue is the aim of clinical treatments designed to
stimulate repair by access to the subchondral bone (section 1.3). It is
important to note that the violation of the bone requires the additional step of
bone reformation for full resolution of this healing process.
In contrast, it is generally agreed that in chondral defects, i.e. those limited to
the articular layers, the reparative response is weak in that little or no
reparative tissue fills the defect (section 2.1.3). In the context of the present
work, it is instructive to consider differences among chondral defects. For
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Figure 2.1. Schematic of types of defects in articular cartilage
CC = calcified cartilage, AC = articular cartilage.
example, a single laceration will heal differently than an injury where a bulk
amount of cartilage is removed (such as shaving). Some articles suggest
differences in responses to chondral lesions of different depths. This should
not be surprising due to the depth-dependent nature of chondrocyte and
matrix properties in the cartilage. Each type of defect may have different
clinical significance.
The use of a "full-thickness" chondral defect, one made through all non-
calcified layers of articular cartilage, reaching to, but not through the
tidemark, is a new development [22, 23, 64]. No study has reported on the
initial appearance of these defects (immediately after creation), and the
natural course healing of these defects is not well established. Grande reported
on only 5 defects at 6 weeks, and Brittberg reported on only 6 defects at 12
weeks, both in a rabbit model. However, there are several important
differences between this type of defect and more superficial defects, most
notably the exposed basal surface to which reparative tissue must bind (the
calcified cartilage vs. articular cartilage), and the mechanical force
environment to which reparative tissue will be exposed, which will depend on
defect geometry, location in the joint, the nature of joint loading, and the
hardness of underlying surface. It is also possible that the proximity to the
subchondral bone may also expose full-thickness chondral defects to a different
chemical environment when compared to more superficial defects, however
little is known about chemical communication through the calcified cartilage.
2.4.4 Critical size defect
It is generally accepted that for any adult species, there is no critical size
chondral defect in articular cartilage, i.e. that even a slight defect (e.g. an
incision) will not heal if the defect is wholly contained within the articular
cartilage layers. Studies have shown that even a scalpel incision, in which no
material is moved will not fully heal [27, 33, 115]. As discussed above, the
response to deeper defects will include formation of reparative tissue usually
described as fibrocartilaginous in nature. Because this material is clearly not
articular cartilage, it is considered reparative or scar-like tissue, not
regenerated cartilage. Thus, the absence of a critical size defect also applies to
osteochondral defects (at least in adults).
2.4.5 Methods of evaluation
There are three primary methods for evaluation of the outcome of healing
cartilage in an animal model: histology, biochemistry, and mechanical
properties. Interestingly, none of these match the criteria used to evaluate
success clinically: pain relief, then function. Other clinical assessments which
can be made through arthroscopic procedure include viewing or probing the
surface, however, these results do not always correlate with patient symptoms,
and thus are not used as reliable indicators of the success of healing.
In experimental work, most authors use histological methods of evaluating
cartilage repair. This allows evaluation of many important factors in the
reparative process: the types of tissues filling the defect (including both cell
and extracellular matrix characteristics), attachment to adjacent structures
(cartilage, calcified cartilage, or bone), and the health of the adjacent tissues.
The method of staining may also be useful in eliciting biochemical
information. For example several staining methods are specific to sulfated
glycosaminoglycans (safranin 0, alcian blue), while immunohistochemical
stains can be used to demonstrate collagen type and cartilage specific proteins.
Finally, histology can reveal structural information, primarily collagen
organization, which may give a general idea of the functionality of the
reparative tissue.
A semi-quantitative schema for assessing the degree of degradation of articular
cartilage- the Mankin scale [112]- has recently been adapted to provide
quantitative assessment of the success of cartilage healing in reparative
procedures [12, 140, 146, 189]. However, this approach must be exercised with
caution. The use of an ordinal semi-quantitative scale precludes accurate use
of parametric statistics. Still, in many studies the ordinal data are used as
parametric input for the reporting of statistical comparisons [12, 54]. The
meaning of these statistics should be considered only approximate.
Furthermore, often a composite score of many categories is reported and used
for comparison between groups. This comparison is therefore made under the
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assumption that the highest score possible in each category accurately reflects
its relative importance in healing. This is most certainly not the case, as the
"importance" in healing is at this time at best a subjective judgment of the
experimenter.
Other methods of analysis are more specialized and may complement
histological analysis. The measurement of mechanical properties on
reparative tissue may indicate the degree to which the tissue functionally
replaces normal cartilage. The major variables examined include modulus
and permeability. Biochemical analysis is normally focused on synthesis of
the major components of the cartilage extracellular matrix: collagen and
proteoglycans. Several studies have measured the relative amounts of collagen
types I and II formed in reparative tissue. Both of these methods have been
limited in use in part due to the destructive nature of the typical ex vivo
testing procedures which prevents histological analysis of the same tissue.
It would be desirable to have information from all of these outcomes, however,
practical limitations of the research area, including the limited size of defects
and expense of animal models, often makes this impossible. For a preliminary
investigation of healing, histology provides the widest range of information
and is widely accepted. Mechanical and biochemical evaluations are more
appropriate for more specialized follow-up studies. Improvements of
technology in mechanical testing, including recently developed non-
destructive probes which may be used in situ [18, 132] promise to expand the
use of mechanical testing in analysis of cartilage repair
2.4.6 Summary
Many types of defects are available for studying cartilage healing. In this work
we chose a dog model for reasons of cartilage thickness, accessibility of the
surgical site, reproducibility of the lesion, animal activity, and loading of the
joint. An adult animal was used to reflect the challenge of repair most often
seen clinically. A specific lesion was chosen extending to, but not through the
calcified cartilage. This type of lesion mimics situations that are often the
direct result of injury or logical steps in minimally invasive repair procedures.
While this defect is the subject of recent research and clinical procedures, no
comprehensive studies have described its initial histological appearance or the
natural course of healing. Based on extensive work with both more superficial
and deeper defects, there is critical sized defect in articular cartilage. In this
work we sought to employ a quantitative method of evaluating the tissue types
comprising the reparative tissue based on histological and
immunohistochemical criteria.
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2.5 Experimental methods of facilitating articular cartilage
regeneration
In general, efforts to regenerate tissues focus on manipulation of the three
pillars of tissue engineering: cells, matrices, and soluble regulators. While this
work focuses only on cells and matrices, the use of growth factors will be
discussed briefly. In addition, as this work attempts to regenerate cartilage in
vivo (as opposed to in vitro), this review will concentrate on in vivo
techniques.
Several novel methods are under development in an attempt to regenerate
articular cartilage, some of which have reached clinical trials and have been
discussed in section 1.3. The majority of these approaches may include one or
more of the following techniques:
1) Inducing existing chondrocytes to more actively repair the defect
through enhanced proliferation, migration, and synthesis, often through
application of soluble regulators (i.e. cytokines or growth factors).
2) Providing a new population of cells to express chondrocytic phenotype
to synthesize new cartilage. This source may be an autogenous or
allogeneic tissue graft, or cells manipulated in culture.
3) Providing a matrix, carrier, or support for cells to facilitate or direct
synthesis of new cartilage.
A final factor to consider in treating a defect in articular cartilage is the post
procedural motion and loading to which the joint will be subjected. Before or
after injury, there is clearly an acceptable range of loading and motion outside
of which cartilage begins to degrade. No loading at all can lead to joint
degeneration [160] (a sort of atrophy), while excessive loading can create
pathology in the cartilage and underlying bone [150]. A series of studies in
animal models have demonstrated the ability of controlled motion to improve
the reparative process in certain defect types subjected to certain treatments
[127, 136, 138, 140, 141, 161]. While not the subject of this work, the
postoperative loading should be investigated in any model of cartilage repair.
2.5.1 Cells with chondrogenic potential/autologous tissue
Several different types of adult cells maintain chondrogenic potential. The
discussion of clinical repair techniques revealed that sources may include bone
marrow, perichondrium, periosteum, or articular cartilage. Although these
cells may normally express different phenotypes in situ, they share a common
mesenchymal lineage and under the appropriate conditions may express the
chondrogenic phenotype. Since there have been few clinical trials with
techniques using several of these sources and there is limited opportunity for
follow-up evaluation in humans, research has proved useful in evaluating the
efficacy of such procedures. In general, these cells may be used as part of a
tissue implant (as with periosteum and perichondrium) or the cells may be
34
isolated and transplanted by a variety of methods. Cells which have been
successfully isolated and transplanted into cartilage defects include articular
chondrocytes, mesenchymal stem cells from bone marrow, and
perichondrocytes.
In early work in cartilage repair, several investigators attempted to transplant
cells, predominantly chondrocytes, directly into cartilage lesions. These
studies included both allografts and autografts [14, 15, 32, 65]. This technique
could only be applied to deep defects, as there was no method of fixing the
cells in a shallow defect without clot forming from the subchondral bone.
Results were in general poor. One study suggested that healing was more
successful when the cells were not completely separated from their matrix [14].
Thus the presence of matrix may be important in providing support for the
cells.
The method of autologous cell transplantation under periosteum is of special
significance to this thesis. Two animal experiments have been performed using
this technique, both in the rabbit [23, 64]. In these studies, the cell treatment
was judged to have a positive effect on healing of chondral defects including
increased amount of reparative tissue and improved quality and durability of
this tissue.
The use of periosteal or perichondrial grafts has been recently extended in
animal models to investigate the use of techniques such as postoperative
treatment (such as continuous passive motion) [127, 141, 157, 159] or in
combination with growth factors [77, 137]. In some studies in osteochondral
defects, these techniques have successfully induced more hyaline-like tissue
than controls, although this repair tissue does not duplicate normal articular
cartilage. Thus, the long term behavior of this repair tissue is in question. In
addition, this technique has the drawback of either requiring an additional
operation on the patient for an autograft, or overcoming immunological
reactions when performed with donor tissue.
2.5.2 Use of matrices for articular cartilage repair
Matrices may function either as insoluble regulators of cell function (section
2.2) or simply as delivery vehicles or a supporting structure for cell migration
or synthesis. Numerous matrices made of either natural (Table 2-1) or
synthetic (Table 2-2) components have been investigated for use in cartilage
repair. Many experimenters have included exogenous cells or growth factors to
further facilitate the reparative process. Natural matrices are made from
processed or reconstituted tissue components (such as collagens and GAGs).
Because they mimic the structures ordinarily responsible for the reciprocal
interaction between cells and their environment, they may serve as regulators
with minimal modification. They are generally biocompatible and, because
they are ordinarily remodeled in the body, also biodegradable. The ability to
35
Matrix cells animal defect type (s) author
natural matrices
ECM, fibrin chondrocytes rooster osteochondral Itay 87 [83]
ECM, hyaluronic acid chondrocytes rooster osteochondral Robinson 90 [155]
collagen none rabbit osteochondral Speer 79 [172]
collagen and gel chondrocytes rabbit osteochondral Grande 93 [62]
collagen bilayer chondrocytes rabbit osteochondral Frenkel 97 [54]
collagen chondrocytes rabbit osteochondral Ben-Yishay 95 [12]
collagen none rabbit osteochondral Sellers 97 [164]
collagen gel chondrocytes rabbit osteochondral Wakitani 89 [190]
collagen gel mesench. stem rabbit osteochondral Wakitani 94 [189]
collagen gel periosteal rabbit osteochondral Wakitani 94 [189]
collagen gel mesench. stem rabbit osteochondral Mochizuki 96 [126]
collagen gel chondrocytes rat osteochondral Noguchi 94 [135]
collagen-TCP none rabbit osteochondral Hogervorst 92 [72]
fibrin chondrocyte horse osteochondral Hendrickson 94 [70]
fibrin none dog osteochondral Paletta 92 [145]
Table 2-1. Summary of natural matrices used to facilitate articular cartilage
repair in vivo
synthetic matrices
non-resorbable
poly vinyl alcohol none rabbit osteochondral Speer 79 [172]
Silicone none rabbit osteochondral Engkvist 82 [45]
PTFE none rabbit osteochondral Hanff 90 [67]
PTFE (/polyurethane) none rabbit osteochondral Messner 93, 94 [117,
118]
Dacron none rabbit osteochondral Messner 93, 94 [117,
118]
carbon fiber none rabbit osteochondral Minns 82 [123]
carbon fiber none human osteochondral Minns 90 [122]
carbon fiber chondrocytes rabbit osteochondral Hemmen 91 [69]
carbon fiber chondrocytes rabbit chondral Brittberg 96 [23]
carbon fiber mesench. stem rabbit osteochondral Robinson 93 [154]
resorbable
poly-glycolic acid (PGA) chondrocytes rabbit osteochondral Freed 94 [52]
PGA chondrocytes rabbit osteochondral Vacanti 94 [184]
polyurethane none dog/rabbit osteochondral Klompmaker 92 [93]
poly-lactide-caprolactone none dog osteochondral Klompmaker 92 [93]
poly-lactic acid (PLA) perichondrial rabbit osteochondral Chu 95 [35]
poly-lactic acid (PLA) none rabbit osteochondral von Schroeder 91 [188]
poly HEMA none rabbit osteochondral Kon 81 [94]
Table 2-2. Summary
repair in vivo
of synthetic matrices used to facilitate articular cartilage
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remodel an implanted material is a prerequisite for regeneration. An
important subset of materials in this category are those made predominantly
from collagen, the main structural component in cartilage.
Synthetic matrices are made predominantly of polymeric materials, and offer
the advantage of a virtually unlimited range of carefully defined chemical
compositions and structural arrangements. It is important to distinguish the
subset of synthetic matrices that are not degradable. While the non-
degradable subset may aid in repair, they will never be replaced by remodeling
and therefore cannot be used to fully regenerate articular cartilage. It is also
undesirable to leave foreign materials permanently in a joint due to the
problems associated with generation of wear particles, thus only degradable
materials would be suggested for work in regeneration. Degradable synthetic
matrices can be engineered to control the rate of degradation. However,
because synthetic implants are made from non-native materials, it must be
shown that they degrade safely, without the evolution of toxic byproducts.
It is important to note that only one of these studies has examined the use of a
matrix in a chondral defect [23], and no degradable matrices have been used
in this system. The use of a carbon fiber matrix to transplant cultured
autolgous chondrocytes was compared to the clinical method of implanting
the cells under periosteum. In this study of healing of defects in the rabbit,
the matrix was found to slightly improve the amount of reparative tissue and
its histologic score at 12 weeks when compared to control treatments without
matrix. These trends held for the use of periosteum alone, and for periosteum
in combination with CAC. However, at one year, the carbon fiber group had
the same amount of reparative tissue with slightly inferior histolgical
appearance.
In work with deeper defects, matrices including porous sponges and gels, have
had varying effects on healing. Cell-seeded matrices had much greater effects
than unseeded matrices. Virtually every study including cell-seeded matrices
(sponges or gels) with unseeded matrix controls found some positive effect of
the cell seeding with regard to histological, biochemical, or mechanical
properties of reparative tissue. However, the magnitude of the effects varied
significantly from study to study. The use of chondrocytes from younger
animals was very effective [12, 83, 145, 154]. Due to the differences in the
models and techniques used, it is difficult to compare the effect of various
matrices and cell types among these studies.
In general, unseeded matrices or gels were less successful than seeded matrices.
Some studies found that porous matrices (some natural, some synthetic)
increased either the amount or maturity of cartilaginous reparative tissue [52,
54, 67, 93, 145, 172]. Two studies of collagen implants reached different
conclusions about the ability of such a material to improve the healing of bone
underlying the defect [164, 172]. Other experiments, however, found no effect
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from matrix or gel implantation [12, 72, 190], or they were deemed
unsuccessful [94, 135]. In general, gels have only been used as delivery vehicles
for cells, thus there is limited reporting of "gels alone," reflecting controls for
cell-seeded experiments.
Even fewer studies have investigated the effects of matrix parameters such as
chemical composition or pore structure by direct comparison in vivo. Speer
found a collagen implant preferable to one of polyvinyl alcohol [172], while
Messner found a porous Dacron implant slightly preferable to one of PTFE [117,
118]. In dogs and rabbits, Klompmaker found no effect of synthetic polymer
composition or pore size [93]. All of these studies used osteochondral defects.
In summary, it is clear that a wide range of materials are appropriate for
implantation due to the positive effects on healing, however, much more work
needs to be done. While the chemical and physical properties of the matrix
are recognized as important determinants in cell-matrix interactions, the
literature indicates very limited work aimed at optimizing the physical and
chemical properties of collagen-based materials for articular cartilage repair.
Several of the studies with collagen and non-collagenous materials have
addressed the idea that the implant structure may be optimized by changes in
physical or chemical properties, however, no study has yet conclusively
demonstrated optimized healing in articular cartilage. While using cell grafts
in conjunction with matrices raises such issues as immunogenicity (for
allogeneic sources) and donor site morbidity (for autologous sources), cell-
seeded matrices have been widely studied and appear to hold great promise.
In addition, there is especially a need to perform experiments in models other
than osteochondral, as this has not been addressed in the literature.
2.5.3 Growth factors
Recently, many authors have investigated the use of growth factors, cytokines,
and other small molecules to enhance the reparative response in the healing of
cartilage defects. Although not the subject of this thesis, this relatively new
approach holds great potential for improving cartilage regeneration. Growth
factors are well-known to affect basic cell processes such as proliferation,
attachment, migration, and synthesis. The effects on cartilage have been
extensively reviewed [106, 110, 179]. Originally, work with growth factors
focused primarily on the ability to affect chondrocytes or cartilage explants in
culture [10, 20, 34, 55, 76, 99, 100, 104, 142, 144, 156, 158, 178, 185]. More
recently, the effect of growth factors on healing of cartilage lesions in animal
models has been studied. Growth factors have been delivered by collagen
sponge [12, 164], fibrinogen [78], and by injection and periosteum [77]. These
experiments concluded that the growth factors used, namely bone
morphogenetic protein-2, transforming growth factor-beta, and fibroblast
growth factor, produced significant effects in healing. As the cell-matrix-growth
factor line of experimentation is likely to be pursued further, the ability of
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matrices, such as the one developed in this thesis, to act as delivery vehicles
will become an important focus of research.
2.5.4 Summary
Where it was once thought that articular cartilage could heal only with fibrous
repair tissue, recent evidence has suggested that methods of tissue engineering,
including cells, matrices, and/or growth factors, may be capable of facilitating
regeneration, or at least improving healing. Several different cell sources
(marrow and periosteal stem cells, perichondrocytes, and chondrocytes) have
been shown to express cartilage-like phenotypes in culture or in treatment of
animals or humans. Controlling the expression and behavior of these cells is
the key to regenerating articular cartilage. For tissue grafts, the primary means
of influencing cell behaviors are mechanical forces and soluble factors. For
isolated or cultured cells, however, an additional important component of
controlling cell behavior is the matrix in which it resides.
Several attempts have been made to use porous matrices to study articular
repair. Some porous implants have been shown to improve repair relative to
untreated defects. However, over a wide range of experimental systems, much
better results were achieved by adding a source of cells to the matrix. Despite
the known importance of matrices as cell regulators, little attention has been
paid to optimizing and controlling the physical and chemical characteristics
of the matrices. Results of studies which did alter the engineering of matrices
are inconclusive. Furthermore, no work has been reported in using the novel
chemistry of a collagen-GAG copolymer to treat articular cartilage defects.
Thus, there is a need to study the use of collagen-GAG porous copolymer
implants for use in regenerating articular cartilage.
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3. Experimental Design
3.1 In vitro experiments
This set of experiments was designed to meet specific aims #1 and #2 of the
thesis: to determine if the chemical composition or pore size of the matrix
would affect chondroctye behavior in vitro. First, analogs of extracellular
matrix composed predominantly of either type I or type II collagen were
synthesized and characterized. Subsequently the interaction of chondrocytes
with these matrices was studied under varying conditions of matrix chemical
composition, cross-linking treatment, seeding density, and pore size. The
outcome variables included chondrocyte morphology, proliferation,
biosynthetic activity, and the ability of the chondrocytes to contract the
matrix. The results of these experiments were used to guide and interpret in
vivo experiments.
3.1.1 Effects of seeding parameters
Numerous pilot experiments were performed to assess the efficacy of various
methods for seeding matrices with chondrocytes, as measured by the retention
of chondrocytes in the matrix after the seeding process. The predominant
outcome variable was the amount of DNA in the seeded constructs after 2-3
hours, but before adding medium. As it was anticipated that a percentage of
cells would be lost through initial medium addition, one experiment
investigated this effect. Unseeded constructs were measured and subtracted
from totals so the effect of only the cells added was measured. In most
groups, n = 4 matrices were used. The specific designs of each component
experiment is found in section 4.2.1.3.2.
3.1.2 Culture of chondrocytes in matrices of different chemical composition
In this experiment two matrices with similar pore characteristics but made of
different chemical components were used as substrates for chondrocyte culture.
The objective was to determine the effect of the chemical composition of the
matrix on chondrocyte morphology, proliferation, and the amount of
glycosaminoglycans synthesized and retained in the matrix. Matrices made
predominantly of type I collagen (from now on referred to as "Type I" matrices)
and type II collagen (from now on referred to as "Type II" matrices) were
obtained or produced as described in section 4.1. Type I matrices for this
experiment were made of bovine tendon collagen and were dehydrothermally
cross-linked, while type II matrices were UV cross-linked for 8 hours (section
4.1.1.3).
Forty-two samples, 4 mm in diameter by 2 mm thick (cored from sheets) were
used, including 18 of type I collagen and 18 of type II collagen, for simultaneous
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cell seeding, and 3 sponges of each material as unseeded controls (Table 3-1).
Six type I and six type II matrices were terminated at each of the three time
points: 3 hours (before addition to medium), 7 days and 14 days. Three of the
seeded matrices at each time point were allocated for histology and three
seeded specimens for biochemical assays. Histological analysis included
histology, immunohistochemistry for types I and II collagen, and morphological
analysis of cell shape (section 4.2.3). Biochemical analysis included
measurement of dry weight, and GAG and DNA analysis (section 4.2.2). One
unseeded matrix was assayed at each time point: three hours, 1 week, and 2
weeks.
seeded matrices unseeded
time matrix histology biochemistry biochemistry
3 hours type I 3 3 1
type II 3 3 1
7 days type I 3 3 1
type II 3 3 1
14 days type I 3 3 1
type II 3 3 1
Table 3-1. Number of matrices evaluated in comparison of matrices of varying
chemical composition
Cells were also seeded in agarose (Seaplaque GTG, FMC Bioproducts, Rockland,
ME) and in 25 cm 2 -flasks to show expression of phenotype in an inert hydrogel
and in monolayer culture.
3.1.3 Effect of cross-linking treatment and cell seeding density
To produce matrices of varying cross-linking, matrices made predominantly of
type II collagen were dehydrothermally cross-linked from 0 to 4 days (section
4.1.1.3). In addition, several samples were UV cross-linked for 12 hours. A
pilot study was first run to 2 weeks, then a long term study was performed.
Pilot study. It was desired to see if the length of dehydrothermal treatment
altered the ability to handle constructs or the proliferation of chondrocytes in
type II matrices in culture up to two weeks. Five groups of matrices,
dehydrothermally cross-linked 0, 1, 2, 3, or 4 days, were used. For each of three
time points (3 hours, 1 week, and 2 weeks), 4 seeded and 4 unseeded samples
were prepared for each cross-linking treatment, making a total of 120 9-mm
cores. Seeding was carried out simultaneously on all groups. At the
termination times (3 hours, 1 week, and 2 weeks), the 4 seeded and 4 unseeded
samples were bisected with a scalpel and the halves processed separately for
histology and DNA assay.
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Long-term study. This study was designed to determine, if 1) the degree of
cross-linking, or 2) the seeding density of chondrocyte-seeded type II matrices
would affect the ability to handle the constructs or chondrocyte proliferative
activity or the amount of GAG retained in the matrix up to 6 weeks in culture.
Three groups of Chondrocell type II matrices were used for this study:
dehydrothermally cross-linked for 1 day and 4 days, and UV cross-linked for 12
hours. 9-mm discs were cored from larger pieces. A total of 72 cores were
used. Samples were allocated to each of three time points: 1 day, 4 weeks,
and 6 weeks. Samples were grouped into one of three seeding categories:
unseeded, high seeding density (3.2 million cells/core), or low seeding density
(1.6 million cells/core). Only 12 UV-cross-linked samples were available, and
therefore were used only for the 6 week time period. Samples were allocated
for biochemical analysis (GAG and DNA assays, Table 3-2) or for histology. For
each cross-linking treatment, seeding condition, and time for which
biochemistry was performed, one additional sample was obtained for histology.
cross-linking
time cell seeding 1 day DHT 4 day DHT UV
high dens. 1 2
1 day low dens. 2 1
unseeded 3 3
high dens. 3 3
4 weeks low dens. 3 3
unseeded 3 3
high dens. 3 3 3
6 weeks low dens. 3 3 3
unseeded 3 3 3
Table 3-2. Number of seeded samples allocated for biochemistry in culture of
matrices with varying degree of cross-linking and seeding density. Also, 1
sample was allocated for histology in each group.
3.1.4 Effect of matrix pore diameter
Pore diameter effects were studied in two different types of matrices: type I
collagen GAG matrices and type II matrices, both produced in our laboratory
(section 4.1.1). The goal was to determine if the pore diameter of the matrix
affected the seeding of the matrix, the phenotypic behavior of chondrocyte,
and the resultant construct after various times in culture.
3.1.4.1 Effect of pore diameter on chondrocytes in type I matrices
This study sought to determine whether the pore diameter of cell-seeded
matrices comprised of primarily type I collagen would affect chondrocyte
morphology or proliferation, or the amount of glycosaminoglycan synthesized
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and retained in the matrix. 4-mm cores of small- and large- pore type I
matrices were manufactured and used in this study (section 4.1.1.2.1). This
experiment was run in parallel with an experiment of the effect of collagen
type, thus the "large pore" type I matrices used here are the same samples
used in section 3.1.2. In addition, the conditions of seeding were identical.
29 sponges were used, including 12 small-pore and 12 large-pore collagen
matrices for cell seeding and 3 large-pore and 2 small-pore sponges as
unseeded controls. Six chondrocyte-seeded type I and six chondrocyte-seeded
type II sponges were terminated at each of the two time points: 3 hours and 7
days. Three of the seeded sponges at each time point were dedicated for
histology and morphological analysis of cell shape (section 4.2.3), and three
seeded specimens for biochemical assays for GAG and DNA (sections 4.2.2).
3.1.4.2 Effect of pore diameter on chondrocytes in type II matrices
This study quantified the ability of the pore diameter of chondrocyte-seeded
matrices comprised predominantly of type II collagen to affect 1) cell number,
2) cell morphology, 3) rate of proteoglycan synthesis, 4) accumulation of
glycosaminoglycan, and 5) matrix contraction. The matrices were
manufactured under different conditions to yield three different pore
diameters, designated small, medium, and large (section 4.1.1.2.2).
The experiment was performed in two parts from a common cell source. In the
first part, samples were allocated for histological processing, primarily for
assessment of cell morphology (Table 3-3).
pore size
small medium large
time description histo:biochem histo:biochem histo:biochem
2 hour seeded 1 0 1 :0 1 :0
1 day seeded 3 4 3 : 4 3: 4
unseeded 1 4 1 :4 1 4
1 week seeded 3 4 3 :4 3 4
unseeded 1 4 1 :4 1 4
2 week seeded 1 4 1 : 4 1 : 4
unseeded 1 4 1 :4 1 :4
4 week seeded 1 4 1 :4 1 4
unseeded 1 4 1 :4 1 4
* 6 week seeded 1 :0 1 :0 3 :0
* Extra samples cultured 2 weeks further for histology.
Table 3-3. Number of samples of seeded type II matrices of varying pore size.
Table entries given as, n for histology : n for biochemistry.
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Most samples were grouped at 1 day and 1 week, as pilot work in the type I
material indicated that pore size effects were lost rapidly. Other times were
included to provide histological evidence for the second part of the experiment
and to aid in evaluation of the suitability of the in vitro cultured constructs
for in vivo implantation.
In the second part of the experiment, samples were allocated for biochemical
analysis to assay cell proliferation and synthetic activity (Table 3-3). Methods
of evaluation included radiolabeled sulfate incorporation, DNA, and GAG
analyses. For the biochemical experiment, a total of 96 matrices were used: 4
seeded and 4 unseeded matrices for each pore size at each of 4 time points (1
day, 8 days, 15 days, and 29 days).
3.2 In vivo experiments
These experiments were designed to meet specific aims #3 and #4 of the thesis:
to determine if transplanted autologous cultured chondrocytes (with or
without an engineered matrix), or if engineered matrices alone could increase
the amount of total reparative tissue or hyaline cartilage in healing articular
cartilage defects in a canine model. An initial study was performed in an
effort to develop the animal model, including methods of creation of the
defect and quantification of results, and to determine the baseline healing of
the lesion created in the model. A series of experiments was then performed to
establish methods of implanting matrices, culminating in a final experiment
designed to test the effect of an engineered matrix in the model. These results
were compared to those using similar matrices in culture to interpret the in
vivo vs. in vitro effects.
3.2.1 Effects of autologous transplanted cells under a periosteal flap
In this experiment, an animal model for a clinical treatment for articular
cartilage repair in defects, limited to articular layers, was developed and the
course of natural repair studied in untreated defects. Healing was evaluated
primarily by quantitative determination of the area occupied by selected types
of reparative tissue found in the defect. In examining the use of cultured
autologous chondrocytes, implanted under a periosteal flap, comparisons were
made between the treatment group and two control groups: one receiving the
identical treatment without cells, and that of untreated defects. Finally, as the
experimental design included sacrifice times from 6 weeks to 18 months, an
evaluation of the time course of healing in this defect type was performed.
The distribution of defects among the treatment group (cultured autologous
chondrocytes, or CAC) and the two control groups (periosteum, or P, and
empty controls, or EC) are shown in Table 3-4. Note that in order to limit the
scope of the experiment, periosteum controls were omitted at 3 and 6 months.
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Treatment Group 1.5 months 3 months 6 months 12 months 18 months
cultured autologous chondrocytes
injected under a periosteal flap 12 10 6 8 8
periosteum alone 6 - - 6 6
empty controls (natural healing) 18* 10 6 8 8
Table 3-4 Number of defects evaluated in autologous chondrocyte
transplantation study. The time given is the time for the right knee
receiving treatment and external fixation. Times for the left knees with
untreated defects was three weeks longer. * 6/18 defects were in the right
knee for 6 weeks with external fixation, 12/18 defects in left knee for 9 weeks.
All defects were evaluated by histological, immunohistochemical, and a
quantitative histomorphometric method.
3.2.2 Effect of matrix composition and cell seeding
This series of studies examined effects on healing in the animal model of a) the
microfracture technique, b) the chemical composition of a matrix, and c) two
methods of introducing cells into the matrix within the defect. The constructs
used were: unseeded type I matrices, type I matrices seeded with
chondrocytes, and type II matrices seeded with chondrocytes. Treatment
groups in these studies were compared to each other and to untreated controls
from the study in 3.2.1 to determine the effect of the treatments. The
number of defects studied and conditions of implantation is shown in Table 3-
5. In the final phase of the study, a matrix was engineered with a specific pore
structure and studied in conjunction with two clinical treatments for cartilage
defects. The 15-week time point was chosen based on the findings of the initial
animal study showing this to be within the phase of remodeling and in the
range where the maximum value of hyaline cartilage was obtained.
Time
group matrix cells (wks.) cover dogs defects
fascia none No 4 fascia 6 6
fascia none No 15 fascia 6 6
unseeded type I Type I No 4 fascia 6 6
unseeded type I Type I No 15 fascia 6 6
seeded type I Type I Yes 15 fascia 4 8
seeded type II Type II Yes 15 type II sponge 4 8
Table 3-5. Summary of experimental groups in initial experiments with
collagen-GAG matrix implants in a canine model.
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All defects in these studies were evaluated by histological,
immunohistochemical, and a quantitative histomorphometric method.
3.2.2.1 Studies with type I matrices
Two studies were run using type I collagen matrix made from a bovine hide
source (section 4.1.1): one using an unseeded matrix, and the other using an
autologous chondrocyte-seeded sponge. 4-mm diameter cores, approximately
1-1.5 mm thick, were cut from a large sheet. In the first study, unseeded
matrices were implanted into 24 defects in 6 mongrel dogs and covered with
an autologous fascia cover. Both knees of the dog were operated, but 11 weeks
apart. Each knee received one defect with only fascia, and one defect with a
fascia-covered matrix. Animals were sacrificed 4 weeks after the second
procedure, providing time periods of 4 and 15 weeks for the respective knees.
Thus, for each time period (4 and 15 weeks) and each treatment (fascia only
and matrix with fascia), 6 defects from six different knees were studied.
In the second experiment, 8 defects in 4 mongrel dogs were used. Each dog
underwent a harvest procedure in the left knee approximately 2 weeks prior to
the actual implantation. Cells were recovered and cultured as described in
section 4.2.1. Matrices, identical to those just described, were seeded with
autologous cultured cells and implanted into all 8 defects. Autologous fascia
was used as a cover for the matrix.
3.2.2.2 Studies with seeded type II matrices
A second cell-seeded study was performed with matrices containing
predominantly type II collagen. The matrices used in this experiment are
Chondrocell matrices, batch 915905, identical to those used in culture
experiments of the nature of the chemical composition of the matrix. These
matrices, approximately 2 mm thick, were cored with a 5-mm dermal punch
and UV cross-linked for 4 hours on each surface. 8 defects were prepared in 4
mongrel dogs. Each dog underwent a harvest procedure in the left knee
approximately 2 weeks prior to the actual implantation. Cells were recovered
and cultured as described in section 4.3. Type II matrices seeded with
approximately 1 million autologous cultured cells were implanted into all 8
defects. A 6-mm diameter type II collagen sponge cover, sutured to the
surrounding articular cartilage, was used to contain the implant within the
defect.
3.2.2.3 Engineered type II matrix and microfracture
The objective of this experiment was to determine the behavior of an
engineered type II matrix in defects to which endogenous chondrogenic cells
were given access through holes perforating the subchondral plate
(microfracture). In addition, the use of the endogenous cells from
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microfracture was compared to autologous chondrocyte transplantation with
an intact subchondral plate. The following groups were used to make the
following assessments:
Effect of matrix: Microfracture group vs. microfracture plus matrix group.
Effect of cell source for healing: Microfracture group (subchondral cells) vs.
cell-seeded matrix group (autologous cultured cells).
Effect of microfracture: Microfracture group vs. untreated defects (from 3.2.1).
Effect of specific cell transplantation method: Cell-seeded matrix group vs.
autologous cultured chondrocyte treatment group (from 3.2.1).
The type II matrix for this experiment was manufactured under conditions
identical to those used to produce the medium-pore size matrix described in
section 4.1.1.2.2. Twelve adult hound dogs were used for this study. Four
underwent a harvest procedure on the left knee for autologous chondrocyte
transplantation. Two defects were made in the right knee of each animal, and
both defects received the same treatment. The three experimental groups
were:
I. Microfracture alone,
II. Microfracture plus unseeded type II matrix, and
III. Seeded type II matrix.
A new cover, consisting of a thin film made from type II collagen slurry was
introduced in this work. The distribution of defects is shown in Table 3-6.
The effect of the treatments was studied by comparison of the quantified
amounts of different tissue types filling the defect among these three
experimental groups and historical groups (section 3.2.1).
time
group dogs defects cover CAC (wks.)
microfracture 4 8 none n o 15
microfracture + matrix 4 8 type II film no 15
cell-seeded matrix 4 8 type II film yes 15
Table 3-6. Distribution of defects in study of cell-seeded matrices and
microfracture in a canine model.
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4. Materials and Methods
4.1 Collagen-GAG analogs of extracellular matrix
4.1.1 Fabrication
Fabrication of matrices involved three steps. First, a slurry was made
predominantly of collagen digested from a specific connective tissue. The
slurry was then placed in a mold, frozen, and the resulting ice crystals
lyophilized to create a porous structure. The third step was cross-linking of
the resulting matrices.
4.1.1.1 Collagen slurries
Type I and type II collagen slurries were obtained from the USDA and two
companies. The type I slurry was made from type I collagen described by one
company as approximately 99% pure. The type II slurry was described as
predominantly type II collagen, but no detailed chemical analysis was
provided with the solution.
Different types of slurries were used to produce matrices comprised
predominantly of type I or type II collagen. The type I slurries were made with
pure collagen and glycosaminoglycan, while the type II slurry was
reconstituted from animal tissue.
4.1.1.1.1 Type I collagen slurries
Two different sources of type I collagen were used in these experiments: 1) a
purified USDA bovine hide source (type I hide collagen) was used to produce
type I collagen matrices for the initial studies in vivo; and 2) a purified bovine
tendon source from Integra life sciences (type I tendon collagen) was used to
produce matrices for in vitro assessment of chondrocyte-matrix interactions.
Type I hide collagen slurry: Before the present work was begun, the following
steps were carried out [180]: type I collagen, purified from bovine hide, was
obtained in the form of a ground slurry from the H. I. Sinnamon (USDA,
Philadelphia, PA) circa 1980. The collagen slurry was lyophilized and ground
to small size using a 20 mesh screen in a Wiley mill (Thomas-Wiley
Intermediate Mill 3383-L10 series, Arthur H. Thomas Co., Philadelphia, PA),
then stored at 40 C until 1988. The ground collagen was then stored at -20 0 C
until use in 1994.
For the present work, two blenders fitted with cooling jackets were equilibrated
to 40C (Eberbach Waring restaurant model blender, Ann Arbor, MI) then filled
with 1.65g wet collagen in 600 ml 0.05M acetic acid solution. The solution was
blended at high speed (approximately 23,000 rpm) for 1 hour. A solution of
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1.1 g GAG (chondroitin-6-sulfate from shark cartilage, Cat. # C-4384, Sigma
Chemical, St. Louis, MO) in 1 L 0.05M acetic acid was prepared. While still
blending at high speed, 120 ml GAG solution was added to the collagen
solution in the blender over 15 minutes by a peristaltic pump (Manostat
cassette pump, Manostat, New York, NY. The complete collagen-GAG slurry was
blended an additional 15 minutes. The complete slurry was decanted into a
separate plastic bottle for each blender and centrifuged at 2200 rpm for 60
minutes at low temperature (swinging cup centrifuge, IEC CRU-5000,
International Equipment Co., Needham, MA). 420 ml (out of 720 ml) was
decanted and discarded. The 300 ml of concentrated solution from each
bottle was combined, reblended at low speed (approximately 14,000 rpm), and
placed into a vacuum flask for degassing under vacuum. The slurry was used
immediately of stored for future use.
Type I tendon collagen slurry: Type I collagen, purified from bovine tendon,
was obtained from Integra Life Sciences Corp., Plainsboro, NJ. The complete
specific protocol for producing the slurry is found in Appendix A. 13.69g wet
collagen was dissolved in a 0.05M acetic acid solution and blended in at 40
(Eberbach Waring restaurant model blender, Ann Arbor, MI) at high speed
(approximately 23,000 rpm). GAG in the form of chondroitin-6-sulfate from
shark cartilage (Cat. # C-4384, Sigma Chemical, St. Louis, MO) was slowly
added to the blender by a peristaltic pump (Manostat cassette pump,
Manostat, New York, NY) to complete the slurry. The slurry was degassed and
stored for use. The slurry pH was approximately 3.5, as measured by pH
papers.
4.1.1.1.2 Type II collagen slurry
Type II collagen slurry was provided by Geistlich Biomaterials, Wolhusen,
Switzerland (Chondrocell slurry). The exact composition of the slurry was not
given, however, it is known that the material was reconstituted from porcine
cartilage and contains predominantly type II collagen. The same batch of
slurry, numbered 901037, was used for all experiments.
4.1.1.2 Freeze-drying
Freeze-drying consisted of two distinct steps: freezing and lyophilization
(sublimating the ice crystal under vacuum). In this work, all slurries were
frozen flat on trays. For all experiments, the freezing took place in the same
machine in which the vacuum apparatus was found. However, two different
machines were used in different parts of the research.
4.1.1.2.1 Freeze-drying bovine hide collagen
Freeze-drying of USDA hide collagen was performed in a single batch. 190.5 ml
slurry was poured into each half of stainless steel tray at room temperature.
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The approximate dimensions of each half of the tray were 21 cm x 29 cm. An
FTS freeze-drying unit was used (triophilizer model, FTS Systems, Albany, NY).
The lower shelf was precooled to -450 C, then the tray with slurry was placed on
the shelf and allowed approximately one hour to freeze before turning on the
vacuum pump in the unit. When the pressure in the chamber dropped below
200 mtorr (approximately 1 hour), the temperature was raised to OoC and the
system left overnight. This procedure produced a matrix varying from 1 to 4
mm thick across the sample.
Small pore type I matrices were manufactured by lowering 4-mm diameter
tubes into a freezing bath as described by Louie [102].
4.1.1.2.2 Freeze-drying of bovine type I tendon collagen and of type II collagen
Freeze-drying of bovine type I tendon collagen and Chondrocell type II collagen
slurry was performed in a VirTis Genesis freeze-drying unit (VirTis, Gardiner,
NY). Freeze-drying conditions varied from batch to batch in efforts to control
pore characteristics. The slurries were prepared and degassed as described
above. Stainless steel freeze-drying pans were cleaned and prepared with
appropriate molds. In some cases the pans were pre-cooled to a low
temperature, but in others used at room temperature. This yielded different
pore structures. Approximately 3 ml of slurry per 8 cm 2 of pan area was used
to yield a matrix of approximately 3 mm thickness.
Type I matrices: Type I tendon sheet matrix was produced in a single batch
(HB95-1). One stainless steel tray, taken at room temperature, was used as a
mold. The mold was divided into three separate sections, each measuring 16
cm x 25 cm. Slightly different volumes of slurry were used to produce matrix
of different thickness. In one section of the mold 160 ml of slurry was poured.
In a second section of the mold 125 ml of slurry was poured. The third section
was left empty. The shelf temperature in the freeze drier was set to -45 0 C.
After freeze-drying overnight (see Appendix A), the thickness of the respective
sections were 3 to 4.25 mm and 1.5 to 4 mm.
Type II Chondrocell matrices. All matrices designated Chondrocell were
provided in solid form (already freeze dried) as approximately 2 cm x 2 cm
square samples, 2-4.5 mm thick, by Geistlich Biomaterials. These materials
were manufactured by the company freeze-drying a slurry reconstituted from
porcine collagen. Most samples were provided not cross-linked. Certain
batches provided for experiments designed to study the effects of the degree of
cross-linking were provided in various states of cross-linking (Table 4-1).
Pore size controlled type II matrices: All matrices for pore size experiments in
type II collagen were manufactured in the Fibers and Polymers Laboratory at
MIT. The starting material was a collagen slurry reconstituted from porcine
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batch cross-linking
914106 not cross-linked
914206 DHT cross-linked* 1 day
914306 DHT cross-linked* 2 day
914406 DHT cross-linked* 3 day
914506 DHT cross-linked* 4 day
Table 4-1. Cross-linking conditions for 914 series of matrices. * DHT
conditions: 105 0C, under vacuum
cartilage, Chondrocell Slurry, batch #901037, Geistlich Biomaterials, Wolhusen,
Switzerland (section 4.1.1.1.2). The slurry was stored at 40 C throughout the
experiments. Initial experiments were performed to estimate pore sizes formed
at different freezing temperatures and conditions. The temperature of the
slurry, the shelf temperature of the freeze dryer, and whether or not the
freezing tray was pre-cooled were all found affect the final pore size and
architecture. Molds were made by sanding the bottom from an 88-mm
diameter plastic petri dish (Falcon #3003, Fisher Scientific, Cat. #08-772-E,
Springfield, NJ), leaving a plastic ring of area approximately 60 cm 2 . This ring
was secured to a freezing tray by four pieces of tape. A standard temperature
of 109 0F was used to melt the slurry. The slurry was poured/scraped from the
storage bottle to a beaker, which was in turn placed into a water bath
maintained at 109 0F. Several minutes were required to meld the matrix after
attaining this temperature.
Two conditions, based on the trial experiments, were selected to produce pores
of different size. To insure reproducibility of pore structure, the same trays
were used in repeating the synthesis procedure multiple times, as the resulting
pore structure was found to vary somewhat from tray to tray. These trays were
chosen such that they were flat-bottomed in the areas used, assuring good
contact between the freezing shelf and the tray.
Condition 1: The freeze drier was pre-cooled and shelves equilibrated to -20 0 C.
A full size stainless steel tray (25 cm x 49 cm) was fitted with two 88 mm petri
dish molds on opposite ends, and maintained at room temperature. The
slurry was melted at 109 0F. A 25-ml serological pipet warmed in an oven to
550C was used to transfer 24 ml of slurry into each mold on the tray. The
slurry was allowed to cool at room temperature for at least 30 minutes, with
the tray placed flat on a benchtop. The tray was then placed on the bottom
freeze drier shelf. Freezing of the slurry was complete within 40 minutes and
lyohpilization was begun, and continued overnight. Samples cored from the
outer 9 mm of the diameter of the final freeze-dried product were considered
"small" pore size. Samples cored from the center 5-6 cm diameter were
considered "medium" pore size (Figure 4-1).
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Figure 4-1. Schematic of coring of small (S) and medium (M) pore size
matrices from an 88-mm diameter sheet of matrix. Individual cores
are 9 mm in diameter.
Cross section of matrix
cut with scalpel
9 mm final form
Figure 4-2. Trimming of small pore matrices from edge of sheet.
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Condition 2: A freezing tray, fitted with one 88 mm petri dish mold, was pre-
cooled in the freezedryer with the shelf temperature set to -250C. The slurry
was melted at 109OF. A second freezing tray was placed on the bench
immediately adjacent to the water bath. 24 ml of slurry was drawn into a 25
ml serological pipet warmed in an oven to 55C and rested across the water
bath. Immediately, the following steps were performed as rapidly as possible,
taking a total of approximately 20 seconds: 1) The tray with a mold was
removed from the shelf at -250C (freezedryer door was shut briefly) and placed
on the benchtop in a tilted position. One edge was elevated by the tray
already on the bench top, the other edge resting on the benchtop itself. 2)
The 24 ml of slurry was pipetted into the 88-mm petri dish mold, specifically
into the lowest point of mold, as determined by it's tilted position. 3)
Immediately after the slurry was transferred, the tray was leveled and shaken
to evenly disperse the slurry. This took place while stepping toward the
freezedryer. 4) The freezedryer was reopened, the tray placed on the bottom
shelf, and the door closed. Note, that because of the urgency in carrying out
these steps rapidly and reproducibly, only one mold at a time could be filled,
at least until the previous mold was frozen and the freezedryer re-equilibrated.
The sample was completely frozen within 35 minutes. Samples were cored
from the center 6 cm of the sample and considered "large" pore size.
At least ten pieces of matrix in each of conditions 1 and 2 (each an 88 mm
diameter sheet of thickness approximately 3 mm) were made. For coring of
matrices for the actual experiment, three pieces from condition 1 and four
pieces from condition 2 were selected. Approximately 100 large-, 66 medium-,
and 62 small-pore 9-mm cores were punched with a brass cork borer and
hammer from these samples. Samples for characterization and
experimentation were selected randomly from these stores. It was necessary to
trim a small outcropping of matrix from the small samples that had formed
from the meniscus of the slurry up against the plastic mold at the outer edge
of the sample (Figure 4-2). These samples were cross-linked for 12 hours total
(6 hours on each side) under UV light (section 4.1.1.3).
4.1.1.3 Cross-linking
Dehydrothermal (DHT) cross-linking was performed in a vacuum oven (Fisher
Isotemp vacuum oven, Fisher Scientific, Medford, MA) at 105C and
approximately 1 to 3 mmHg for 24 hours.
Ultraviolet cross-linking was performed at a standard distance (30 cm) from an
ultraviolet lamp (Philips Sterilamp #G10T5 1/2 L, X = 253.5 nm) in a sterile
tissue culture hood. The UV lamp was rated at 5.3 W total output, 55 gW/cm 2
at 1 m. Cross-linking time was varied from 8 to 16 hours, with the material
being flipped half way through to expose both surfaces to approximately the
same radiation.
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4.1.2 Characterization
Pores were observed by scanning electron microscopy (to provide images with
excellent depth of field) and by light microscopy for the purpose of
quantitative pore characterization.
4.1.2.1 Scanning electron microscopy
Scanning electron microscopy was performed with a JEOL model #6320 field
emission gun scanning electron microscope (Tokyo, Japan). Samples were
coated with carbon with a Varian vacuum thermo-evaporator.
4.1.2.2 Quantitative pore characterization
Quantitative pore characterization involved several key steps: 1) embedding,
2) sectioning, 3) capturing and preparing a digital image, and 4) stereological
analysis of the image. The first two steps were critical for two reasons. First,
the pore structure of the original matrix must be maintained. Second, the
success of these two steps, as reflected in the quality of the sections prepared,
was critical in determining the ease of image preparation in step 3. It was
desired to provide the method of embedding and sectioning which would allow
for the least time spent on image analysis while still capturing a true image.
In order to determine the best method of embedding and sectioning the
matrices, several variables in the embedding process were varied including
fixation of matrices (to use formalin or not), method of dehydration (including
the order of solutions, and the use of a machine or not), and embedding
medium (paraffin vs. plastic). Experiments included measuring the gross
dimensions of the matrices before and after these treatments, and embedding
and comparing some combinations for ease of sectioning and quality of
sections. One semiquantitative experiment was performed to determine
whether cross-linking or formalin fixation affected the quality of matrix
sections obtained from plastic embedding. Twelve 7-mm matrix cores were
chosen at random from a single source of type II matrix produced in our
laboratory. The matrices were divided equally into a cross-linked group, (6
matrices, UV cross-linked for 12 hours), and a not cross-linked group (6
matrices). From each group, 3 matrices were placed in formalin for 16 hours,
then dehydrated by hand to 100% ethanol, while the other 3 matrices were
placed directly in 100% ethanol. The matrices were then embedded in
paraffin, and sectioned blindly without knowledge to treatment group. The
ease and quality of sectioning was rank ordered from 1 to 12, then the
treatments revealed. Two analyses were performed using the Mann-Whitney
ranked order test: one with the matrices grouped by cross-linking treatment,
and a second with the matrices grouped by formalin treatment.
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Qualitatively, the response of the matrices to the various treatments varied
slightly with matrix stiffness, collagen type, and pore size, but overall the
following observations were made:
1) Placing the matrices directly into alcohol created the least change in pore
size due to solution. Formalin or water sometimes caused significant
(though sometimes reversible) changes in matrix dimensions.
2) Most matrices were damaged significantly by the automatic dehydrating
machine (Tissue Tek VIP 1000), possibly due to the vacuum suction and
pressure used to change solutions. It is therefore necessary to dehydrate all
matrices by hand.
3) Paraffin sections did not preserve the pore structure as well as plastic
4) Paraffin section provided the advantage of much less background in
staining.
5) The blinded experiment suggested that improved sections were obtained
from type II matrices if: 1) the matrices were NOT UV cross-linked (p=0.05,
and 2) the matrices were NOT placed in formalin before dehydration
(0.05<p<0.10).
Conclusion: Although embedding in plastic created more background staining
(and thus more difficulty in the pore analysis), it was preferred as more
consistent and accurate means of preserving pore structure during embedding
and sectioning. Still some problems persisted, including crumbling or tearing
out of some of the matrix material during sectioning. It was necessary to
manually delete certain background elements and to replace matrix material
which was torn away in the final digitized image. Thus, official pore analysis
was done following the following protocol with embedding in plastic medium.
Matrix pore characteristics, including average pore diameter, percent porosity,
and matrix wall thickness were evaluated from digital images. The detailed
protocols are presented in Appendix B. Briefly, matrices selected for evaluation
were embed in glycol methacrylate (JB-4 embedding system, Polysciences, Inc.,
Warrington, PA) and 5 gm thick histological sections were prepared. Digital
images were captured via videocamera (Hamamatsu CCD Camera Control
#C2400 with camera), edited to eliminate background and provide a complete
image of pore walls (Scion Image 1.60c), and analyzed by an automated image
analysis computer program (Digit) developed for our laboratory. This program
uses the method of parallel secants to assess pore diameter, as described
previously [102].
The methods of sampling matrices for analysis were as follows:
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Multiple pieces of each type of matrix to be characterized were removed at
random from the same supply from which samples were taken at random
experiments. The samples used were:
Geistlich type II matrices: Two groups were examined:
1) Three 9-mm cores were selected from batch 914106 (This batch was one of
five used in the experiment on the effect of cross-linking, and was used for
the majority of additional experiments with this material).
2) Three 9-mm cores were selected from batch 914306, one of four made in the
same manner as 914106, but subjected to varying degrees of cross-linking for
the experiment to determine effects of cross-linking.
Type II pore size experiment matrices: Three types of matrices, designated
Small, Medium, and Large, were produced in this laboratory and were used in
in vitro experiments (see section 4.1.1.2.2). Three 9-mm cores from each group
were analyzed.
Canine implant type II matrices: These matrices were produced in our
laboratory in the same manner as the medium-pore group of pore diameter
experiments. Three matrices were chosen randomly from the extra samples
taken to the operating room.
For each of the individual samples, at least three images representative of the
overall pore structure were captured. These images were taken from across the
breadth of the sample, in some cases from different serial sections. On each
image, two circular regions were chosen for analysis. The circles were
constructed as large as possible to include as many pores as possible. Due to
the size of the images, the circles overlapped significantly, and therefore
contained many of the same pores. Thus, the values for the pore diameters
from the two regions were averaged to provide a single value for each image.
The values for the three images from a given sample were then averaged and
reported.
Additional pore diameter analysis: Analyses on several samples were
performed using the same embedding and image analysis techniques, as
reported previously [102, 130]. The samples analyzed included:
- A sample of Geistlich type II collagen from previous batches used for
initial in vivo studies and in vitro comparison of type I and type II
materials.
- A sample of type I collagen used for in vitro comparison of type I and
type II materials.
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- small pore size type I material made in tubular form by Libby Louie
[102], used for in vitro comparison on matrix pore size of type I collagen
materials.
4.1.2.3 Chemical characterization
The glycosaminoglycan content of freeze-dried matrices was measured and
expressed as a weight percent. Three pieces of matrix (9 mm cores or 1 cm x 1
cm squares, approximately 1.5-4 mm thick) were selected from each of the
following matrix groups:
1) Type I hide
2) Type I tendon
3) Type II Geistlich (batch 914306)
4) Type II small-pore
5) Type II medium-pore
6) Type II large-pore
The matrices were vacuum lyophilized and immediately weighed on a
microgram balance. The matrices were then digested with papain and assayed
for GAG content by the dimethyl-methylene blue method (see section 4.2.2).
The weight percent of GAG for each individual piece was calculated.
In addition, for types I hide and tendon collagens, the expected value, based
on the dry weights of the purified raw materials, was calculated.
4.1.3 Preparation of matrices for experiments
Matrices for experimental use were cored from larger sheets with either a
dermal punch (4 mm or 5 mm in diameter) or brass cork borers (for diameters
over 5 mm). All coring was performed under sterile conditions in a laminar
flow tissue culture hood on a sterile teflon cutting board. Matrices were stored
in sterile tubes or petri dishes at room temperature until use.
4.2 In vitro experiments
4.2.1 Methods of seeding matrices with chondrocytes
Seeding of chondrocytes in matrices involved several steps. First, articular
cartilage was harvested from canine knee joints. The chondrocytes were then
isolated from the harvested cartilage, expanded in culture, in some cases
frozen, recovered from culture, and actually seeded into the matrices. These
procedures are reviewed in this section.
4.2.1.1 Chondrocyte isolation from cartilage
Cartilage was harvested in sterile procedures in the operating room either from
dogs undergoing survival surgery or as soon as possible after sacrifice or animals
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undergoing other studies. Shavings were taken with a scalpel, with care being
taken not to take bone, synovium, or other surrounding tissues. Cartilage was
temporarily stored in PBS supplemented with 1% Penicillin/Streptomycin and
0.5% Fungizone kept on ice. Digestion was performed within 4 hours of harvest.
The cartilage shavings were diced to less than 1 mm squared pieces and placed
in a spinner flask in sterile filtered collagenase solution. Slightly varying
collagenase concentrations were used based on the desired digestion time and
collagenase activity. The most often used and recommended concentration was
0.15% collagenase in DMEM/F12 supplemented by 2% penicillin/streptomycin
(20,000 U / 20,000 gg per 100 ml) and 1% fungizone (collagenase activities
ranged from 212 to 370 U/mg). The solution was placed in a tissue culture
incubator (37 0C, 5% C0 2) on a magnetic spinner plate (Thermolyne cellgro stirrer
type 45600, Dubuque, IA) for 4 hours, with the spinner set for the slowest speed
consistent with keeping the cartilage pieces suspended. Digested cartilage was
filtered through 70m nylon cell strainers (Falcon #2350, Fisher #08-771-2) and
spun down (1500 rpm X 10 min.) in 50 ml centrifuge tubes. The digest was
rinsed 2-3 times by resuspension in tissue culture medium followed by similar
centrifugation. The cells were counted in a hemacytometer (including trypan
blue viability assay), resuspended one final time, and plated into tissue culture
flasks for expansion. Plating density was approximately 200,000 to 2 million
cells/75 cm 2 flask.
4.2.1.2 Culturing of chondrocytes in monolayer culture
Cells were cultured in standard 75 cm 2 polystyrene tissue culture flasks (Falcon
#3084, Fisher #08-772-1). Complete culture medium was made as follows (end
values in parentheses indicate amount to make 500 ml total):
Base medium: Dulbecco's modified Eagle Medium/Nutrient Mixture F12
(HAM), 1:1 mixture, (DMEM/F12), Gibco #11320-033. (420 ml)
10% Fetal Bovine Serum (FBS), Hyclone #SV 3002.01. (50 ml)
2% Penicillin (5,000 U/ml) /Streptomycin (5,000 gg/ml) Gibco #15070-
063. (10 ml)
1% L-glutamine (2.5 mM), Gibco #25030-081. (5 ml)
2% Ascorbic acid (solution of 0.125 mg, Gibco #13080-023 in 10 ml
DMEM/F12). (10 ml)
1% Fungizone, Gibco #15295-017. (5 ml)
All Falcon supplies obtained through Fisher Scientific, Springfield, NJ.
All Gibco items obtained from Life Technologies, Grand Island, NY.
Culture medium was changed as indicated by yellowing of the pH indicator in
the medium, approximately every two days. Cells were recovered by
trypsinization for seeding, passaging, or other uses. The cells were released by 5
ml 0.05% trypsin, 0.53 mM EDTA-4Na, lx liquid (Trypsin/EDTA, Gibco #25300-
58
062), and rinsed 3 times in complete medium before being concentrated and
allocated as needed.
4.2.1.3 Seeding of matrices
Seeding of matrices occurred in three main steps: 1) pre-wetting/sterilization,
2) cell recovery from 2-dimensional culture in which the cells were proliferated,
and 3) the introduction of the cells into the matrices. The specifics of these
procedures are contained in Appendix C. Below, the experiments designed to
study seeding conditions are first described, then the conditions of seeding for
all other experiments.
4.2.1.3.1 General methods used in cell seeding
Matrices were either pre-wet or used dry. Most matrices were pre-wet. These
matrices were first sterilized for 10 minutes in 70% ethanol. Ethanol was
rinsed by 5 x 10 minutes in PBS, and 2 x 10 minutes in culture medium. The
matrices were compressed lightly with rounded-end forceps at each step to
ensure thorough rinsing. Pre-wet matrices were stored in medium while cells
were being recovered. Matrices used dry were kept in sterile packaging until
needed.
Cells were then collected by trypsinization of cell culture flasks and stored
temporarily in complete culture medium while matrices were prepared in their
wells for seeding.
In preparation for seeding, matrices were placed either in empty plastic wells
(12, 24, and 96-well plates, Falcon #'s 3043, 3047, and 3072, Fisher #'s 08-772-
29, 08-772-1 and 08-772-2C), or wells lined with agarose or poly-
hydroxyethylmethacrylate (polyHEMA). Agarose-lined tissue culture plates
wells were prepared at least several hours prior to the experiment. 2% agarose
(Bio-Rad #062-0100, Cambridge, MA) was autoclaved and aliquotted to cover
the bottom of the wells being used (the amount depending on the size of the
wells). PolyHEMA-coated wells were prepared at least 16 hours in advance.
PolyHEMA was coated onto wells in a thin film by filling wells with a solution
of 0.3 gm polyHEMA in 100 ml 95% ethanol and letting the alcohol evaporate
overnight in a sterile hood.
Matrices were moved to their wells in one of two conditions: 1) "wet": pre-wet
with medium and transferred by forceps directly to a well for seeding, or 2)
"filter-dried": placed on filter paper to partially dry the matrices before being
placed in their wells. Matrices were let dry as much as possible without drying
so much as they would collapse irreversibly, as estimated from trial and error.
All matrices were placed in the center of the tissue culture plate wells in which
they would be seeded.
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Cells were resuspended at the desired concentration (typically at 25 million
cells/ml) and placed on the matrices by drops from a micropipettor. When
many matrices were seeded, the order of seeding matrices was chosen to ensure
that matrices in each experimental group received aliquots spaced relatively
evenly throughout the seeding process. Matrices in some experiments were
seeded on both surfaces. In these instances, after one surface of all matrices
were seeded, the matrices were flipped over in their wells and the second
surface then seeded. The seeding of the second side was performed in reverse
order of the first side. Seeded matrices were placed in the tissue culture
incubator for 1-3 hours before they were transferred to tissue culture 24-well
plates into wells with 1.5 to 2 ml complete tissue culture medium.
4.2.1.3.2 Pilot studies to determine optimal seeding conditions
In these studies, matrices were seeded with chondrocytes and examined for
DNA content within 24 hours. These samples were prepared for DNA analysis
by protease digestion. To terminate each experiment, samples were removed
from the wells, placed in microcentrifuge tubes, and put directly in a -70 0C
freezer. The chondrocytes used for seeding were all second passage canine
chondrocytes, cultured as described earlier in section 4.2.1. Six separate
experiments were performed, as described below.
Effect of medium addition: Forty 9-mm diameter cores of type II Chondrocell
matrix (not cross-linked batch 914106) were used and prepared for seeding by
filter paper drying and centered in agarose lined wells in 24-well plates.
Approximately 940,000 cells were seeded onto one surface of each matrix in a
40 pl aliquot of cell-medium suspension. Four matrices were left without cells.
The matrices were placed in the incubator. One group of four matrices was
terminated at each of the following times: 20 minutes, 1 hour, 3 hours, and 6
hours. One extra sample was processed for histology at each of these time
points. At each of these same times, an additional group of four matrices was
transferred to a well containing 1.5 ml of culture medium and placed back in
the incubator for termination at 24 hours. Finally, at the one hour time
point, a third group of 4 matrices was added to wells containing medium. At
24 hours, the medium was changed, then the samples terminated as just
described.
Effect of cell number and flipping matrices: Three groups were used in this
experiment to determine the effect of the number of cells delivered to the
matrix, and of seeding on one or both sides. Most matrices were found to have
one surface more porous than the other (section 5.1):
1) 1 million cells delivered to more porous surface only
2) 2 million cells delivered to more porous surface only
3) 2 million cells delivered: 1 million to one surface, flipping the matrix after
a few minutes, then 1 million to the opposite surface.
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Four 9-mm cores of type I bovine tendon matrices were used in each group.
Each million cells were delivered in 40 pl of medium. The 2 million cell
aliquot was delivered in 60 pl medium. Samples were terminated after 3
hours.
Effect of experimenter and matrix type: To determine the effect of the
experimenter in seeding cells, the number of cells contained in 9-mm diameter
cores of two different types of matrices was compared: Chondrocell type II
matrices, and type I bovine tendon matrices. One million cells in 40 pl were
delivered to the porous side only, with the cores placed in agarose-coated wells.
Samples were terminated after 3 hours. The number of samples reported is
shown in Table 4-2:
matrix collagen type
experimenter Type I Type II
HB 4 20
SM 4 4
Table 4-2. Matrices used in seeding experiment of experimenter and type of
matrix (number of matrices seeded)
Effect of coating of culture wells: This experiment examined the effect of
coating of culture wells on the number of cells retained in matrices. Three
groups were examined: uncoated wells, polyHEMA -coated wells, and agarose-
coated wells. Agarose coatings were achieved by allowing 0.5 ml 2% Bio-Rad
agarose and 120 gl medium to solidify in each 24-well plate. Three to four
drops of this mixture were used in 96-well plates.
Two conditions were used to test these groups: 9-mm cores of type I bovine
tendon matrix in 24-well plates (an unconfined condition), and 5-mm cores of
type I bovine tendon matrix in 96-well plates (a partially confined condition).
4 cores of each size for each coating were filter dried and seeded with 1 million
cells in 40 gl. After 2 hours in an incubator, the samples were terminated and
the cells counted by DNA assay.
Effect of filter-drying: Matrices were seeded in one of two conditions: 1) "wet"
or 2) "filter-dried". Two sub-experiments were run on separate days. In the
first experiment, cores of bovine tendon matrix of 5 mm, 7 mm, and 9 mm
were used in uncoated 24-well plates, each with n=4 wet matrices and n=4
dried matrices. 1.3 million cells in 40 gl were seeded onto each matrix.
Matrices were incubated for 2 hours, then terminated for DNA count.
In the second experiment, 5-mm cores of bovine tendon matrix were confined
in 96-well plates coated with polyHEMA, coated with agarose, or uncoated, each
with n=4 wet matrices and n=4 dried matrices. I million cells in 40 pl were
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seeded onto each matrix. Matrices were incubated for 2 hours, then
terminated for DNA count.
Effect of confinement of matrices: This experiment was designed to test
whether preventing the cell suspension from escaping from the periphery of
the cores to be seeded would increase the number of cells in the matrix. Five-
mm diameter cores of type I bovine tendon matrix were used. In the
unconfined group, the cores were seeded in the center of 24-well plates (well
diameter approximately 16 mm). In the confined group, the cores were seeded
in 96-well plates (well diameter approximately 6.4 mm). For each confined
group, 4 matrices were seeded wet and 4 seeded filter dried. After 2 hours in
an incubator, the samples were terminated for DNA assay.
4.2.1.3.3 Seeding of matrices for in vitro or in vivo investigation
In experiments where matrices were seeded on an agarose bed, agarose-lined
tissue culture plates wells (12, 24, and 96-well plates, Falcon #'s 3043, 3047,
and 3072, Fisher #'s 08-772-29, 08-772-1 and 08-772-2C) were prepared at least
several hours prior to the experiment. Two percent agarose (Bio-Rad #062-
0100, Cambridge, MA) was autoclaved and aliquotted to cover the bottom of
the wells being used (the amount depending on the size of the wells). Matrices
were first sterilized for 10 minutes in 70% ethanol. Ethanol was rinsed by 5 x
10 minutes in PBS, and 2 x 10 minutes in culture medium. Cells were then
collected by trypsinization of cell culture flasks and stored temporarily in
complete culture medium. The pre-wet matrices were placed in the center of
the tissue culture plate wells in which they would be seeded. In some cases
they were first partially dried by placing them briefly on sterile filter papers.
Cells were resuspended at the desired concentration (typically at 25 million
cells/ml) and placed on the matrices by drops from a micropipettor. When
many matrices were seeded, the order of seeding matrices was chosen to ensure
that matrices in each experimental group received aliquots spaced relatively
evenly throughout the seeding process. Matrices in some experiments were
seeded on both sides. In these instances, after one side of all matrices were
seeded, the matrices were flipped over in their wells and the second side then
seeded. The seeding of the second side was performed in reverse order of the
first side. Seeded matrices were placed in the tissue culture incubator for 1-3
hours before they were transferred to tissue culture 24-well plates into wells
with 1.5 to 2 ml complete tissue culture medium.
Seeding conditions for in vitro testing of type I and type II matrices: Second
passage canine chondrocytes were obtained and resuspended at a
concentration of 2 x 107 cells / ml. The sponges were pre-wet, placed directly
into their wells, and seeded with 50 gl of the cell suspension containing one
million chondrocytes on the more visibly porous side to provide optimal
penetration of cells into the sponge. Pilot studies in our laboratory showed
that a sponge at the size of 4 mm diameter can hold 50-80 gl of fluid, and that
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there was a trend to a higher seeding efficacy in the type II sponge. Culture
medium (1.5 ml) was added 3 hours after seeding and changed every day.
Seeding conditions for in vitro degree of cross-linking pilot study. Cores were
prepared by pre-wetting, filter drying, and placement in agarose-lined wells.
Cells were resuspended at 25 million/ml and the cores were seeded with
approximately 1 million cells in 40 gl on the porous side of the matrix.
Seeding conditions for in vitro degree of cross-linking long-term study. Cores
were prepared by pre-wetting, filter drying, and placement in agarose-lined
wells. Cells were resuspended at 40 million/ml and the cores were seeded in
two steps. In the first step, 1.6 million cells in 40 jl were placed on every
matrix. Approximately 10 minutes after seeding the first surface, half the
matrices were turned over, and the opposite side was seeded with 1.6 million
cells in 40 gl aliquots. 40 jl complete medium was added the matrices that
received cells on only 1 surface. Seeded matrices were transferred to wells with
medium after 2 hours.
Seeding conditions for in vitro testing of matrix pore size: The seeding
conditions for seeding of type I matrices of different pore size (experiment #1),
were identical to those of in vitro testing of type I and type II matrices as
described above.
For the second experiment, seeding in type II matrices of varying pore size, the
following conditions were used: canine chondrocytes were resuspended at a
concentration of 25 million/ml. The matrices were pre-wet, dried on filter
paper, and placed into agarose-lined 24-well plates. Both surfaces were seeded
with 40 gl of cell suspension. The matrices were added to culture medium 2
hours after seeding.
Seeding conditions of initial experiments with type I and type II matrices for in
vivo implantation: The matrices were prepared only by pre-wetting and
placement in 24-well plates. Cells were suspended at a concentration of 20
million/ml. Seeding was performed by placing a 50 gl drop containing 1
million cells on the more porous surface of the matrix. After 1 hour, 0.5 ml
medium was added to the well.
Seeding conditions of engineered type II matrices for in vivo implantation:
Five-mm diameter cores of matrix were filter dried and placed in agarose-lined
96-well plates. Cells were suspended at 25 million/ml. A total of 1.5 million
cells were seeded by 30 pl aliquots of 750,000 cells to each surface of the core.
One hour after seeding, the matrices were placed in 24-well plates with 1 ml
medium.
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4.2.1.4 Frozen chondrocyte procedures
Freezing: Cell for freezing were first resuspended at a concentration of roughly
2 million/ml complete medium. 5% sterile filtered DMSO (0.45g acrodisc
filter) was added, and up to 3 ml aliquots placed in tubes for freezing (Nalgene
5 ml cryovial, #5000-0050). Vials were frozen in a tilted position in -200
freezer, then transferred to a -70 0 C freezer after about 3 hours.
Thawing: Frozen tubes were removed from the -70 0 C freezer and disinfected.
The tubes were placed in 370 bath until the outside just turned liquid (less
than 1 minute), then the tubes opened and add drops of pre-warmed complete
medium slowly added to help thawing. When the tube was all liquid, it was
re-capped and shaken to mix and suspend the cells. The resulting suspension
was pipetted into a 50 ml tube and rinsed and spun three times before use.
4.2.1.5 Measurement of matrix contraction
Matrix contraction was assessed by measurement over time of the diameter of
matrices cored as discs. A millimeter scale ruler was placed above the matrix core
and read to the nearest half millimeter. Two readings were taken per matrix, along
orthogonal diameters. For matrices which displayed shrinkage into an oblong shape,
the measurements were taken along the short and long axes.
4.2.2 Biochemical analysis
Biochemical analyses of cell-seeded matrices in vitro included: 1) radiolabeled
sulfate uptake (to measure rate of GAG synthesis at a given time point), 2)
total GAG content (to measure the net GAG accumulated in the sample over a
given time period), and 3) total DNA content (to estimate the number of cells
in the constructs at a given time). For each assay, it was necessary to first
digest the matrix to break down the large collagen molecules to allow binding
of assay dyes their substrates, and to prevent interference from large molecules
in the readings. Before digestion, all samples were freeze-thawed three times in
the -70 0C freezer to assist in lysing of cell membranes and releasing DNA from
the nucleus. Samples were then frozen until the end of the experiment for DNA
and GAG analysis.
4.2.2.1 Digests for biochemical analysis
Two different digests of cell-seeded matrices (or controls) were performed in
this study. In the majority of experiments a papain digest was used. Papain
was prepared from a commercially available 2x suspension in 0.05 M sodium
acetate , pH 4.5 with 0.01% thymol, 24 mg protein/ml; 32 U/mg protein. (Cat.
#P-3125, Sigma, St. Louis, MO). The complete protocol for DNA digestion is
presented in Appendix D. In summary, 50 [l papain, 1 ml digestion buffer
(17.54 ml 0.5M NaH2 PO4, 2.46 ml 0.5M Na 2HPO 4 , 80 ml dH20, 87.82 mg L(+) -
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Cysteine HC1, and 186.12 mg Disodium Ethylenediamenetetraacetate (EDTA),
pH 6.2), and the sample are combined and set overnight in a 650 C water bath.
For experiments investigating the effects of seeding parameters and the degree
of cross-linking in type II matrices, a protease digest was used. Protease
(Pronase E, Cat. #P 5147, Sigma Chemical Corp., St. Louis, MO) was prepared in
TBS buffered at a concentration of 2.5 mg/ml. 1 ml of this solution was added
to each sample and allowed to digest in a 550C water bath overnight.
4.2.2.2 DNA quantification and cell counting
The detailed protocol for DNA assay is found in Appendix D. In summary, a
TNE 10x buffer solution (100 mM TRIS, 10 mM EDTA, 1.0 M NaCl, pH 7.4) and
concentrated Hoechst dye stock solution (1 mg/ml) were prepared. On the day
of the assay, a fresh working solution working solution of dye was prepared
with 90 ml dH 2 0, 10 ml TNE 10x buffer, and 10 to 100 gl concentrated Hoechst
dye stock solution (dependent on the cell concentrations expected in the
samples). Samples were centrifuged at 3000 rpm for 10 minutes, then a 100-
200 gl aliquot of from the supernatant added to a glass cuvette and brought
to 2.0 ml total with working dye solution. The sample was read immediately
in a flourometer (model TKO 100, ex= 3 6 5 nm, Xem= 4 6 0 nm, Hoefer Scientific
Instruments, San Francisco, CA). The flourometer was scaled with standards of
calf thymus DNA.
4.2.2.3 GAG determination
The same digests used for DNA analysis were used for GAG quantification.
Samples were vortexed to completely mix the samples, and a 100 pl aliquot
was placed in a polystyrene disposable cuvette. 3 ml dimethylmethylene blue
dye solution (32 mg 1,9-dimethylmethylene blue (DMB), 10 ml 100% ethanol, 2
L distilled H20 (d H2 0), 4 ml 90% formic acid, pH 3.5, see Appendix D) was
added to the cuvette. Samples were read for absorbance at 535 nm in a
spectrophotometer (LKB Biochrom Ultrospec 4050, Pharmacia, Piscataway, NJ).
Standards were obtained from shark chondroitin sulfate in dH20.
4.2.2.4 Radiolabeled sulfate incorporation
The rate of synthesis of proteoglycan was assayed with the use of radiolabeled
sulfate. 35-SO 4 was obtained from New England Nuclear, Bedford, MA. Samples
in 24-well plates (both seeded and unseeded matrices) were prepared by
removing medium. 1.5 ml of complete medium containing 35-SO 4 (10
gCi/ml) were added and the samples incubated (370 C, 5% CO2) for 4 hours.
Unincorporated sulfate was removed by rinsing with a solution of culture
medium (DMEM/F12) supplemented by 0.6 mM cold sulfate (from Na 2 S04) for
a total of 1.0 mM cold sulfate. A total of 12 rinses were performed over a
period of 200 minutes, with the samples incubated an average of 10 minutes
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between rinses. Confirmation of rinsing was documented by scintillation
counting of 100 gl aliquots of the recovered rinse solution. Rinsing was
stopped when the pooled rinse medium from each group read less than 50
cpm. Samples were freeze-thawed three times, digested in papain (section
4.2.2.1) and assayed for 35-SO 4 within 2 days. 100 gl of digest was combined
with 5 ml scintillation fluid (Scintiverse II, cat. # SX12-4, Fisher Scientific, Fair
Lawn, NJ) and counted for 2-5 minutes in a liquid scintillation counter
(Packard Tri-Carb 4640, United Technologies Packard, Downer's Grove, IL).
Counting times were adjusted so the standard deviation of all counts more
than five times the background values was less than 5%.
Verification of sulfate incorporation into macromolecular forms: In order to
verify that scintillation counting was recording macromolecular GAG chains
(as opposed to unincorporated sulfate), several samples were analyzed by
chromatography to demonstrate the approximate molecular weight of the
radioactive species. Sephadex PD-10 columns (Pharmacia Biotech, Piscataway,
NJ) were used. The column is run by gravity, with all solutions pipetted
manually. The buffer consisted of 150 mM TRIS (Tris-(Hydroxymethyl)-
Aminomethane, C4 H 1 1NO 3) pH'd to 6.6 with HC1 (referred to as column buffer).
Columns were equilibrated with 25 ml buffer, then allowed to run almost dry
before adding 0.5 ml of sample. The sample was chased with 12 ml buffer
while fractions were collected manually in 1.5 ml microcentrifuge tubes,
typically 0.5 ml to 1 ml per fraction.
Aliquots of each fraction (100-300 gl) were mixed with 5 ml scintillation fluid
and counted for 4-5 minutes in a liquid scintillation counter. The larger
aliquots were used for groups with lower expected counts. Specifically, the
following columns were run:
Control column #1 (Unincorporated sulfate with high molecular weight dye):
Sample consists of 400 gl saturated solution of Blue Dextran 2000, molecular
weight 2,000,000 (Pharmacia, Uppsala, Sweden) plus 100 il of 35-SO 4 , 10
gCi/ml in DMEM/F12 culture medium.
Control column #2 (Unincorporated sulfate): Sample consists of 100 gl of
35-SO 4 , 10 gCi/ml in DMEM/F12 culture medium + 400 gl column buffer.
Sample verification columns: One sample from each time period (1 day, 8
days, 15 days, and 29 days) was used to demonstrate the molecular weight
of the labeled fractions. The medium pore size, seeded group was chosen in
each case. The sample consisted of 100 gl aliquots from each of the 4 seeded
samples, plus 100 gl column buffer.
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4.2.3 Cell morphology
Cell morphology was evaluated in certain seeded matrices. Cells were assigned
to one of three categories:
1) elongated: cells with greater than a 2:1 ratio of length to width
2) round or ovoid: cells with a round or elliptical shape with length to
width ratio less than 2:1, and
3) not assigned: cells which had a length to width ratio very close to 2:1
and therefore could not be confidently assigned to groups 1 or 2, or in
rare cases, cells with odd shapes in which neither categories 1 nor 2
seemed appropriate.
Methods of selecting and counting cells: Histological cross-sections of cell-
seeded matrices, generally taken from near the central diameter of the matrix
cores, were stained with hematoxylin and eosin. Areas for analysis were
selected by "randomly" placing a microscope eyepiece grid insert on the
section to be evaluated. The grid was moved until an area with a suitable
number of cells for analysis was found. Only cells within the interior pore
structure of the matrix were counted; cells in surface layers were excluded.
Therefore the grid was always placed at least 80 gm from the surface of the
matrix. The grid was used to outline the area for counting. Each area was
selected at an objective magnification of 20X (the grid corresponding to an
analysis area of 300 x 300 Rm), however, morphology was generally graded
using the 40X objective. Generally, the grid was placed on five different areas
of a given histological section. In addition, several (3 or 4) sections from each
sample were evaluated to improve the sampling and statistical analysis.
4.3 The animal model
4.3.1 Surgical technique and postoperative care
Dogs involved in the study were adult mongrel or hound dogs, each weighing
approximately 25-30 kilograms. Prior to operation, the knee joints were
examined roentgenographically to exclude animals with degenerative joint
disease. All operations were performed under general anesthesia and sterile
conditions. The basis for most experiments was a 4-mm diameter defect
created in the trochlear groove of the stifle (knee) joint. A 4-mm diameter
dermal punch was used to outline the defect. Using loupe visualization, an
attempt was made to remove all non-calcified cartilage from the defect by
scraping the calcified cartilage surface with a customized curette, without
fissuring the calcified cartilage. The objective was to remove as much articular
cartilage as possible so as not to leave residual articular cartilage which might
interfere with healing or affect the validity of the histomorphometric
measurement. Defects were placed approximately 1.25 and 2.25 centimeters
proximal to the intercondylar notch, each slightly lateral or medial to the
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midline (Figure 4.3). Before closing the capsule, bleeding vessels were clamped
and cauterized. The knee joint was closed by zero point suturing.
Figure 4-3. Schematic depicting the location of the proximal (P) and distal (D)
defects in the canine trochlea. The defects are 4 mm in diameter.
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The procedure for manipulating autolgous cultured chondrocytes is shown in
Figure 4.4. In animals receiving cultured autologous chondrocytes, articular
cartilage was removed from the lateral and medial margins just outside the
femoral groove of the left femur, and was used for chondrocyte culture. The
dogs were allowed free cage activity after the harvest procedure. The cartilage
from the defects and margins was either sent to Genzyme Tissue Repair
(Cambridge, Massachusetts), where the cells were isolated and expanded in
culture, or the isolation and expansion was performed in our laboratory
according to our cell culture protocols (section 4.2.1). Approximately two to
three weeks later, the cultured autologous chondrocytes were provided for
reimplantation in a variety of implants and treatment conditions (section
4.3.2).
Defects for treatment, whether or not they included cultured cells, were
prepared in the contralateral right femur as described above. One of a variety
of treatments were applied (see below), the patella replaced resting roughly
between the defects, the incision was closed, and the knee was immobilized by
external fixation (IMEX Veterinary, Longview, Texas) for ten days to prevent
dislodging of the graft or reparative tissue.
4.3.2 Treatments applied to animal model
4.3.2.1 Untreated defects and defects with autologous transplanted cells
4.3.2.1.1 Use of periosteum
Periosteum was harvested from the proximal tibia, and the defect was covered
with a four-millimeter diameter circular periosteal flap, with the cambium
layer facing the base of the defect, and sutured to the articular cartilage
surrounding the defect using 8-0 sutures. Cultured autologous chondrocytes
were injected under the periosteum in culture medium (2x10 6 cells/defect).
4.3.2.1.2 Fibrin glue
The defect was sealed with autologous fibrin. This procedure utilized
autologous fibrinogen isolated from the animal's blood by cryoprecipitation
several weeks before surgery. At surgery, the frozen cryoprecipitate was thawed
and I cubic centimeter drawn into a syringe. One cubic centimeter bovine
thrombin, (Parke-Davis, Morris Plains, New Jersey) at a concentration of 5 units
per milliliter with 0.5 per cent calcium chloride and 10 milligrams per
milliliter aminocaproic acid, was provided in a separate syringe. After drying
the defect area, the contents of both syringes were co-injected into a sterile
container, mixed, and spread to cover the entire surface of the periosteal cover
and immediately adjacent cartilage.
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Figure 4-4. Procedure for manipulation of cultured autologous chondrocytes.
Surgeries on the left and right knees performed approximately 3 weeks apart.
4.3.2.1.3 Beta-galactosidase labeling
Two dogs in both the 1.5-month and 3-month groups were selected at random
for beta-galactosidase labeling. In these four animals, the harvested
chondrocytes were transfected with the gene for beta-galactosidase (performed
by Genzyme Tissue Repair) in vitro before re-implantation.
4.3.2.2 Use of fascia cover
In animals receiving a fascial cover to the matrix, a separate incision was made
in the lateral aspect of the thigh before opening the knee. A piece of the tensor
fascia latae, approximately 1 cm square, was removed. Covers were cored out
on a tongue depressor using the 4-mm dermal punch. The covers were
hydrated with saline until the defects were prepared.
4.3.2.3 Use of collagen sponge cover
Collagen type II sponge covers were made from one of the same Chondrocell
matrix batches (#915905) that were used for in vitro and in vivo seeding
experiments. The matrices were compressed manually, cross-linked under UV
light for 12 hours, and recompressed before use. The sponge covers were placed
dry on the defect for suturing.
4.3.2.4 Use of collagen film cover
Type II collagen films were produced by allowing melted Chondrocell slurry to
air dry in stainless steel pans. Molds were formed by sanding the bottom from
50-mm or 85-mm plastic petri dishes and taping them to the pans. The
thickness of the film can be controlled by the amount of slurry placed in the
mold. For this work, 42 ml of slurry was used in the 85-mm petri dish. Air
drying took from one to several days, depending on the amount of slurry. Flat
bottomed plastic weigh boats also were suitable molds. Films were sterilized
and cross-linked by UV radiation. The films were placed approximately 30 cm
from the UV source (Philips Sterilamp #G10T5 1/2 L, 1 = 253.5 nm), and
remained for 8 hours total, 4 hours on each side. 5 mm cores were made with
a dermal punch. The covers were pre-wet in saline for several minutes before
being sutured to the defect.
4.3.2.5 Type II matrix
Two different type II matrices were used in these experiments. These matrices,
described in greater detail in section 4.1.1, were Geistlich matrix, batch 915905,
and a medium-pore size matrix produced in our laboratory. When matrices
were employed for implantation in the model, the cover was first partially
sutured into place, then the matrix placed into the defect, suturing completed,
and the joint closed and immobilized.
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4.3.2.6 Microfracture technique
Microfracture was performed with the straight pointed end of a microsurgical
pick. Once the defect was completely prepared, the pick was forced into the
subchondral bone with a twisting motion to a depth of approximately 1.5-2.0
mm. The width of the pick at this depth was approximately 0.8 mm.
Bleeding from the subchondral bone varied, both from one pick hole to
another within a defect or knee, and from one animal to another. The
orthopedic surgeon who developed this procedure has emphasized the
importance of a light scraping of the calcified cartilage to facilitate integration
of the reparative tissue to the underlying structure.
4.3.2.7 Seeding of matrices
Matrix seeding was performed from 4-12 hours before surgical implantation of
the matrices, as described in section 4.2.1.3. Seeded constructs were placed in
the tissue culture incubator until being moved to the operating room 30
minutes to 3 hours before implantation.
4.3.2.8 Matrix implantation
Seeded matrices were brought to the operating room in a sterile container.
After the joint was opened and the defects prepared, the cover was first
partially attached by 2 or 3 sutures. The seeded implant was then placed
under the cover and suturing was completed. Care was taken in replacing the
patella into the patellar groove so as not to disrupt the implant in closing the
joint.
4.3.3 Animal sacrifice and tissue retrieval
Animals were sacrificed by injecting 10 cubic centimeters Pentobarbital Sodium
CII euthanasia solution (0.6 milligrams per milliliter). At necropsy, the defects
were examined grossly and photographed. The distal femurs were excised and
placed in 10 per cent neutral buffered formalin. Several hours later the
trochlea was carefully dissected with a fine tooth coping saw and placed into
formalin for four days. The trochlea was rinsed of formalin, further dissected
to individual samples of approximately five millimeter thickness by sharp
blows from a hammer to a razor blade, and placed into 15 per cent disodium
ethylenediamene tetraacetate decalcifying solution, pH 7.4. The sample was
placed on a shaker at 4 degrees Celsius with three changes of the decalcifying
solution each week for approximately four weeks. Samples were rinsed
thoroughly, dehydrated, and embedded in paraffin at 60 degrees Celsius.
Seven-micrometer thick sections were prepared and stored at 4 degrees Celsius.
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4.3.4 Methods of evaluation
4.3.4.1 Histology
Samples of tissue or cell-seeded matrices were embed either plastic or in
paraffin using standard techniques (Appendix E). Samples containing bone
were first decalcified in 15% EDTA decalcifying solution, pH 7.4 (Appendix E).
Decalcification took approximately 4-6 weeks, depending on the amount of
bone remaining on the sample. Histological sections were cut at 7 gm for
paraffin sections, and 5 gm for GMA. Slides were coverslipped and sealed with
Cytoseal 60 cell-mounting medium (Stephens Scientific #8310-16, Riverdale,
NJ).
Samples were stained with one or more of the following stains, listed with their
primary uses (complete protocols are found in Appendix F):
* hematoxylin and eosin (general tissue and cell morphology)
* safranin O/fast green (stains sulfated proteoglycans deep red)
* Masson's Trichrome (reveals collagen fiber structure)
* aniline blue (used to stain matrix structure for pore analysis)
4.3.4.2 Immunohistochemistry
Selected paraffin embed specimens of both in vivo and in vitro experiments
were stained with antibodies to type I collagen, type II collagen, link protein,
fibronectin, and a-smooth muscle actin. All staining protocols used the ABC
colorimetric staining method. Protocols for each of these procedures are found
in Appendix G).
4.3.4.3 Histomorphometric evaluation
4.3.4.3.1 Quantitative evaluations
Overview of defects with healing tissue: Quantitative analysis of the entire
defect area of the selected sections was performed with the aid of an eyepiece
reticle inscribed with a 10 line by 10 line square grid. An overview of the
process is given in Appendix H. In the evaluation process, the geometry of the
defect was first defined, then certain healing characteristics were determined as
an areal or linear percent of the appropriate parameters. These percentages
refer only to the representative histological cross-section through the middle
portion of the defect. They do not imply values equivalent to the actual
volume percents of tissues in the defects. Due to edge effects (regenerating
tissues tended to form at the periphery of the defect), only sections
representing 60% or more of the defect diameter were analyzed. Sections taken
too close to the edge of the defect could preferentially show regeneration,
which could give misleading data.
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Grading was performed at a magnification of 100 times (a 10 X objective and
10 X eyepiece), with each grid opening measuring 60 micrometers on each
edge. The defect area was calculated as a rectangle of base, b, equal to the
distance along the base of the defect at the tidemark, and height, h, equal to
the average height of the articular cartilage 600 micrometers lateral to the two
edges of the defect (see Appendix H). The height was recorded away from the
margins in this standard manner to reflect the original height of the defect; the
height of the cartilage at the edge of the healing defect was normally slightly
depressed relative to the original height of the cartilage, a finding associated
with rounding of the surface at the defect edge and flow of material into the
defect during healing. (The average dimensions of a defect in histological
cross-section were approximately 0.64 millimeters by 3.4 millimeters.) The
area of each specific type of tissue within the defect was measured by counting
the number of grid openings that fell on that specific tissue type. The actual
defect shape was that of a trapezoid, as the heights of the cartilage on either
side of the defect were not necessarily identical. Dividing the area of the
specific tissue type by the total defect area yielded an areal percent.
Additional quantitative measures included the percent of the total length of
the base of the defect (0 to 100 per cent) that was bonded to the healing tissue,
and the percent of the total length of the edges of the defect (0 to 100 per
cent) at which repair tissue integrated with the adjacent cartilage. The final
parameter recorded was the percentage of the length of the calcified cartilage
with a normal appearance (0 to 100 per cent).
4.3.4.3.1.1 Definition of tissue types
Foreword on matrix flow: Matrix flow, e.g. apparent bulging of adjacent articular
cartilage into the space created by the defect, is thought to represent a
mechanical flowing of adjacent tissue into the defect (as opposed to proliferation
of this adjacent tissue). This flow did not extend laterally into the defect beyond
a distance approximately equal to the thickness of the cartilage layer. The
flowing matrix occupied space in the defect, but did not represent newly
synthesized repair tissue. Matrix flow material could usually be readily
identified in areas at the periphery of the defect. Areas of flow appeared as
hyaline tissue continuous with the adjacent cartilage. This flowing material
often displayed a variety of degenerative changes such as cloning and loss of
matrix staining. The extent of these changes was reflected in the grading of
adjacent cartilage (see below, semiquantitative grading). The collagen fibers
under polarized light and the columnar architecture appeared continuous with
the adjacent cartilage, but bent over, leaning into the defect. The collagen fibers
bent over as much as 900, with some parts touching the base of the defect, but
they did not attach to the calcified cartilage. Matrix flow was recorded
separately in grading of tissue types within a defect.
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Five tissue types (fibrous tissue, fibrocartilage, hyaline cartilage, articular
cartilage, and bone) were distinguished on the basis of the appearance of cells
and matrix when examined by normal microscopy and polarized light
microscopy. Representative micrographs of selected tissues are shown in Figure
4-5. Fibrocartilage was further subdivided into three distinct subsets. Safranin
O staining was used to identify the presence of sulfated glycosaminoglycans. A
summary of the major characteristics of each soft tissue type is presented
below:
a) Fibrous tissue consisted of spindle-shaped cells with bipolar, tapered ends
and elongated nuclei. The cells were intimately associated with
surrounding collagenous matrix and did not reside in lacunae.
The matrix contained type I collagen fibers, oriented parallel to each other,
which formed bundles roughly parallel to the surface. The collagen fibers
were clearly visible at low power under polarized light, and the matrix did
not stain positively for glycosaminoglycans.
b) Fibrocartilage had characteristics intermediate between fibrous tissue and
hyaline cartilage. Some matrix domains stained for glycosaminoglycans. The
visibility of fibers in the matrix distinguished this tissue from hyaline
cartilage. Cells were rounded, and often resided in lacunae, thus
distinguishing fibrocartilage from fibrous tissue. There were different three
versions of fibrocartilage. Often, these tissues were closely juxtaposed, with
indistinct borders between them due to gradual changing of cell or matrix
characteristics:
i. Type 'a' resembles fibrous tissue, except that cells are ovoid or rounded
instead of spindle shaped. The cells lack lacunae. The matrix is usually
highly oriented and stains for type I collagen, but does not stain with safranin
O or type II collagen.
ii. Type 'b' fits the traditional definition of fibrocartilage, such as that seen in
meniscus. The matrix is fibrous, but often disoriented. The cells are
chondrocyte-like, including lacunae. The matrix sometimes stained for type I
and/or type II collagen.
iii. Type 'c' is similar to hyaline tissue, except that the matrix retains some
fibrous characteristics. While not completely fibrous like types 'a' and 'b', the
matrix has some visible fibers and often has a patchy or cloudy appearance,
with variable safranin O staining. There is normally much more staining for
type II vs. type I collagen. The cells normally resemble chondrocytes,
complete with lacunae, although some may appear slightly immature.
c) Hyaline cartilage was identified primarily by the characteristic appearance
of its type II collagen matrix. No individual collagen fibers or bundles were
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Figure 4-5. Light micrographs of tissue types found in articular cartilage and healing defects. E) Normal
articular cartilage stained with safranin O/fast green. D) Hyaline cartilage stained with safranin O/fast
green. Note the complete absence of red safranin O staining for glycosaminoglycans. C) A mixture of
hyaline cartilage (bottom of figure) and fibrocartilage (top of figure). This fibrocartilage is nearly hyaline
in appearance. B) Fibrocartilage stained with Masson's Trichrome. Note the fibrous nature of the matrix
and chondrocytic appearance of the cells. A) Fibrous tissue, hematoxylin and eosin stain. The collagen
fibers and elongated cells are aligned parallel to the tissue and joint surface.
visible in the matrix. The hyaline matrix also had a distinctive appearance
under polarized light, with diffuse transmission through the matrix except
where the large collagen bundles were seen inserting into the calcified
cartilage at the tidemark.
Cells displayed a spherical morphology (except near the surface where they
were usually elongated as in normal articular cartilage). Normally, the cells
in hyaline cartilage have well-developed lacunae, and pericellular staining
by safranin O is more intense than interterritorial matrix staining.
However, tissue lacking normal safranin O stain or cellular appearance was
seen and graded as hyaline. Portions of hyaline cartilage which met the
histological criteria of articular cartilage, including complete matrix
staining and columnar arrangement of cells, were recorded as a subset of
hyaline cartilage.
d) Articular cartilage was defined as a specialized subset of hyaline tissue
which displays the distinctive organized articular structure including:
columnar arrangement of cells at the base; an arcuate collagen fiber
structure originating with thick fibers rising perpendicularly from the
calcified cartilage, then arching to becoming thin fibers running parallel to
the surface; a limited region lacking safranin O staining at the surface; the
flattening of chondrocytes in a horizontal plane near the surface; and other
characteristic variations in chondrocyte density and staining intensity from
superficial to deep regions. These histological features, as well as cell
density, matrix staining, and appearance under polarized light were
required to be near normal, as made by comparison with adjacent healthy
cartilage. Due to the variations with depth, reparative tissue was judged
according to its position relative to the base of the defect. While
attachment to the calcified cartilage was required for tissue to be deemed
"articular cartilage", continuity with other adjacent tissues was not. In
addition, the overlying tissue did not need to complete the articular
structure as long as the deep portions were intact.
e) Bone was defined as any tissue with a histological appearance more closely
resembling bone than cartilage.
4.3.4.3.1.2 Descriptions of quantitative categories examined
Total defect filling: given as an areal percent of the original defect site filled with
any type of tissue, but NOT matrix flow. Filling was measured by counting
grid boxes filled by reparative tissues (Appendix H). Material which may have
been left over from surgery was included. Only material in or above the
original defect site (not below) was counted. Tissue overflowing the surface
could result in greater than 100% filling.
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Individual tissue types (percentage of defect area that was articular cartilage,
hyaline cartilage, fibrocartilage, fibrous tissue, or bone): given as an areal
percentage of total defect area. Because the very surface of the cartilage often
had a more fibrous appearance, when thin layers of fibrous material (3 cells or
less) were found at the surface of the defect and appeared continuous with
another tissue type just below the surface, this tissue was not graded as fibrous
tissue. It was instead included with the underlying tissue type.
Bonding of repair tissue to the calcified cartilage: For reparative tissue to be
bonded to the base of the defect, the calcified cartilage layer was required to
be intact. Bonding criteria were based on collagen fiber continuity from
reparative tissue to calcified cartilage, not simply by apposition of the two
surfaces. Very thin bonded hyaline regions- about 20 [m or 1/3 box- were
presumed left from creation of the defect and were excluded. All larger areas
of bonded tissue are counted, even those that may have never been removed
during surgery at the defect margin.
Attachment of repair tissue to adjacent cartilage: given as a percentage of the
vertical length (perpendicular to the base- NOT along any contours of flow or
damage) of both edges of the defect. The height of the attached tissue from
the two edges were totaled, then converted to a percent by dividing by the
total defect height (the two edge heights added together). This grade was
somewhat subjective, judging the useful integration of repair tissue to the
adjacent cartilage. This judgment is based primarily on the appearance of at
least some collagen fibers integrated at the interface. Polarized light was used
as much as possible. Tissue was excluded from the "attached" category if the
appearance of features or borders (other than a change in matrix staining)
parallel to the defect edge suggested a lack of integration.
Percentage of length of calcified cartilage with normal appearance: given as a
linear percentage of the entire length of the original defect. Abnormalities in
the calcified cartilage included pits, large cracks, fissures, resorption, thinning,
or invasion by vasculature. Microfractures (small cracks not more than 20
gm wide and 30 tm deep) were distinguished from larger cracks and were
judged as normal. Microfractures occurred in almost all samples at surgery.
4.3.4.3.1.3 Method of performing measurements
To ensure reproducibility in grading, markings were made on photographs of
each defect to define the defect margins (edges and, if not clear due to
significant bone remodeling, the base). Photographs were taken with a 4 X
objective lens, with 2 exposures needed to capture the entire defect.
Identification of defect margins: The edges of the defect were not always
obvious, especially in the case where tissue presumably left at the defect edge
at surgery was not completely separated from the adjacent cartilage. In
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general, the fissures made by the dermal punch were distinguishable at least by
higher power microscopy (20-40 X) or with the use of polarized light. The
lateral most fissure consistent with the operation to create the defect was
chosen as the edge. Fissures and damage to the defect periphery sometimes
made it difficult to distinguish matrix flow from small amounts of remnant
material in the corners of the defect.
The base of the defect was defined by the tidemark with two exceptions. First,
when there was significant bone remodeling, the calcified cartilage and tidemark
were often resorbed. Second, in rare cases after resorption, bone reformed within
the defect area clearly above the level of the adjacent tidemark. In these cases
the path of the base was estimated with straight or slightly curved paths
(reflecting the anatomy of the specific defect being analyzed) between points of
the actual tidemark (points clearly connected to the adjacent cartilage at the
correct level).
Recording measurements: All measurements were made without photo eyepiece
magnifiers engaged. The units of measurement were either square grid areas (for
areal measurements) or grid edge lengths (for linear measurements). Heights
were always measured perpendicular to the base. Base measurements were made
along the actual or estimated path of the tidemark.
Grading of mixed tissue types: Certain regions of tissues seen in healing were not
clearly assignable to a single tissue type. These regions were either intermediate
between two tissue types, or an intermingled combination of two tissues. In cases
such as these the grader made a judgment on the relative contributions of the
contributing tissue types, and assigned relative percentages of the area of these
tissues accordingly. Example 1: 40 grid areas with a fibrous matrix contains
about 80% elongated cells and 20% rounded cells. The grader marked 32 units
fibrous tissue and 8 units fibrocartilage, type 'a'. Example 2: 40 grid area of
tissue with rounded cells in lacunae display a matrix which was neither clearly
blurry nor clearly hyaline. The grader split the tissue types and marked 20 units
of fibrocartilage, type 'c' and 20 units of hyaline cartilage.
4.3.4.3.1.4 Assessment of interobserver error
A separate experiment was conducted to evaluate interobserver error in grading
of tissue types. Three observers took part in this study: 1) The author, HB,
who developed the criteria; 2) a graduate student, CL, previously unskilled in
histology/pathology who was trained in depth on how to use the scale by HB,
and 3) a pathologist, QW, given minimal training on the scale by the author.
Ten histological sections were selected to provide a broad range of defect
appearance with respect to tissue types, filling, geometry, integrity of
surrounding tissues, and perceived ease of grading. Each defect was graded for
geometry and tissue types blindly by each of the three authors. Interobserver
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agreement was assessed by computing the mean, standard deviation, and
covariance among the three observers for each category on each sample.
4.3.4.3.2 Semiquantitative grading of pathological changes to surrounding
structures
Semiquantitative grading was based on a qualitative assessment: scores ranged
from 0 to 3, with 3 representing tissue similar to normal. A score of 0
represented severe damage or degenerative change; 1, moderate degenerative
change; and 2, slight degenerative change. Categories examined included the
state of the subchondral bone and the effects on the adjacent cartilage:
glycosaminoglycan staining, cloning, and the integrity of the surface and
deeper tissues.
4.3.5 Characterization of the initial lesion
Six fresh defects were processed for histology immediately after their creation
and examined to demonstrate the extent of the original lesion. These defects,
identical to those used for the treatment groups, were created in three dogs
immediately after the animals were euthanized. Each original, untreated
defect was serially sectioned through approximately sixty percent of the defect
width. At least eight sections, spaced approximately 250 micrometers apart,
were examined.
The amount of articular cartilage remaining in the defect was determined in
three transverse sections made through the middle of the lesion. The values
were recorded as the percent of the total area of the defect and included: 1)
cartilage remaining in the corners of the defect, and 2) cartilage remaining
elsewhere on the base of the defect. Additional parameters, related to the
inability to remove all cartilage to the tidemark, were expressed as the percent
of the length of the defect base and included: 3) the percentage of the base of
the defect covered by residual articular cartilage, and 4) the percent of the
base with damaged calcified cartilage. Cartilage was described as damaged if
there was evidence of thinning, or if there were large fractures, more than 20
micrometers wide or 30 micrometers deep from the tidemark. Fractures
smaller than the stated size were termed microfractures and were not included
as damage (see Figure 5-23).
4.4 Statistics
The predominant methods for evaluating quantitative data were ANOVA and
the students t-test. ANOVA was used for all experiments with more than two
experimental groups. One-way ANOVA and balanced 2-way ANOVA were
performed on Microsoft Excel software, while unbalanced 2-way ANOVA was
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performed with BMDP software at the Orthopedic Biomechanics Laboratory,
Beth Israel Deaconess Medical Center, Boston, MA.
T-tests were used for comparison of data with 2 groups. All t-tests were
performed on Microsoft Excel with the assumption of equal standard
deviations. In certain cases, such as animal with empty defects in one leg and
treated defects in the contralateral leg, a paired t-test was employed.
Statistical analysis of semiquantitative data was performed using the Mann-
Whitney ranked order test, computed by hand.
The number of samples chosen for the study of the effect of microfracture and
engineered type II matrices was determined by a power calculation based on
results from previous studies in the model (Appendix I). This calculation was
performed by hand.
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5. Results
5.1 Chemical composition and pore characteristics of the collagen-
GAG analogs of extracellular matrix
In many of the matrices, the pore structure of the two surfaces differed in
appearance, and sometimes also from the bulk. It was common for at least
one surface to contain material aligned primarily with the surface. This
structure created a sheet across the surface (sometimes with smaller pores than
the bulk), and was normally found on the surface which was exposed to air in
freezing. It was also normal for the other side of these matrices, exposed to the
stainless steel pan during freezing, to have more open (and sometimes larger)
pores. An example of the pan and air surfaces of a matrix are shown in Figure
5-1.
5.1.1 Type I matrices
In these matrices, the surface contacting the pan during freezing was judged to
have a more open pore structure, and is therefore described as the more porous
surface (Figure 5-1).
The average pore diameter of the two different type I matrices made from
bovine hide and previously analyzed were:
* 27 gm ("small-pore")
* 83 gm ("large-pore")
top
(air)
bottom
(pan)
Figure 5-1. Photomicrograph showing the air (top- less porous) and pan
(bottom- more porous) surfaces of a type I collagen-GAG matrix. The
matrix is approximately 2 mm thick. Aniline blue stain.
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The calculated and measured GAG content of type I matrices are shown in
Table 5-1.
n=3 GAG content
measured
Matrix (mean ± SD) calculated
Type I hide 7.7% + 1.3% 7.4 %
Type I tendon 8.7% + 0.1% 8.6 %
Table 5-1. Glycosaminoglycan content of type I collagen matrices as a
percentage of total dry weight (mean ± SD). n=3 samples from each group
were analyzed. For type I materials, calculated values are from dry weights
of purified components used to make the slurry.
5.1.2 Type II matrices
Type II matrices differed from type I matrices in that they contained remnant
block-like features of varying size that contained features consistent in
appearance with a hyaline matrix and empty cell lacunae. These blocks
ranged from slightly thicker than pore walls (approximately 10 gm) to as large
as 120 jim by 1000 gm or 300 jim by 400 pm. The pore structures of these
matrices varied considerably with controlled changes in the processing
conditions.
Analysis of matrices received from Geistlich Biomaterials. Two different
primary batches of Geistlich matrices were evaluated. The first batch was used
in the in vitro experiment comparing matrices of varying chemical
composition and in early canine implant studies (batch #915905). The second
batch was used in in vitro experiments of the effect of cross-linking and cell-
seeding density. Five sub-batches of these matrices, numbered 914X06 (X=l to
5), were intended to differ only in degree of cross-linking. The pore
characteristics of two different sub-batches (not cross-linked, #914106, and
cross-linked 2 days, #914306) were evaluated. These data are presented in
Table 5-2.
average pore standard percent
batch diameter (gm) deviation porosity
not cross-linked (914106) 297 66 87
2-day cross-linked (914306) 298 13 8 8 8
early implants, test of
chemical composition (915905) 86 - 85
Table 5-2. Pore characteristics of Geistlich matrices.
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The GAG content of these matrices is found in Table 5-3 under the heading
"Geistlich", measured from batch 914306. Measurements of matrices from
batch 915905 also gave values of approximately 2%.
n=3 GAG content
Matrix (mean ± SD)
Type II, "Geistlich" 2.0% + 0.1%
Type II, small pores 3.1% + 0.1%
Type II, medium pores 3.0% + 0.1%
Type II, large pores 2.9% + 0.03%
Table 5-3. Glycosaminoglycan content of type II collagen matrices as a
percentage of total dry weight (mean ± SD). n=3 samples from each group
were analyzed.
Analysis of matrices synthesized with different pore diameters. The dry
thickness of the small-pore matrix (approximately 3.3 mm) was slightly greater
than that of the medium- and large-pore matrices (approximately 3.0 mm).
Small- and medium-pore matrices had a fairly homogenous appearance
(Figure 5-2a), although a region of the small-pore matrices very close to the
edge of the specimen had even smaller pores. Since this was a minor portion
of the specimen, these pores were not analyzed. The large-pore matrices,
however, were divided roughly into thirds, exhibiting a "sandwich" type
structure. The outer surfaces (the 'air' surface and 'pan' surface) had very
large pores, while the center third had much smaller pores. The transition
between these areas was generally abrupt (Figure 5-2b). The pore diameters of
these two different regions within the larger-pore matrices were graded
separately. The pore diameters for all three types of matrices are given in
Table 5-4.
average pore percent
structure diameter (gm) porosity
small-pore 52 + 9 91
medium-pore 88 + 14 90
large-pore (outer pores) 257 ± 41 86
large-pore (center pores) 44 ± 2 87
canine implants 86 + 8 93
Table 5-4. Pore characteristics of type II matrices of varying pore size. Pore
diameter given as mean ± S.D.
The pore size of the type II implants for the canine study of the effect of
microfracture closely matched that of the medium pore matrices produced
under identical conditions in different batches (Table 5-4).
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Figure 5-2. Scanning electron micrographs of a) small-pore and b) large-pore
type II matrices. The small-pore matrix (a) has a homogenous structure.
The large-pore matrix (b) has very large pores near the surface (bottom-
right of micrograph), and very small pores in the middle region (upper-left
of micrograph). The transition between the two different regions is abrupt
and clearly seen (arrow).
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5.2 In vitro experiments
5.2.1 Parameters related to seeding
The specific results of the experiments designed to optimize seeding of matrices
are presented below:
Effect of medium addition. The number of cells remaining in each construct
before and after medium addition is shown in Figure 5-3. Across all groups,
the number of cells remaining in the matrix at one day were comparable. Up
to three hours, about 70% of the cells delivered to the matrix were retained
after addition of medium. The percentage retained was increased by letting
the cells equilibrate to the matrix for 6 hours. The change of medium at one
day did not wash out additional cells.
Effect of matrix type and experimenter. The quantitative results of this
experiment are shown in Figure 5-4. Under identical seeding conditions, the
type II matrices absorbed significantly more cells than type I matrices of
approximately the same volume. This difference was consistent for the two
experimenters.
Effect of cell number and surface(s) seeded. Doubling the number of cells
seeded to one side (1 million vs. 2 million) significantly increased the number
of cells retained by the matrix (p=0.002, 2-tailed t-test), but did not double
this value (1.12 million vs. 0.73 million) (Figure 5-5). Seeding 1 million cells
on each surface also increased the number of cells contained in the matrix
(p=0.00002, 2-tailed t-test), and did approximately double this value to 1.44
million. Finally, the two-sided seeding with 2 million cells delivered more cells
to the matrix than the one-sided seeding with 2 million (p=0.001, 2-tailed t-
test).
Effect of coating of culture wells: Seeding in agarose-coated culture wells was
technically easier than with other conditions, primarily because the agarose
coating raised the matrix to a position where it was easier to manipulate. In
addition, flipping matrices in the agarose was easier, and the agarose formed a
slightly dimpled surface which collected some of the excess medium from
seeding. The flipped matrix easily settled into this depression, and spread out
due to the slight pool of medium. The number of cells retained in each matrix
as a function of well coating and seeding condition is shown in Figure 5-6. In
both conditions, there was a uniform increase in number of cells in going from
uncoated to polyHEMA-coated to agarose-coated wells. These trends were
found significant by ANOVA in both the 5-mm matrices (p=0.016) and in the 9-
mm matrices (p=0.003). The increase from uncoated to agarose-coated wells
was approximately 75% (174,000 ± 13,000 to 305,000 ± 58,000, mean ± SEM) in
the 5-mm matrices and 36% (418,000 + 54,000 to 568,000 ± 47,000, mean ±
SEM) in the 9-mm matrices.
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T of medium
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1 day
20 min 1 hour 3 hour 6 hour
Time of first sacrifice and medium addition
Figure 5-3. Cells retained in matrices when medium was added at different
times based on DNA analysis; n=4 samples per group. Data given as mean
+ SEM. The number above each column indicates the percent of cells lost
from medium addition and culture to 1 day.
12.5-
O type I
S 10 T
75 type II
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Experimenter #1 Experimenter #2
Figure 5-4. Effect of experimenter and matrix type on cells retained in
chondrocyte seeding; n=4 when not indicated. Data given as mean ±SEM.
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1 million, 2 million, 1 million each,
porous side porous side both surfaces
Seeding condition
Figure 5-5. Effect of cell number and surface seeded on cells retained
in type I collagen matrices 3 hours after seeding; n=4. Data given as
mean ± SEM.
none
I I Io
polyhema
i I
agarose
Coating
Figure 5-6. Effect of well coating and matrix size on cells retained in
chondrocyte seeding of type I matrices; n=4 except as noted. Data
given as mean ± SEM.
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Effect of filter drying: The results of the two experiments examining the effect
of filter drying are presented in Figures 5-7 and 5-8. When matrices were
unconfined (Figure 5-7), filter drying increased the number of cells seeded into
all three sizes of matrices, but with a p-value of only 0.252 by 2-way ANOVA.
When small matrices were partially confined in small wells (Figure 5-8), there
was no effect from filter drying (same result with all coatings). One
unexpected finding in these experiments was the higher number of cells found
in 7 mm vs. 9 mm matrices. This may in part be attributed to the larger
standard deviations in this experiment, as it was one of the first performed
and the experimenters technique was not yet well-practiced.
Effect of confinement of matrices: The number of cells retained in 5-mm cores
under unconfined and partially confined conditions are shown in Figure 5-9.
More cells were found in the confined condition for both wet and filter-dried
matrices. This effect was found significant by 2-way ANOVA (p=0.014).
Summary of seeding results: The following parameters were found to improve
the number of cells delivered to a matrix: removing excess medium on filter
paper ('drying' the matrices), seeding on agarose lined wells, constraining the
matrix, and dividing cells aliquots to seed on both surfaces. Approximately
70% of delivered cells were retained after normal patterns of medium addition.
5.2.2 Interaction of chondrocytes with matrices of different chemical
composition
Comparison of pore structure: The pore structures of the type I and type II
matrices were found to be comparable (Table 5-5). The primary difference in
appearance was the finding of block-like structures throughout the type II
material (see section 5.1.2).
Matrix Pore Percent Pore Wall
Diameter Porosity thickness
Type I 83 gm 87 % 11 gm
Type II 86 gm 85 % 13 gm
Table 5-5. Comparison of key pore characteristics of the predominantly type I
and type II collagen matrices used for chondroctye culture.
Chondrocyte culture in agarose. Passaged chondrocytes always adopted a
flattened morphology on plastic substrates, and, when cultured in agarose,
reverted to a rounded morphology. This experiment was repeated several
times with canine chondrocytes after varying number of passages and different
cell density with similar results.
89
5 mm 7 mm 9mm
Matrix diameter
Figure 5-7. Effect of filter drying and matrix size on cells retained in
seeding of type I matrices; n=4. Data given as mean ± SEM.
none PH agarose
Coating
Figure 5-8. Effect of filter drying and matrix coating on cells retained in
seeding
mean ±
of partially constrained type I matrices; n=4. Data given as
SEM.
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Figure 5-9. Effect of partial cell constraint on cells retained in seeding of
type I matrices; n=4. Data given as mean + SEM.
Gross observations, contraction measurements: After 7 days, the surface of
cell-seeded type I specimens had fibrous appearance and the specimens had
decreased in diameter from 4 mm to an average size of 2.8 mm ± 0.08 with
curling at the edges of the implants. The type II sponges maintained a flat
surface and displayed no shrinkage after 7 days (4.0 mm ± 0.03). The
difference in diameter was found statistically significant (p<0.05, 2-tailed t-
test).
Cell morphology: At all time periods, a significantly greater percentage of cells
in the type II sponge displayed the spherical morphology consistent with
chondrocytic phenotype, when compared with cells in the type I material
(Table 5-6).
3 hours 7 days 14 days
Tye I Tye II Tye I Tye II TyeType   pe ype II
rounded 22 ± 1 68+ 4 27 ± 2 70 ± 1 30 ± 4 60 ± 1
elongated 69 ± 1 25 + 2 63 + 3 22 + 2 62 + 3 35 + 1
not assign. 9 ± 1 7 + 2 10 ± 1 8 ± 2 8 + 1 5 ± 0.5
Table 5-6. Percentage of chondrocytes with different cell morphologies in
matrices of different chemical composition, predominantly either type I or
type II collagen. Data given as percent of total cell number, mean ± SEM.
91
By three hours after the seeding the cells in the type I matrix spread along the
walls of the sponge and 69 ± 1 % of the chondrocytes took on a fibroblast-like
morphology. At the same time period, 68 ± 4 % of the cells in the type II
matrix displayed spherical cell shape. In the type II sponge, the cells were
initially more uniformly dispersed in the porous structure. After one week
some pericellular matrix had formed around spherical cells in the type II
matrix (Figure 5-10a), whereas in the type I material the cells mostly
maintained fibroblastic appearance (Figure 5-10b). By two weeks, clusters of
round shaped cells with small amounts of surrounding matrix had formed (in
the type II matrix. In contrast, at two weeks in the type I matrix, cells
attached in a flattened morphology and formed a dense fibroblast-like layer of
elongated cells on the surface.
Inside the type I construct, an increasing percentage of spherical cells were
observed with time. However, after 14 days, 60 + 1 % of the cells in the type II
sponge continued to display spherical shape, compared with 30 ± 4 % in the
type I. Statistical analysis by ANOVA showed a significant difference in cell
morphology between the two matrices (p<0.01). There was no significant
difference between the two types of material in the amount of cells, that were
not assigned to a category of cell morphology. The percentage of
undetermined cells ranged from 5-10 %.
Histochemistry and Immunohistochemistry: There was no safranin O-staining
matrix in the intercellular area of chondrocyte-like cells in either type of
sponge after three hours. Safranin O stained lightly the pericellular matrix
around spherical cells in the one- and two-week implants in the type II sponge.
But there was no significant increase of the stained areas of the two-week
samples compared to the one-week specimen. Positive staining was only seen
in cell aggregates and was distinctive in the intercellular area of the spherical
cells.
Immunohistochemistry revealed positive type II collagen antibody staining of
pericellular matrix of spherical cells in the type II sponge, but this was often
difficult to distinguish from positive staining of the degrading pore walls.
There was no staining for type II collagen in the type I sponge.
Biochemical Assay: One sample was lost in the type I group at the 14-day time
point. There was a higher amount of DNA in the unseeded type II collagen
sponge than in the type I sponge: 0.83 gg ± 0.02 vs. 0.61 gg ± 0.02 (mean ±
SEM). The net values of DNA content, after subtracting the values for unseeded
sponges, are presented in Figure 5-11. At three hours, more cells were retained
in the type II matrix (p< 0.10, 2-tailed t-test). Both groups showed increases in
DNA content from 3 days to 7 weeks (type I: p<0.03; type II: p<0.04, 2-tailed t-
test). However, from 7 to 14 days, cells continued to proliferate in type II
matrix (p<0.13, 2-tailed t-test) while there was no change in type I matrices.
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Figure 5-10. Light micrographs of chondrocytes in predominantly type I (a)
and type II (b) collagen matrices 7 days after seeding (hematoxylin and
eosin stain). (a) Cells in the type I matrix are primarily elongated along
the matrix walls. (b) Cells maintain a more rounded morphology in the
type II matrix. Small amounts of pericellular matrix can be detected
around cell clusters (arrow).
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Figure 5-11. DNA content of chondrocyte-seeded matrices of varying
chemical compostition. Unseeded values have been subtracted; n=3.
Data given as mean ± SEM.
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Figure 5-12. Net glycosaminoglycan accumulation in chondrocyte-seeded
matrices of varying chemical composition with time. Three-hour values
have been subtracted; n=3. Data given as mean ± SEM.
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The 14-day result showed more cells in the type II matrices compared to type I
matrices (p<0.13, 2-tailed t-test).
The mean GAG contents of the unseeded type I and II sponges were 5.05 ± 0.36
and 6.35 ± 0.07 gg/sponge, respectively. The increase in GAG content in both
types of matrices relative to the value of the seeded matrix at 3 hours is shown
in Figure 5-12. All values were significantly increased compared to the 3-hour
value (maximum p value =0.007, 2-tailed t-test). 14-day values were greater
then 7 day values in both groups (type I: p<0.0 6 ; type II: p<0.09, 2-tailed t-
test). The increase in GAG from 3 hours was greater in type II matrices versus
type I matrices at 7 days (p<0.03, 2-tailed t-test) and at 14 days (p<0.17, 2-
tailed t-test).
5.2.3 Effect of cross-linking treatment and cell seeding density
Gross observations of degradation: The ability to handle matrices was used as
a practical measure of resistance to degradation. Not cross-linked, unseeded
matrices were already noticeably soft and somewhat difficult to pick up with
forceps at one day in culture. At one week, not cross-linked, unseeded matrices
completely fell apart into small pieces when disturbed. Seeded matrices could
not be picked up whole by forceps, however, although they were extremely soft,
they could be moved with a spatula. The not cross-linked matrices were not
suitable for longer culture experiments.
Matrices DHT cross-linked for 1 to 4 days, whether seeded or unseeded, all were
easily picked up by forceps for up to 2 weeks. Seeded matrices at these times
seemed slightly more stiff than unseeded matrices. There was no gross
difference in size of the seeded and unseeded matrices at these times. Only
matrices cross-linked by UV, 1 day DHT, and 4-day DHT were cultured for 4
and 6 weeks. All of these matrices could be picked up by forceps at 4 weeks,
however unseeded matrices were noticeably softer. Also, the UV-cross-linked
matrices began to delaminate in a plane parallel to the surfaces of the cores
(although they maintained stiffness at least that of the 4-day DHT matrices).
Some pieces came completely apart by 6 weeks, although the seeded matrices
could still be picked up with forceps. By 6 weeks, only the 4-day DHT, seeded
samples could be handled by forceps. One-day DHT seeded samples were
noticeably softer and had to be handled with a spatula. Small pieces were
breaking off the matrix at this time. Unseeded matrices cross-linked by DHT
were softer still, and had to be handled very carefully with the spatula to
avoid breaking them up.
Biochemical data: A biochemical analysis of unseeded matrices is included in
Appendix J. This analysis measured the degree of loss of matrix components
over the 6 weeks in culture, and provided another type of estimate of the
resistance to degradation.
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The DNA content of seeded matrices (seeded at two different densities) is
shown in Figure 5-13. The values for unseeded matrices were subtracted. The
DNA content of all groups decreased with time. For either seeding density, the
patterns seen in the 1-day and 4-day DHT groups were essentially the same,
with slightly higher values in the 4-day group vs. the 1-day group. However,
for a given degree of cross-linking, the trends for the two different seeding
densities differed. The DNA content in the high seeding density group was
initially higher, but fell much more rapidly than in the low seeding density
group. By 6 weeks, the DNA content of all groups was very similar, equal to
approximately 300,000 to 400,000 cells.
20
low seeding density
S(n = 1 or 2) UV
o ....... DHT 4 day
0
rc (n =3)
0 10 - high seeding density
S UV
.............................. (n = 3)---- DHT 1 day
S 5 -.... - DHT4day
I I I I
0 10 20 30 40 50
Time (days)
Figure 5-13. Net DNA content of chondrocyte-seeded type II collagen
matrices of varying degree of cross-linking in culture up to 6 weeks.
Three different cross-linking treatments are indicated in the legend.
Unseeded values have been subtracted. Data given as mean + SEM.
Initial numbers of cells delivered were 3.2 million (high seeding density,
solid lines) and 1.6 million (low seeding density, dashed lines).
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The GAG content of these matrices is shown in Figure 5-14. Again, for each
seeding density, values for the 4-day DHT groups were higher than those for the
corresponding 1-day DHT groups. Given a seeding density, the patterns of the
corresponding changes with time were identical in the 1-day and 4-day groups.
In contrast, for each degree of cross-linking, patterns based on seeding density
differed (although not statistically significantly): matrices seeded at low
density continued to increase the accumulated GAG content from 4 to 6 weeks,
while those seeded at high density exhibited an overall loss of GAG from 4 to 6
weeks.
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Figure 5-14. Net accumulated glycosaminoglycan content of chondrocyte-
seeded type II collagen matrices of varying degree of cross-linking in culture
up to 6 weeks. Three different cross-linking treatments are indicated in the
legend. Unseeded values have been subtracted. Data given as mean + SEM.
Initial numbers of cells delivered were 3.2 million (high seeding density, solid
lines) and 1.6 million (low seeding density, dashed lines).
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5.2.4 Effect of matrix pore diameter
5.2.4.1 Pore diameter in type I matrices
Comparison of pore structure: The predominant difference in pore structures
of the small- and large-pore type matrices was pore diameter (Table 5-7).
Matrix Pore Diameter Percent Porosity Pore Wall thickness
Type I, small pore 20 ptm 83 % 7 gm
Type I, large pore 83 gm 87 % 11 Rm
Table 5-7. Comparison of key pore characteristics of small- and large-pore
collagen matrices used for chondroctye culture.
Matrix contraction: The large- and small-pore type I matrices underwent a
comparable amount of shrinkage: 30 % for the large-pore diameter matrix
(from 4.1 ± 0.1 mm at three hours to 2.8 ± 0.1 mm after 7 days) and 35 % for
the small-pore material (from 4.9 ± 0.1 to 3.2 ± 0.2 mm).
Morphological data: The percent of cells graded as rounded, elongated, or not
assigned is shown in Table 5-8. At 3 hours, there were more rounded cells (and
fewer elongated cells) in the small-pore matrices than the large-pore matrices
(p<0.0001, 2-tailed t-test). By 7 days, there was no difference in rounded cells.
3 hours 7 days
pores: small large small large
rounded 43 ± 1 22 + 1 27 + 1 27 + 2
elongated 48 + 1 69 + 1 68 + 1 63 + 3
not assigned 8 ± 1 9 + 1 5 ± 1 10 ± 1
Table 5-8. Percentage of chondrocytes with different cell morphologies in type
I collagen matrices of different pore size. Data given in percent of total cells,
mean ± SEM.
Biochemical results: Unseeded small-pore matrices had a higher DNA content
(1.03 ± 0.02 gg vs. 0.61 ± 0.02 gg) and GAG content (11.9 ± 0.1 jgg vs. 5.0 + 0.4
gg) than unseeded large-pore matrices. The data for DNA content with
unseeded values subtracted are shown in Figure 5-15. DNA content increased
from 3 hours to one week in both matrices, with slightly higher increases in the
small pore matrices. Two-way ANOVA gave p-values of p=0.001 with respect to
time and p=0.23 with respect to pore size.
The change in GAG content from 3 hours to 7 days for these matrices is shown
in Figure 5-16. Small pore matrices exhibited a greater increase in GAG content
(p<0.11, 2-tailed t-test).
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Figure 5-15. DNA content of chondrocyte-seeded type I collagen matrices
of varying pore diameter. Unseeded values have been subtracted; n=3.
Data given as mean ± SEM.
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Figure 5-16. Net glycosaminoglycan accumulation in chondrocyte-seeded
type I collagen matrices of varying pore diameter. The change is from 3
hours to 7 days; n=3. Data given as mean ± SEM.
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5.2.4.2 Pore size in type II matrices
During seeding, additional aliquots of cell suspension were saved for DNA
analysis at six times throughout the seeding process (from beginning to end) to
verify the variability in the number of cells delivered to each matrix. The
coefficient of variation in DNA content of these aliquots was 3.7% (readings of
573 ± 21 units, mean ± SD).
Matrix contraction. All seeded matrices showed visible contraction by 1 week
in culture, and continued to shrink as long as 6 weeks. Shrinkage was
accompanied by the curling of the edges of the matrix. There was no
discernible difference in the amount of shrinkage among the varying pore sizes
(Figure 5-17). Each group shrank to roughly 55% of the original diameter.
Unseeded matrices showed no shrinkage.
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Figure 5-17. Shrinkage of chondrocyte-seeded type II collagen matrices of
varying pore size. Data given represents mean average diameter ± SEM;
n= 2 to 8.
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Histology. Histology showed varying degrees of cell penetration and
distribution related to the time in culture and pore size of the matrix seeded
(Table 5-9). At 2 hours very few cells penetrated into small-pore matrices,
slightly more penetrating medium-pore matrices, and many more cells in
large-pore matrices (Figure 5-18). All samples showed many cells attached to
the surface of the matrix. There was not a complete layer of cells on the
surface of any sample at this time.
penetration evaluated by:
time pore size dep th cell number
small 0 0
2 hour medium 1 1
(n=1) large 2 2
small 0 0
1 day medium 0 0
(n=3) large 2.7 1.7
small 1 1
1 week medium 1.3 1.3
(n=3) large 3 3
Table 5-9. Semiquantitative assessment of chondrocyte penetration into type
II collagen matrices of varying pore size. Data given as mean value. 0 =
minimal penetration, 3 = maximum penetration.
At one day, there was still little penetration of cells in small- or medium-pore
matrices. In large-pore samples, cells were found throughout the thickness in
the matrix, except in the central areas with the very small pores. Cell numbers
appeared slightly reduced in medium- and large-pore samples. The cells on
the surface began to align and form layers, generally only 1 cell thick at this
time. The cellular morphology varied but was generally ovoid to elongated.
The layers were slightly more complete on small- and medium-pore surfaces, in
part due to the highly irregular surface of the large pore matrices.
At one week, there was increased cell penetration of the matrix in small- and
medium-pore matrices, although still much less than in large-pore matrices.
Large pore matrices maintained a fairly even distribution of cells, however cells
still did not penetrate well into the smallest pore regions in the center. Cells
in the interior of the matrix were often found clustering, with visible
extracellular matrix surrounding them. This matrix did not stain measurably
for safranin O or type II collagen. At this time, there was a complete or nearly
complete layer of cells surrounding all surfaces in small- and medium-pore
matrices. This layer was thickest in small-pore matrices, often more than 5
cells thick on one surface, while typically 2-4 cells thick in medium pore
matrices. In several samples, the cells were concentrated on one surface with
contraction causing a curling toward that surface. In large-pore matrices, the
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Figure 5-18. Light micrographs of chondrocyte-seeded large- and medium- pore matrices cultured for 2 hours
and 2 weeks. At 2 hours (A and B), virtually all cells are rounded in morphology. In the medium-pore
sample (A), cells are seen predominantly on the surface, or at most at a depth of several pores. Cell
penetration is much deeper in the large-pore sample (B). At 2 weeks (C and D), a layer of cells has formed
at the surface of both matrices (open arrows). Cells have now penetrated slightly deeper in the medium-
pore matrix, and most of the cells in the interior are now elongated (C, arrowheads). Cells at the surface
of the large-pore matrix appear to be contracting the adjacent structures and curling the surface (D).
(Small-pore matrices, not shown, appear similar to medium-pore matrices.)
cell layer surrounding the matrix was slightly less complete, but greater than 1
cell thick on at least most of one surface.
By two weeks, there was a complete layer of cells more than 1 cell thick
surrounding all matrices (Figure 5-18). The layers were nearly the same
thickness around the periphery of each sample, generally slightly thicker for
small-pore matrices (about 5 cells) and medium-pore matrices (about 4 cells)
than large-pore matrices (about 2-3 cells). In all matrices, there were thicker
layers covering over pores or holes in the surface, as well as areas where the
cells appeared to be drawing or pinching the adjacent regions of the surface
together (Figure 5-18).
By four weeks, for all pore sizes, the cell layer was slightly more thickened on
one surface (6-10 cells for small-pore, 5-7 cells for medium-pore, and 4-5 cells
for large-pore), while the opposite surface maintained a cell layer roughly 2-4
cells thick.
Cell morphology: At 2 hours, over 90% of the cells in each size matrix were
spherical in morphology. By 1 day, quantitative analysis showed that fewer
than 50% of the cells remained spherical (Table 5-10). At one day, there were
no differences among the pore sizes by ANOVA. The results at one week were
similar to those at 1 day, except that the large pore size group had fewer
spherical cells, and more elongated and not assigned cells. 2-way ANOVA
analysis for time and pore size gave the following results:
round cells: p (time)<0.10, p (pore size)=0.12;
elongated cells: p (time)<0.34, p (pore size)=0.31.
time: 1 day 1 week
pore size: small medium large small medium large
rounded 39 + 1 36 + 6 37 + 3 38 ± 3 36 + 2 25 ± 3
elongated 49 + 2 55 ± 7 52 + 3 51 ± 2 54 ± 2 60 + 3
not assigned 11 ± 1 9 + 1 11 ± 1 11 + 1 11 + 1 14 + 1
Table 5-10. Morphology of chondrocytes cultured in type II collagen matrices
of varying pore size. Data given as a percent of total cells, mean ± SEM.
n=3 for all groups. Note that observations at 2 hours, not reflected in this
table (with n=1l) showed greater than 90% round cells for each pore size.
A biochemical analysis of unseeded matrices is included in Appendix J. These
results describe the rate at which matrix components are eluted to the
medium during culture.
DNA content of cell-matrix constructs: The DNA content of cell-seeded matrices
are shown by time and treatment group in Figure 5-19. In this figure, the
value of unseeded matrices have been subtracted, and the data is converted
from counts to cell equivalents based on our standard curve. There was a
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Figure 5-20. Net accumulated GAG in chondrocyte-seeded type II collagen
matrices of varying pore size. Unseeded values have been subtracted.
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slight proliferation of cells over the first week (found significant by 2-way
ANOVA of time and pore size, p(time)=0.03), however, this was followed by loss
of cells during the remaining time in culture. The loss of cells in the small
matrix took place earlier than in the medium and large pore matrices (from 1-
2 weeks vs. 2-4 weeks), however the long term number of cells retained was very
similar and not found significant by ANOVA (p=0. 2 9 4 ).
GAG content of construct: The net amount of GAG accumulated in the
matrix over each time in culture is presented for each treatment group (Figure
5-20). This total GAG represents the value of seeded matrices minus those of
unseeded controls, and is a function of the number of cells in the matrix, their
rate of GAG synthesis, and the amount of GAG lost to the medium. There is a
consistent increase in GAG content over time, however, the rate of
accumulation decreases after the first week in culture. The results are very
similar for all pore sizes.
Demonstration of high molecular weight fractions: The running of PD10
columns was able to establish that the counts for radioactive sulfate measured
in the digested matrix reflected high molecular weight GAG chains or
proteoglycans manufactured and retained by the cell-matrix constructs. Figure
5-21 depicts the elution of column fractions from two sets of samples:
1) Control samples of high and low molecular weight fractions, and
2) Representative experimental samples from each of the time periods.
The appearance of radiolabeled unincorporated sulfate fractions to the right
indicates the presence of low molecular weight fractions which are eluted more
slowly by the column. In contrast, high molecular weight fractions, as
estimated by the visual observation of dextran blue 2000 (molecular weight
2,000,000), move more quickly through the column. Uniformly, in the
experimental samples, any radioactive species were eluted in the high
molecular weight fraction, and therefore must have represented sulfate
incorporated into long chains.
Normalized sulfate incorporation: The amount of sulfate incorporated into
the cell-matrix construct during the four hour labeling period (Figure 5-22) was
expressed as counts per minute of incorporated sulfate divided by the number
of cells as determined by the DNA assay. The normalized incorporation
increased in all groups at each time. In addition, the small pore matrices
always demonstrated the highest synthetic rate, albeit by a small amount.
The effect of pore size was not found significant in a 2-way ANOVA of pore size
and time (p=0.11).
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Figure 5-21. Demonstration of incorporation of 35-S radiolabeled sulfate into
high molecular weight molecules. All experimental samples coincide with
the high molecular weight region (as visualized by blue dextran), and do
not overlap the low molecular weight region in which counts from
unincorporated 35-S-labeled sulfate were measured.
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Figure 5-22. Normalized uptake of 35-S-labeled sulfate by chondrocytes in
type II matrices of varying pore diameters. The counts per minute (cpm)
for the sample has been normalized by the mean DNA measurement for
the group (Figure 5-21).
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5.3 The animal model
5.3.1 Description of the lesion
The description of the original lesion is taken from the six fresh defects
examined immediately after their creation. The average amount of residual
cartilage left in these defects was 1.7 ± 2.1% (mean ± standard deviation,
range: 0.2 to 6.0%). Of this, 0.7 ± 0.6% (range: 0.2 to 1.8 per cent) was in the
corners, and 1.0 ± 1.6% (range: 0 to 4.2%) was elsewhere along the base of the
defect. The percentage of the length of the base that was covered by residual
cartilage was 16 ± 26%. The high coefficient of variation was due to an
outlying value of 68% (Figure 5-23a), one of 17%, and four of under 4% (Figures
5-23b,c,d).
Histological analysis of serial sections of the original, fresh defects revealed
three types of injury to the calcified cartilage: fracture at the defect edge,
thinning, and microfracture. In four of the six defects, at least one large
fracture (50 to 100 micrometers wide) at the extreme edge was noted. This
damage was consistent with overpenetration by the dermal punch in
circumscribing the defect. Two of these fractures extended through the
calcified cartilage, but only superficially into the subchondral bone (Figure 5-
23c). A second type of damage was thinning of the zone of calcified cartilage,
presumably from scraping the base of the defect with the curette. Calcified
cartilage thinning was inconsistent, varying from sample to sample (Figure 5-
23a-d), and even within a given sample. The percentage of thinned or
fractured calcified cartilage was 22 ± 14% (range: 2 to 39%). The final type of
damage was microfracturing of the calcified cartilage surface (Figure 5-23c).
Each of five defects which contained little or no residual articular cartilage
showed microfractures ranging from one or two per slide to ten or more per
slide. In no case did the microfractures penetrate into the underlying bone.
In summary, one defect showed no thinning of the calcified cartilage, but had
much more residual cartilage than the other defects (Figure 5-23a). Two
defects showed thinning of the calcified cartilage; a portion of the calcified
layer was completely removed on these samples (up to 700 micrometers along
the base), with consequent damage to the underlying bone (Figure 5-23b). In
the remaining three samples the defect depth generally extended to the
tidemark, with little residual cartilage and thinning (if present) limited to the
superficial portions of the calcified cartilage (Figure 5-23d). Some of these
samples had a corner fracture and all had microfractures.
It is important to note that the technique used for this study was that for the
18 month study of the effect of CAC and periosteum, as well as the two studies
including type I matrices. The observation of corner fractures prompted a
change in technique which involved less penetration by the dermal punch.
Thus, in the first study with type II matrices, as well as in the examination of
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Figure 5-23. Light micrographs of original, acute, untreated full-thickness
chondral defects in the canine trcohlear groove. Adjacent cartilage,
stained red with safranin 0, is visible to one side of each defect (arrows).
The subchondral bone (SCB) stains blue with fast green. A, B, and D (next
page) were taken at the same magnification. A) This sample was the
outlier, with the most residual cartilage left at the base of the defect (RC).
B) One of two samples with injury through the calcified cartilage caused
by the curette. The marrow space has been violated near the defect edge
(open arrow). (continued on next page)
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Figure 5-23, continued (light micrographs of original, acute, untreated full-
thickness chondral defects in the canine trcohlear groove). C) This defect
shows the maximum of residual cartilage in a corner, as well as a corner
fracture (open arrow) through the calcified cartilage. In addition, the
calcified layer to the right of the residual cartilage is thinned and exhibits
several microfractures (small arrows). D) Virtually all articular cartilage
has been removed to the level of the tidemark.
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engineered type II matrices and microfracture, the defects likely experienced no
damage from corner fractures.
5.3.2 Interobserver error
Coefficients of variation (COVs) for recorded measurements of defect geometry
(base and heights) were all under 5%, indicating that the geometry of the
defect could be accurately determined by a single observer.
The coefficient of variation between the observers for identification of tissue
types varied somewhat from tissue to tissue, and was related to the absolute
value of the quantity recorded. In general, the higher the value measured, the
lower the coefficient of variation.
Key results of the analysis of interobserver error are shown in Figures 24 a-c.
These figures plot the coefficient of variation of total repair tissue, hyaline plus
articular cartilage, and fibrocartilage versus the average value of the
measurement. Fibrous tissue, bone, and matrix flow are not plotted due to
their minor contributions to the total repair in most samples (and
consequently large COVs). The downward slope of the data with increasing
abscissa indicates the inverse relation between absolute measurement and
coefficient of variation. Also plotted on these graphs is the interdog error,
shown on a similar scale; each data point represents an experimental group
with a given treatment and time point. Thus, the importance of the
interobserver error can be compared to the interdog error for a given mean
value of measurement. In total repair tissue, all values for interobserver error,
as measured by the interobserver coefficient of variation, are below those for
interdog error. For hyaline cartilage, the result is similar, with all but one
interobserver value less than all of the interdog values. In the case of
fibrocartilage, there is slightly more overlap, however, the interobserver values
are in general lower than the interdog values.
5.4 In vivo experiments
5.4.1 Overview of gross results for all in vivo experiments
All animals ambulated normally after removal of external fixation and
survived the planned period to sacrifice. In the vast majority of animals,
when the joints were opened, synovial tissue appeared grossly normal,
although there was evidence of slight hypertrophy or, less commonly, atrophy
in certain joints. Similarly, the joint fluid was grossly within a normal range,
with some slightly more wet or more dry. In two cases, the gross appearance of
the joint suggested significant pathology. These observations included
significant effusion with turbid synovial fluid, pronounced synovial
hypertrophy, or lateral patellar displacement with denuded cartilage
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Figure 5-24. Comparison of interobserver to interdog error for grading of
healing full-thickness chondral defects. Errors given as coefficients of
variation. Each interobserver error represents 3 observers on one sample.
Each interdog error represents a group of dogs with a given sacrifice time and
treatment. Categories: (a) total filling; (b) hyaline cartilage; (c) fibrocartilage.
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Figure 5-25. Photograph of typical gross appearance of healing 4-mm diameter
defects in an opened joint at sacrifice. This treatment group comprised 3-
month empty controls. Note the partial filling of the defects with a whitish
reparative tissue. The intercondylar notch is to the left.
consistent with patellar subluxation. Defects from these two knees were
excluded from subsequent analysis.
All defects were grossly distinguishable from surrounding cartilage, although
there was wide variability in the amount of filling and general appearance
(Figure 5-25). Repair tissue usually had a whiter, more opaque, and less
glistening appearance than normal cartilage. In some cases the appearance of
the reparative tissue more closely resembled the surrounded cartilage, however,
the margins of the defect were always visible. Variability was generally found
within treatment groups as well as between groups. Histologic examination
confirmed the variable filling of the defects observed grossly, however visual
estimates did not always correlate well with the histological appearance.
Certain defects were relatively unfilled, while others were filled with repair
tissue to or above the level of the surrounding cartilage.
5.4.2 Healing of untreated chondral and microfracture defects
5.4.2.1 Histological results
Representative histology of untreated defects from 1.5 months to 12 months
(Figure 5-26a-d) demonstrate a changing profile of tissues in the defect. These
specimens are chosen from samples which are at least half-filled. Some
specimens not pictured were mostly empty. At 1.5 months, the tissue filling
the defect was predominantly fibrous in nature, either fibrous tissue or
fibrocartilage (Figure 5-26a). In this micrograph, resorption of much of the
calcified cartilage and a portion of the underlying bone has occurred. This
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Figure 5-26. Light micrographs of healing untreated full-thickness chondral
defects in the dog trochlear groove. Defect margins are shown by
arrowheads. A) 1.5 months, hematoxylin and eosin stain. The reparative
tissue consists of fibrous tissue (elongated cells) and fibrocartilage (type 'a',
rounded cells). A large portion of the calcified layer has been remodeled
by a severe resorptive process allowing direct communication between the
bone and defect (150 X). B) 3 months, hematoxylin and eosin stain. The
reparative tissue seen in this defect is almost all fibrocartilage, type 'a'
near the center, and type 'c' near the periphery (50 X). (continued, C and
D on next page)
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Figure 5-26, continued (light micrographs of healing untreated full-thickness
chondral defects in the dog trochlear groove). C) 6 months, hematoxylin
and eosin stain. Hyaline cartilage has formed on the base of the defect
near the center and at the edge of the defect next to the adjacent
cartilage. The remaining reparative tissue is fibrocartilage (60 X). D) 12
months, trichrome stain. Hyaline cartilage is still visible on the base in
the center of the defect and at the extreme edge. Fibrocartilage, primarily
type 'b', is variably attached to the hyaline cartilage. This tissue is
fibrillating and coming detached from the calcified cartilage (75 X).
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reaction normally consisted primarily of dense round or ovoid or rounded
cells, and was not inflammatory in nature. The communication between the
defect and the bone varied considerably at this time- this would be graded as a
severe reaction. Many other reactions were much less subtle, with damage to
the calcified cartilage limited to sections 300 gm or less in with. In some
sections, even with serial sectioning across the defect, no communication was
found. The finding of breaks in the subchondral plate was associated with the
formation of blood vessels in the defect area in some samples: 1 of 6 six-week
samples and 2 of 11 9-week samples.
By 3 months, little fibrous tissue was found (Figure 5-26b). Furthermore, the
calcified cartilage layer was substantially more intact than at 1.5 months. In
this sample, fibrocartilage near the edge of the defect has started to take on a
more hyaline appearance. In some samples, significant levels of hyaline
cartilage did form by this time. No vessels were found in the defect at 3
months or later times, although two samples at 3 months demonstrated vessels
just below the level of the defect where the calcified layer was resorbed. Figure
5-26c shows a mixture of hyaline cartilage and fibrocartilage in the defect at 6
months. As was typical, the hyaline cartilage in this defect formed
preferentially at the base of the defect, especially at the periphery. Through 6
months, most fibrocartilage was of types 'a' or 'c', those similar to fibrous tissue
or hyaline cartilage. Meniscus-like type 'b' fibrocartilage was not as common.
At 12 months (Figure 5-26d), the reparative tissue again consisted primarily of
fibrocartilage and hyaline cartilage. However, the amount of type 'b'
fibrocartilage was greatly increased, shown in the figure by trichrome stain
fibrillating and coming detached. At 12 and 18 months, much of the hyaline
cartilage exhibited reduced staining by safranin O for glycosaminoglycans (not
shown).
Microfracture defects were only observed at 15 weeks (Figure 5-27). Compared
to untreated defects, these defects were generally more filled with reparative
tissue and had greater reactions in the subchondral bone. The reparative
tissue was predominantly fibrocartilaginous. While approximately half of the
untreated chondral defects at 3 months were found to have a perforated
subchondral plate, with at least some associated remodeling, perforation was
universal in microfracture defects and degree of the remodeling was often more
notable in microfracture specimens (but not in Figure 5-27). Further
description of microfracture defects is given in section 5.4.4.
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Figure 5-27. Light micrograph of a healing microfracture-treated full-thickness
chondral defect in the dog trochlear groove at 15 weeks (safranin O/fast
green stain, 60 X). There is relatively little subchondral bone remodeling in
this defect compared to others in the group. Safranin O-stained tissue from
the subchondral bone appears to be pushing up into the defect. However
the bulk of the fibrocartilaginous tissue in the defect appears separated from
the tissue arising from the visible break in the plate. Near the adjacent
cartilage at the defect edge, near-hyaline tissue is forming. Note that this
reparative tissue has not bonded to the intact portions of the calcified layer.
5.4.2.2 Quantitative results and statistical analyses
Reporting of proximal and distal defects: Quantitative data were analyzed by
two methods:
1) all defects treated independently (results reported with n = number of
defects examined).
2) the proximal and distal defects were averaged to give one value for each
knee (results reported with n = number of knees examined).
In cases where all samples are successfully recovered and graded, the means are
necessarily identical in using these two methods. Means will vary between
these two methods only if one of the two defects in a knee does not yield data.
However, the two methods will normally give different results for measures of
variance and statistical significance.
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Based on an analysis summarized in Appendix K, there was little correlation
among proximal and distal defects for the most important grading categories.
Thus, the method of reporting proximal and distal defects independently has
been used for quantitative results and statistics below. In one special case
(that of hyaline and articular cartilage in study of untreated defects and
defects treated with autologous cultured chondrocytes alone, see Appendix K),
additional statistics are reported for the method of averaging the defects by
knee. In addition, a complete listing of the alternate data format (averaging
the two defects in each knee), is given in Appendix L.
The contributions of different tissue types to the healing of chondral defects
(from 6 weeks to 18 months) and from chondral defects also undergoing
microfracture (15 weeks only) are shown in Table 5-11. The values for
attachment of reparative tissue to adjacent structures and the amount of
intact calcified cartilage are found in Table 5-12.
The quantitative data reflect the trends reported in histological assessment.
There was significant variation with time in all tissue types filling the defect
and total filling (Table 5-13). The trends matched those seen histologically
(Table 5-11). Fibrous tissue was at a maximum at the shortest time (1.5
months), fibrocartilage at the longest time (18 months), and hyaline plus
articular cartilage in the intermediate times (3 to 12 months). The evolution
of the profiles of tissue types can be shown by plotting the normalized
contribution of the major tissue types as a percent of the total amount of
reparative tissue (Figure 5-28). In addition, the amount of intact calcified
cartilage and bonding of reparative tissue to this calcified layer were at a
minimum at 1.5 months. The ANOVA values reflect increases by three months,
defect fibrous fibro- hyaline articular total matrix
time type (n) tissue cartilage cartilage cartilage bone filling flow
6wk C(6) 24.5 ±4.0 20.5 ±4.8 3.1 ±0.8 0 0 0 0 48.0 ± 5.6 0.6 ± 0.4
9wk C(9) 11.7 ±2.0 18.0 6.9 5.3 ± 2.0 0.7 ± 0.6 0 0 35.7 ± 5.8 5.1 ± 1.4
6&9wk C(15) 16.8 2.6 19 4.4 4.4 ± 1.3 0.4 ± 0.3 0 0 40.6 ± 4.3 3.3 ± 1
3mo C(9) 1.2 ±0.9 13.5 ±5.5 15.9 3.7 3.3 ± 1.4 0 0 33.9 ± 6.9 1.5 ± 0.5
15 wk MF(8) 10.9+3.5 52.4 ± 8.2 0.7 0.3 0 +0 0 +0 64 ± 17.9 1.8 ± 0.6
6mo C(5) 3 ± 1.7 14.8 ± 6.7 11.4 + 3.1 2.1 ± 1.2 0 0 31.2± 10.1 7.6 ± 3.0
12 mo C (8) 1.3 ± 1 17.2 ± 5.9 19 2.7 3.7 ± 1.3 0.2 0.2 41.4 + 4.7 2.5 ± 0.9
18mo C(6) 8.4 ± 2.9 51.8 ± 10.5 9.6 2.1 0 0 5.8 5.875.7 14.2 1.6 ± 0.6
Table 5-11. Components of healing full-thickness chondral defects in an adult
canine model. C = untouched chondral defect. MF = chondral defect with
microfracture. Values given as an areal percent of total defect area seen in
a histological cross-section from the center diameter of the defect, mean ±
SEM (data averaged by defect).
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Figure 5-28. Composition of reparative tissue in untreated defects. Mean
contributions of each category are normalized by the total percent of defect
filling at the time point.
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Integration with
adjacent AC
Bonding to
calcified cartilage
Intact
calcified cartilage
6 week chondral 0±0 6.3 ± 2.1 56.8 ± 16.2
9 week chondral 15.4 + 4.5 27.5 ± 10.9 60.4 ± 13.4
6+9 chondral 9.2 + 3.3 19 +7 58.9 + 10
3 months chondral 11.7 + 3.4 50.8 + 10.7 95.4 ± 2.2
15 weeks microfracture 25.3 ± 8.7 1.8 ± 0.7 35.6 + 11.1
6 months chondral 15 + 6.4 44.4 + 13.3 87.2 + 10
12 months chondral 15.6 + 7.1 88.6 + 8.6 92.3 + 7.1
18 months chondral 24.6 ± 6.2 40.7 + 14.2 73.4 + 12
Table 5-12. Integration of reparative tissue and status of the underlying
calcified cartilage in healing full-thickness chondral defects in an adult
canine model. One group, as indicated, was treated with microfracture.
Values given as a linear percent of the length of the defect base or height, as
seen in a histological cross-section from the center diameter of the defect,
mean ± SEM (data averaged by defect).
value category
.0012 fibrous tissue
.0054 fibrocartilage
0.0083 **hyaline plus articular cartilage
0.006 total filling
0.59 integration with adjacent
.0055 bonding to calcified cartilage
.056 intact calcified layer
Table 5-13. ANOVA values for quantitative data in untreated defect series from
1.5 to 18 months. Data is reported as individual defects. ** ANOVA value of
hyaline plus articular cartilage when grouped by knee: p<0.09
however there were no clear trends from 3 to 18 months. No significant
variation in integration with adjacent cartilage was detected with time.
Statistical comparison of untreated defects with microfracture defects.
Untreated defects from the 3 month time point (actual sacrifice time: 16
weeks) were compared with 15 week microfracture defects by t-test (Table 5-
14). The microfracture defects had more total reparative tissue, more fibrous
tissue, more fibrocartilage, and less hyaline cartilage. Untreated defects had a
substantially more intact calcified cartilage layer, and also, more bonding to
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time defect type
value category
.012 fibrous tissue
.046 fibrocartilage
0.0011 **hyaline plus articular cartilage
.120 total filling
.144 integration with adjacent
.0006 bonding to calcified cartilage
5.1E-05 intact calcified layer
Table 5-14. T-test comparison of untreated defects and microfracture defects
at approximately 15 months in a canine model. Data is reported as
individual defects. ** t-test value of hyaline plus articular cartilage when
grouped by knee: p<0.05.
the base of the defect. Integration with the adjacent cartilage was higher in
the microfracture defect, but low in both cases.
5.4.2.3 Pathologic changes in surrounding structures
Changes in the surrounding structures were revealed through semiquantitative
grading (Table 5-15). Application of microfracture to the defect caused
substantial loss of bone support under the defect. While such reactions were
seen in untreated defects, they were much less common. Changes in other
adjacent structures were similar in all groups, with some loss of safranin O
staining and cloning common. There were often slight disruptions in the
smoothness of the surface of adjacent tissue, but the deep tissue adjacent to
the defect was generally intact in structure.
5.4.3 Effect of cultured autologous chondrocytes and a periosteal flap in
chondral defects
Results presented in this section will compare the experimental group of
defects treated with cultured autologous chondrocytes under a periosteal flap
with two control groups: defects treated with periosteum alone, and untreated
chondral defects (same data as presented in section 5.4.2). Several defects
were excluded from analysis due to pathology such as subluxated patella or
pannus formation in the joint. In addition, several additional samples were
not processed in a satisfactory manner and are not reported.
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adjacent
structures
category: bone saf O stain cloning surface integrity deep tissue integrity
grade: 0 1 2 3 0 1 2 3 0 1 2 3 0 1 2 3 0 1 2 3
18mo. EC 2 0 4 0 4 2 6 0 1 7 4 1 4 7 1 0 0 11
mean 2.33 2.17 2.25 2.50 2.75
12 mo. EC 1 0 1 16 0 19 7 1161 9 10 1 1 6 0 10 1 15
mea 2.50 2.44 1.50 2.19 2.94
6mo. EC 1 0 2 2 0 1 6 3 1 1 71 0 13 5  0 0 0 10
mean 2.00 2.20 1.80 2.44 3.00
15 wk. MF 5 2 1 2 1 5 8 0 F39 4 0 0 5 111 0 1 0 15
mea 0.50 2.19 2.06 2.69 2.88
3 mo. EC 0 1 2 6 0 101513 2 4 10 2 0 1 1610 0 1 1 16
mean 2.56 2.17 1.67 2.53 2.83
1.5 mo. EC* 6 1 3 5 0 2 124 13 0 4 223 0 3 9 17 0 0 1 28
mean 1.50 2.03 1.97 2.48 2.97
Table 5-15. Pathologic changes in structures surrounding full-thickness
chondral articular cartilage defects in an adult canine model. Data given as
the number of observed grades by defect. 3= little or no change, 2= slight
change, 1= moderate change, 0= severe change. For all categories except
bone, separate grades were given to the two different lateral edges. Mean
values approximate the average of all observations. *6 and 9-week data
combined in 1.5 month EC group.
5.4.3.1 Histological results
Histologic examination confirmed the variable filling of the defects observed
grossly in all treatment groups and times. Histological micrographs of sections
that are substantially filled and contain representative reparative tissues are
shown for untreated defects (section 5.4.2, Figure 5-26a-d) and for cultured-
autologous chondrocyte-treated (CAC) defects (Figure 5-29 a-d).
The histological description of healing was broken into early, intermediate, and
later times. The appearance of all groups was relatively similar to the
untreated defects at early and later times, with some differences at
intermediate times as described below:
Early times (1.5 months): By this time reparative tissue formed in defects in
all groups. The average filling was about half of the defect, although the
amount varied significantly from sample to sample. Most of the tissue filling
the defect was fibrous tissue or fibrocartilage (Figure 5-29a). A limited number
of cells, most often found at the sides of the defect, displayed various stages of
formation of lacunae and type II collagen production. But there was little
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Figure 5-29. Light micrographs of healing CAC-treated full-thickness
chondral defect in the dog trochlear groove up to 18 months. Defect
margins are shown by arrowheads. A) 1.5 months, hematoxylin and eosin
stain (60 X). The reparative tissue consists of primarily fibrous tissue
(elongated cells), with some fibrocartilage (type 'a', rounded cells) at the
base of the defect (arrow). The tissue does not bond to the calcified layer.
B) 3 months, safranin O/fast green stain (50 X). The reparative tissue is
primarily hyaline cartilage bonded to the defect base, with some
fibrocartilage superficially (arrows). The right margin of the defect is
pictured and virtually indistinguishable. (continued, C and D on next
page)
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Figure 5-29, continued (light micrographs of healing CAC-treated full-
thickness chondral defect in the dog trochlear groove up to 18 months).
C) 6 months, safranin O/fast green stain (50 X). This was the best-healing
defect of the experiment. The defect is nearly filled with hyaline cartilage
staining intensely for glycosaminoglycans. However, integration with the
adjacent cartilage is not complete, and the repair surface is somewhat
rough. D) 12 months, safranin O/fast green stain (60 X). Hyaline
cartilage is still visible on the base of the defect, but stains weakly for
glycosaminoglycans and is continuous with type 'c' fibrocartilage (thin
arrow). The superficial region of the defect is filled with fibrocartilage type
'b' that is fibrillating and coming detached from the other reparative
tissue (open arrow).
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hyaline cartilage and very little articular cartilage. Most hyaline cartilage that
was found was consistent with small "islands" of material left over from
surgery. This assessment was based on previous studies which examined
identical defects at the time of creation and similar defects at 2 and 4 weeks
[169]. The remnant tissue typically showed poor integration with surrounding
fibrous tissue. While the findings were generally comparable among groups,
the CAC treated lesions appeared to have slightly less fibrous tissue and
slightly more hyaline cartilage than the periosteum or empty control groups.
In the several histological sections examined from the center of the defect,
about half of these samples from all groups showed evidence of resorption of
the underlying bone with fracturing of the subchondral plate. Reparative
tissue was clearly seen flowing between the bone and the defect site. Serial
sectioning of the entire defect may have revealed an even greater prevalence of
bone damage. Infrequently (less than 20% of samples in each treatment
group), neovascularization was found in the defect area.
Intermediate times (3 and 6 months): These times were characterized by a
chondrogenic change in tissue composition. Compared with 1.5-month
samples, less fibrous tissue and more hyaline and articular were found in these
defects (Figures 5-29b). Fibrocartilage tended to have a more hyaline
appearance and more staining with safranin 0. Both hyaline and articular
cartilage were concentrated in the corners and at the base of the defect. Much
of the hyaline tissue stained at or near normal for safranin 0, although some
regions had reduced matrix staining. The regions with reduced staining
tended to be at the fringes of larger pieces, or thin regions in the defect center,
especially the "islands" that may have been remnant material. Some of the
islands also displayed surface fibrillations. In certain samples, the regions that
appeared to be degenerating tissue left over from defect creation were clearly
distinguished from adjacent regions which appeared to be regenerating
cartilage.
Fibrocartilage was found superficial to the hyaline tissue, and the small
amounts of fibrous tissue was almost always on the surface. Bone formed in
small quantities at the base of one defect; however, no neovascularization was
found in the defect area at this time.
During this remodeling phase, the CAC treated group contained more hyaline
and articular cartilage, and less fibrous tissue than empty controls (no
periosteal controls were included at this time). The defect which displayed the
most regeneration of hyaline cartilage (Figure 5-29c) was from the CAC group
(this was not the typical appearance of these defects). Both CAC and EC
samples appeared to have a more intact calcified cartilage layer than 1.5-
month samples, and breaches of the subchondral bone were found less
frequently. The appearance of adjacent cartilage was similar to the earlier
times, except that there seemed to be increased cloning in the vicinity of some
defects.
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Later times (12 and 18 months): Degenerative changes in the reparative tissue
and/or in the adjacent cartilage characterized most specimens after one year
(Figure 5-29d). For all treatments at 12 months, the tissue profile appeared
similar to the EC group at 3 and 6 months. At 18 months there was an
increase in fibrocartilage (mostly type 'b') and decreased hyaline and articular
cartilage. It appeared that fibrocartilage was able to displace previously
formed hyaline cartilage. In addition, other transitional tissue which did not
progress to hyaline instead appeared likely to form fibrocartilage. There was
little fibrous tissue consistent with scar in the long-term defects, mostly limited
to the superficial layers.
Overall, there was no discernible difference among CAC, P, and EC samples with
respect to reparative tissues. While degradative changes were observed in a few
specimens as early as 3 months, by one year they were more widespread. Most
of the hyaline cartilage did not stain normally with safranin O, was acellular,
contained abnormal cloning, or appeared fibrillated (especially at the surface).
Also, bone appeared more frequently in reparative tissue at the base of the
defect. This occurred in 5 of 44 samples, with no preference among the
treatment groups. Only 1 of 62 defects from 1.5 to 6 months exhibited bone in
the defect area.
Observations of damage in adjacent cartilage: Samples which were covered
with periosteum (P and CAC groups) displayed disruption of the adjacent
cartilage where sutures cut through (Figure 5-30). In certain cross-sections, the
suturing was found to create clefts and completely separated the superficial
layers from deep layers of articular cartilage (Figure 5-30). Regions
surrounding suture marks often displayed increased cloning, decreased
safranin O staining, and occasionally, complete disruption of normal
architecture.
Furthermore, many specimens exhibited degenerative changes in the adjacent
cartilage which may have been attributable to the operation or harvest
procedure, but not necessarily to suturing. These changes were most
pronounced after one year. At 12 and 18 months, in the cultured autologous
chondrocyte and periosteum alone groups this included cloning and loss of
safranin O staining beyond the suture marks (several millimeters from the
defect edge). In addition, almost every defect in the empty control group
(subjected to cartilage harvesting, but not suturing) showed at least slight
cloning in the cartilage far from the defect. Three of the eight untreated knees,
including a knee excluded from grading, showed severe cloning, loss of safranin
O stain, and disruption of the normal collagen architecture across at least
several millimeters of the articular surface. Furthermore, in two of these knees,
pannus formed over the cartilage surface, in some locations invading the
superficial zone. In the excluded knee, the pannus completely covered the
defects.
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Figure 5-30. Light micrograph of a defect showing damage to adjacent
cartilage from suturing of the periosteum cover. The defect is empty,
except in the corner where there is a small amount of hyaline cartilage
(open arrow). The adjacent cartilage still shows the path of the suture
(solid arrow), with obvious mechanical disruption and some loss of
safranin O staining. The damage to subchondral bone is an artifact of
processing.
Figure 5-31. Light micrograph of a 6-week specimen containing cultured
autologous chondrocytes labeled with the gene for 3-galactosidase. The
cells toward the base of the defect stain only with safranin O (red), while
those at the surface stain only with X-gal (blue). This section was taken
from the center portion of the defect. The tidemark is shown by the
arrowhead.
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Beta-galactosidase results: Of the four defects at the six-week time point, two
contained cells stained blue for beta-galactosidase. One contained numerous
cells in all sections (Figure 5-31), while the second had very few cells, with some
sections containing no visible labeled cells. At three months, only one of four
defects was found to contain labeled cells. The stained cells were encountered
very infrequently (again absent in certain sections), and staining was very
faded
5.4.3.2 Quantitative results and statistical analysis
Tissue tvoes filling the
all times are shown in
defect: Defect filling by all
Table 5-16.
tissue types in all groups at
time treat- Fibrous Fibro- Hyaline Articular Total matrix
(mo.) ment n Tissue cartilage Cartilage Cartilage Bone Repair flow
*EC 15 16.8 ± 2.6 19 4.4 4.4 ± 1.3 0.4 ± 0.3 0 0 40.6 4.3 3.3 ± 1
1.5 P 6 17.2 5.2 33.9 8.6 5.4 2.9 0 0 0 ± 0 56.5 13.2 0.9 ± 0.4
CAC 11 11.4 ± 7 16.2 + 8.1 10.7 ± 4.8 2.1 ± 2.1 0.2 ± 0.2 40.5 + 10.4 1.6 ± 0.7
EC 9 1.2 ±0.9 13.5 5.5 15.9± 3.7 3.3 ± 1.4 0 0 33.9 6.9 1.5 ±0.5
3 P not studied
CAC 10 0.7 ± 0.6 12.5 6.3 30.2 + 5.4 4.7 + 3.6 0 0 48.1 ± 6.5 0.9 ± 0.4
EC 5 3 ± 1.7 14.8 +6.7 11.4 ± 3.1 2.1 ± 1.2 0 0 31.2 ± 10.1 7.6 ± 3.0
6 P not studied
CAC 6 6.1 ±4.5 10.9 3.7 18.7 ± 3.7 18.6 9.4 0 0 54.3 ± 9 1.3 ± 0.6
EC 8 1.3 ± 1 17.2 + 5.9 19 ±2.7 3.7 ± 1.3 0.2 + 0.2 41.4 + 4.7 2.5 + 0.9
12 P 6 2.2 + 1.4 27.8 ± 10 14.7 + 7.6 1.7 + 1.7 1.6 + 1.3 48 + 7.8 2.7 ± 1.2
CAC 8 1.5 1 19.1 ± 6.5 14.9 + 2.7 0.5 + 0.3 0 ± 0 35.9 ± 7.7 2.8 ± 0.9
EC 6 8.4 ± 2.9 51.8 + 10.5 9.6 ± 2.1 0 ±0 5.8 ± 5.8 75.7 ± 14.2 1.6 ± 0.6
18 P 6 1.6 0.8 41.4 8.1 9.5 2.4 0.4 0.4 0 0 53 9.8 2.1 0.6
CAC 8 2.5 ± 1 27.5 + 6.2 12.9 ± 3.2 0.3 ± 0.3 2.7 ± 2.7 45.9 ± 7.3 1.7 ± 0.7
Table 5-16. Components of healing full-thickness chondral defects in an adult
canine model. Defects are untreated (EC), treated with periosteum alone (P),
or treated with periosteum and cultured autologous chondrocytes (CAC); n =
number of defects. Values given as an areal percent of total defect area seen
in a histological cross-section from the center diameter of the defect, mean +
SEM (data averaged by defect). *1.5 month EC group includes both 6-week
and 9-week defects.
Statistics of tissue types early and intermediate results: (less than 1 year): At
1.5 months ANOVA for the three treatments showed no difference with respect
to total filling (p=0.3 3 ) or with filling by fibrous tissue (p=0.54), fibrocartilage
(p=0.18), or combined hyaline and articular cartilage (p=0.17). Furthermore,
there were no significant differences in bonding to adjacent tissue (p=0.33) or
127
calcified cartilage (p=0.18), or the amount of calcified cartilage remaining
intact (p=0.42).
At 3 and 6 months, no periosteal controls were included. Comparisons
between groups were made by 2-tailed paired t-test. At 3 months, CAC-treated
defects were found to have more total filling (p=0.04) and combined hyaline
and articular cartilage (p=0.0003, p=0.005 when proximal and distal defects
were averaged) than empty controls, but no difference in fibrous tissue
(p=0.72) or fibrocartilage (p=0.96). The trends appeared the same at 6
months, but with lower "n", higher p-values were found in the categories where
differences were found at 3 months: total filling, p<0.15 and combined hyaline
and articular cartilage, p=0.12, p=0.26 when proximal and distal defects were
averaged. There was still no difference in fibrous tissue, p=0.43, and
fibrocartilage, p=0.38.
Statistics of tissue types long term results: The results of the 12 and 18 month
time points are of special interest, as they include all treatment groups. It was
desired to know if the treatment had any effect at these times. Two-way
analysis of variance with respect to treatment and time showed that there were
no significant findings with respect to treatment group. Analysis of variance
did, however, indicate several differences between twelve- and eighteen-month
groups, the trends (from twelve to eighteen months) of which included:
1) increasing fibrous tissue (p=0.016)
2) increasing fibrocartilage (p<0.003)
3) increasing total repair tissue (p=0.016)
4) decreasing hyaline and articular cartilage (p=0.032, p=0.087 for
averaging proximal and distal defects)
For completeness, the twelve- and eighteen-month results were separated and
each examined for differences among treatment groups in the critical healing
categories (viz., total filling and hyaline cartilage) by t tests. T test was chosen
over analysis of variance to take advantage of the paired comparison of the
empty control and cultured autologous chondrocyte groups, representing
contralateral legs of the same animal. T tests with the periosteum alone group
were unpaired. When t tests were performed with proximal and distal defects
considered independent, twelve-month EC defects had more combined hyaline
and articular cartilage than twelve-month CAC defects (p=0.05). With defects
averaged by knee, the corresponding value was p=0.13.
Overall, the evolution of the profiles of tissue types was very similar in all
groups to that already presented for the untreated group (Figure 5-32). This
figure shows that the initial contribution from hyaline and articular cartilage
in CAC-treated defects is slightly higher than that for the other groups. Also,
the changes in tissue types which follow (intermediate times: increasing
hyaline tissue, decreasing fibrous tissue and fibrocartilage; and longer times:
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Figure 5-32. Composition of reparative tissue in three types of defects. Mean
contributions of each category are normalized by the total percent of defect
filling for the category at that time point. CAC=cultured autologous chondrocyte,
P=periosteum alone, EC=untreated, empty control.
decreasing hyaline tissue and increasing fibrocartilage) are generally even more
pronounced in the CAC-treated group.
Attachment, bonding, and calcified cartilage: Attachment to adjacent tissues
and preservation of the calcified cartilage are shown in Table 5-17.
Integration with
adjacent AC
Bonding to
calcified cartilage
Intact
calcified cartilage
*EC 9.2 + 3.3 19 + 7 58.9 + 10
1.5 months P 8.3 + 6 27.3 + 10.8 59.1 + 18.9
CAC 16.4 + 3.9 42.5 + 11.2 77.5 ± 8.6
EC 11.7 + 3.4 50.8 + 10.7 95.4 ± 2.2
3 months P not studied
CAC 20.8 + 5.3 75.5 ± 12.2 96.4 ± 2.6
EC 15 + 6.4 44.4 ± 13.3 87.2 + 10
6 months P not studied
CAC 35.1 + 7.3 87.4 + 8.7 91.2 ± 7.2
EC 15.6 ± 7.1 88.6 ± 8.6 92.3 + 7.1
12 months P 32.4 + 7.2 43.6 ± 19.2 65.1 + 17
CAC 21.2 ± 4.8 60.1 ± 10.5 80.1 + 12.1
EC 24.6 ± 6.2 40.7 ± 14.2 73.4 ± 12
18 months P 16.1 ± 5.7 46.7 ± 12.7 98.3 + 1.4
CAC 21.6 + 6 59.3 + 16 79.9 11.6
Table 5-17. Integration of reparative tissue and status of the underlying
calcified cartilage in healing full-thickness chondral defects in an adult
canine model. Defects are untreated (EC), treated with periosteum alone (P),
or treated with periosteum and cultured autologous chondrocytes (CAC).
Values given as a linear percent of the length of the defect base or height, as
seen in a histological cross-section from the center diameter of the defect,
mean ± SEM (data averaged by defect). *1.5 month EC group includes both
6-week and 9-week defects.
Statistics of attachment, bonding, and calcified cartilage: At 1.5, 12, and 18
months, ANOVA found no differences among all three treatment groups with
respect to bonding to adjacent cartilage or the base, or in the amount of intact
calcified cartilage. When periosteum was omitted analysis was performed by 2-
tailed paired t-test. In cell-treated samples vs. empty controls there was more
bonding to adjacent cartilage (p=0.067 and p=0.015) and the calcified
cartilage (p=0.004 and p=0.078) at 3 and 6 months respectively, but there were
no differences in the amount of calcified cartilage remaining intact (p=0.81
and p=0.86).
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time treatment
Like the untreated group, the periosteum and CAC groups also displayed
minimal values for intact calcified cartilage and bonding to calcified cartilage
at 1.5 months.
5.4.3.3 Pathologic changes in surrounding structures
As previously described, reactions at the base of the defects sometimes resulted
in disruption of the calcified cartilage layer, penetration into the subchondral
bone, and resorption of the subchondral bone resulting in decreased bone
support under the defect (Table 5-18). In all groups, the bone support was
graded lowest at 1.5 months, corresponding to the greatest amount of damage
to the calcified cartilage in Table 5-17. At all times, the empty control group
had approximately as much or more safranin O staining than CAC- treated
defects. This was consistent with damage that was seen to have occurred from
suturing. However there did not appear to be consistent differences in cloning
reactions to the treatment or with time. Excluding damage from sutures, the
superficial and deep tissue integrity was similar in all times and groups, with
these structure substantially intact in most specimens.
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adjacent articular cartilage
................. ........... . .... . .... . I ................... .................. ............................. ................................
category: bone saf O stain cloning surface integrity deep tissue integrity
grade: 0 1 2 3 0 1 2 3 0 1 2 3 0 1 2 3 0 1 2 3
18 month CAC 2 0 3 3 5 0 3 7 0 3 9 3 0 1 4 10 0 0 1 14
.....n t .. . ......... ..........  ...... ............ .......... .........I ... .... ..... . ............ . ...... ..... ...... ......... ............ ......... .. ...i .... . . O ........ 0..........0 ..... ..... ....... .. ...
mean 1.88 1.80 2.00 2.60 2.93
18 month P 0 0 2 4 2 2 2 6 0 1 6 5 0 0 4 8 0 0 2 10
mean 2.67 2.00 2.33 2.67 2.83
18monthEC 0 2 0 4 0 4 2 6 0 1 7 4 0 1 4 7 1 0 0 11
mean 2.33 2.17 2.25 2.50 2.75
12 month CAC 2 1 4 1 5 5 4 2 2 4 8 2 0 1 7 8 0 2 2 1.2
mean 1.50 1.19 1.63 2.44 2.63
12 month P 1 1 2 2 4 1 4 3 2 4 5 1 0 1 4 7 01 10
mean 1.83 1.50 1.42 2.50 2.75
12 month EC 1 0 1 6 0 0 9 7 1 6 9 0 1 1 8 6 0 0 1 15
mean 2.50 2.44 1.50 2.19 2.94
monthCAC 1 0 2 3 1 0 6 5 0 1 4i 7 1 1 317 0 1 2 9
........... i.......... ..... ......... ............ .............. ..... ......... .......... .......1 ...... ....... . ...... ........... ... ............. ....... ......... ........... 0 . ............. I ............. 9 ......
mean 2.17 2.25 2.50 2.33 2.67
6 month EC 1 0 2 2 0 1 6 3 1 1 7 1 0 1 3 5 0 0 0 10
mean 2.00 2.20 1.80 2.44 3.00
3month CAC 0 1 3 6 9 3 7 1 1 1 7 10 0 3 4 12 0 2 1 163 o nth A C ..... . ..... 1........ . ..  ..... .... ..... ............... ..... i.. ... ................... ..... ............ ........ . ... 1...... .. ..  ... ...1..2. " ...... ... . ....... ..
mean 2.50 1.00 2.37 2.47 2.74
3 month EC 0 1 2 6 0 0 15 3 2 4 10 2 0 1 6 10 0 1 1 16
mean 2.56 2.17 1.67 2.53 2.83
1.5 month CAC 3 1 2 5 2 2 12 0 0 1 12 7 0 4 9 7 0 2 6 121 .5 m o A ... . 3 ..... ......... . .. . 2....... 5 ........... .... ..... 2 ..... ............. ............ ..... 1. ..... .... 1.. .  ..... . ....... .... .....4 .............. .......... ........ ... . . .. .... .............. ;........1. .
mean 1.82 1.63 2.30 2.15 2.50
1.5monthP 3 1 0 2 2 2 4 0 1 0 8 2 0 3 4 4 0 1 1 9
mean 1.17 1.25 2.00 2.09 2.73
1.5monthEC 6 1 3 5 0 i 2 24 3 0 4 :22i 3 0 3 9 17 0 i0 1 285 m t E..........
.
1. . . .. .. .... .. ........... 0. .. . ........ ... ... ................ .... .. ....... ........... . .... ..... ....... .... ........... ......... ............. ....... ...
mean 1.50 2.03 1.97 2.48 2.97
Table 5-18. Pathologic changes in structures surrounding full-thickness chondral articular cartilage defects in an adult canine
model. Defects are untreated (EC), treated with periosteum alone (P), or treated with periosteum and cultured autologous
chondrocytes (CAC). Data given as the number of observed grades by defect. 3= little or no change, 2= slight change,
1= moderate change, 0= severe change. For all categories except bone, separate grades were given to the two different
lateral edges. Mean values approximate the average of all observations. *6 and 9-week data combined in 1.5 month EC group.
5.4.4 Effects of matrix treatments
This work included two series of experiments involving matrix implantation in
the canine model, all evaluated quantitatively at 15 weeks. In the first series,
implants included fascia alone, fascia-covered type I matrix (seeded and
unseeded), and seeded type II collagen matrix. In the second series,
implants/treatments included seeded type II matrix, microfracture treatment,
and microfracture with unseeded type II collagen. The gross appearance of
defects at sacrifice was variable, resembling that of the original series of dogs
for testing autologous chondrocyte transplantation.
Overall histological impression: Histologically, there were several clear
differences between these series and the original series. First, communication
with the subchondral bone occurred more frequently and to a more significant
extent in all of these groups compared to the original series at this time. This
was especially true for the second series. The reactions in the underlying bone
often resorbed nearly all of the calcified layer. Also, unlike the original series
in which vascularized reparative tissue was limited to a few samples at 1.5
months and none at all at 3 months, vascularized tissue was seen in the defect
area in several of the specimens in these series.
Original defect area: While the level of filling was increased in most groups
compared to untreated defects (excluding fascia and type I matrix alone), the
vast majority of the tissue forming was fibrous in nature, either fibrous tissue
or fibrocartilage. Safranin O and type II collagen staining were found in the
original defect area in many of these specimens. This staining was very
preferentially in the corners of the defect (at the periphery and base). These
locations corresponded to regions which were graded as fibrocartilage types 'b'
or 'c', or with the slight amounts of hyaline cartilage. In some specimens
where the calcified cartilage was resorbed, staining in remodeling tissue in the
underlying bone (see below) extended upward into the defect, in some cases
almost to the surface. When there was safranin O staining, there was also type
II staining. However, some specimens stained with type II in areas that did not
stain with safranin 0.
Vascularization was always found in defects in which there was increased
communication with the bone, and with vessels extending into the underlying
bone region. This was the case primarily in the second series, which had the
most communication and in which 7 of 24 defects contained vessels in the
original defect area. In the first series, only 1 of 22 defects had
neovascularization in the defect area, with two exhibited new vessels just below
the defect area. Tissue with vessels did not stain for safranin O or type II
collagen.
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Underlying bone: Bone remodeling took place in a variety of manners. In
some sections, there was evidence of remodeling despite an intact overlying
plate. In others, there was a small crack (30-200 gm) in the calcified cartilage
with a teardrop-shaped area of resorption immediately beneath. These areas
varied in size, from almost nothing to over 1 mm in depth and width. In
other samples, the resorptive process included nearly the entire width of the
defect. The depth varied from barely below the calcified layer to over 1.5 mm.
Because of the reaction in the bone, observations were also made of the tissue
filling this region. The appearance of tissues in the subchondral region varied
significantly (Figure 5-33). In many samples in which a remodeling reaction in
the underlying bone was visible despite an intact overlying plate, or in which
communication was limited to one small break in the plate, the tissue filling
the marrow spaces was primarily very dense rounded or ovoid cells lacking
lacunae (Figure 5-33a). Some elongated cells were also seen. These areas did
not stain for safranin O or type II collagen. In some sections regions of highly
vascularized tissue were found in the subchondral region (Figure 5-33b).
Vascularized areas did not stain for safranin O or type II collagen, even in
defects which also included other types of tissue that did (see below).
Other samples contained regions with a variety of appearances from fibro-
cartilaginous (Figure 5-33c) to cartilaginous, distinguished by subtle differences
in matrix appearance. The characteristic feature of these regions was
chondrocyte-like cells in lacunae. Pericellular matrix was often visible, and
there was often staining for both safranin O and type II collagen. Again, type II
collagen staining was always at least as prevalent as safranin O staining. Type
II and safranin O staining were most intense around the most cartilaginous
appearing areas (less fibrous matrix with chondrocytic, rounded cells with
lacunae). There was a tendency for the most intense pericellular and
intercellular matrix staining in the deepest portions of the defect. In virtually
all specimens with staining for safranin O above and below the original
location of the calcified layer (which was mostly resorbed), the extent and
intensity of the staining was greater below this level.
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Figure 5-33. Light micrographs showing a range of appearances of tissue
found in remodeling subchondral bone in the canine trochlea (type 1I
collagen/hemnatoxylin stain). (a) fibrous, vascularized tissue, with dense
ovoid and elongated cells. Numerous vessels are found (arrows) and there
is no visible brown staining for type II collagen. (b) fibrous tissue with
dense cells of more ovoid and rounded appearance. Some bone is visible
(open arrow). (continued on next page)
-- BFigure 5-33. Light micrographs showing a range of appearances of tissue
found in remodeling subchondral bone in the canine trochlea (type IL
collagen/hematoxylin stain). (a) fibrous, vascularized tissue, with dense
ovoid and elongated cells. Numerous vessels are found (arrows) and there
is no visible brown staining for type II collagen. (b) fibrous tissue with
dense cells of more ovoid and rounded appearance. Some bone is visible
(open arrow). (continued on next page)
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Figure 5-33, continued (light micrographs showing a range of appearances of
tissue found in remodeling subchondral bone in the canine trochlea). (c)
fibrocartilaginous tissue with fibrous matrix staining brown for type II
collagen and chondrocyte-like cells in lacunae with some pericellular
staining (arrow). Bone is seen in the lower right of the micrograph.
Quantitative and semiquantitative results: The quantitative and
semiquantitative data for the two series are summarized in Tables 5-19 though
5-24. General discussion of these results is contained within this section.
Results specific to comparison between specific groups follow. The amount of
matrix flow was similar in all treatment groups (approximately 2%). No bone
was found in the defect site in any of these groups.
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defect filling (percent, mean ± SEM)
total Fibrous Fibro- Hyaline Articular
Treatment n filling Tissue cartilage Cartilage Cartilage
Seeded type II (initial) 8 58 + 10 16 ± 4 41 + 11 2 1 0
Seeded type I + fascia 8 51 + 12 17 + 7 28 + 7 4 3 1 + 1
Unseeded type I + fascia 6 37 + 7 19 ± 5 17 + 5 0 0
controls
Fascia 6 16 ± 8 5 ± 2 11 7 0 0
Untreated 8 32 + 7 3 ± 1 14 + 3 12 + 2 4 ± 2
Table 5-19. Components of healing full-thickness chondral defects in an adult
canine model. Defects were treated with collagen matrix implants or
controls as indicated. n = number of defects. Values given as an areal
percent of total defect area seen in a histological cross-section from the
center diameter of the defect, mean ± SEM (data averaged by defect).
defect filling (percent, mean ± SEM)
total Fibrous Fibro- Hyaline Articular
Treatment n filling Tissue cartilage Cartilage Cartilage
Seeded engineered type II 8 70 + 16 15 ± 7 54 + 19 1 ± 0.2 0
Engineered type II +
microfracture 8 90 + 9 17 + 9 72 ± 12 2 + 1 0
controls
Microfracture 8 64 ± 18 11 ± 4 52 ± 8 1 + 0.3 0
Untreated 8 31 ± 10 1 + 1 14 + 6 16 ± 4 3 ± 1
Table 5-20. Components of healing full-thickness chondral defects in an adult
canine model. Defects were treated with collagen matrix implants and/or
microfracture, or left untreated. n = number of defects. Values given as an
areal percent of total defect area seen in a histological cross-section from the
center diameter of the defect, mean ± SEM (data averaged by defect).
In both series, all implanted matrices increased the amount of defect filling
compared to fascia or untreated controls. However, the untreated controls had
the highest level of hyaline and articular cartilage. Fibrous tissue contributed
about the same amount to defect filling in all matrix implants (15-19%),
however, the most prominent tissue type was fibrocartilage.
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Bonding to Attachment to
calcified adjacent Percent of intact
Treatment cartilage cartilage calcified cartilage
Seeded Type II (initial) 6 ± 2 52 + 7 43 ± 14
Seeded Type I + fascia 22 + 13 33 + 4 58 + 14
Unseeded Type I+ fascia 14 ± 6 32 ± 9 67 ± 11
controls
Fascia 5 4 16 13 71 ± 13
Untreated 55 + 12 23 4 87 + 11
Table 5-21. Integration of reparative tissue and status of the underlying
calcified cartilage in healing full-thickness chondral defects in an adult
canine model. Defects were treated with collagen matrix implants or
controls as indicated. Values given as a linear percent of the length of the
defect base or height, as seen in a histological cross-section from the center
diameter of the defect, mean ± SEM (data averaged by defect).
Bonding to Attachment to
calcified adjacent Percent of intact
Treatment cartilage cartilage calcified cartilage
Seeded engineered type II 1 ±1 34 ± 8 39 + 13
Unseeded type II+ microfracture 3 ± 1 24 ± 6 18 ± 5
controls
Microfracture 2 + 1 25 ± 9 36 + 11
Untreated 51 + 11 12 + 3 95 + 2
Table 5-22. Integration of reparative tissue and status of the underlying
calcified cartilage in healing full-thickness chondral defects in an adult
canine model. Defects were treated with collagen matrix implants and/or
microfracture, or left untreated. Values given as a linear percent of the
length of the defect base or height, as seen in a histological cross-section from
the center diameter of the defect, mean ± SEM (data averaged by defect).
Bonding to the calcified cartilage was much less in treated defects than
controls. This appeared to be directly related to the criterion that a
prerequisite for bonding was an intact calcified cartilage layer. The calcified
layer was substantially damaged in all implant groups, ranging from 18 to 67%
intact. The calcified cartilage in untreated controls were approximately 90%
intact, and the fascia group 71%. The lack of bonding to the calcified layer
also matched the lack of formation of hyaline tissue and was reflected in
semiquantitative grading (Tables 5-23 and 5-24, below). These results were
similar to those in the study of untreated defects and the effect of CAC in this
respect. The attachment to adjacent cartilage was increased in most matrix
treated groups compared to controls, with attachment levels ranging from 25
to 50% of the interface with adjacent cartilage.
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The grades assigned to the semiquantitative categories in the two series dogs is
shown in Tables 5-23 and 5-24. For the adjacent cartilage section, the two
grades given to the two adjacent edges are both recorded. For each group, the
mean grade is given. Note that this mean does not have full quantitative
significance due to the ordinal nature of the scale. Also, the semiquantitative
grading from this series may not be directly compared to results from the first
series because the grading was performed by a different observer.
adjacent articular cartilage
category: bone saf O stain cloning surface integrity deep tissue integrity
grade: 0 1 2 3 0 1 2 3 0 1 2 3 0 1 2 3 0 1 2 3
Seeded II 4 2 2 0 1 8 6 1 0 8 8 0 1 7 8 0 0 4 11 1
mean 0.75 1.43 1.50 1.44 1.81
SeededI 3 2 2 1 0 4 1210 2 0114 0 0880 0 18 8 0
mean 1.13 1.78 1.78 1.50 1.50
Unseeded I 2 2 210 1 6 5 0 0 0 112 0 1 10 2 0 0 4 8 0
mean 1.00 1.35 2.00 1.17 1.67
Fascia 012 3 1 4 2 6 0 1 6 5 0 1 6 5 0 1 3 8 0
mean 1.83 1.19 1.34 1.33 1.59
Untreated 0 1 6 2 0 2 16 0 0 2 16 0 0 0 18 0 0 0 0 18
mean 2.11 1.90 1.90 2.00 3.00
Table 5-23. Pathologic changes in structures surrounding full-thickness
chondral articular cartilage defects in an adult canine model. Defects were
treated with collagen matrix implants or controls as indicated. Data given
as the number of observed grades by defect. 3= little or no change, 2= slight
change, 1= moderate change, 0= severe change. For all categories except
bone, separate grades were given to the two different lateral edges. Mean
values approximate the average of all observations. *6 and 9-week data
combined in 1.5 month EC group.
Note on semiquantitative tables: the semiquantitative results for pathology of
specimens used for studying the effect of matrices on healing in Tables 5-23
and 5-24 were recorded by different observers. The interobserver reliability of
the semiquantitative assessment was not tested and is not known. Thus,
within each table, ordinal comparison of data is valid. However, data in one
table CANNOT be directly compared to that in other tables due to the changes
made between experiments.
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adjacent articular cartilage
category: surface deep tissue
bone saf O stain cloning integrity interity
grade: 0 1 2 3 0 1 2 3 0 1 2 3 0 1 2 3 0 1 2 3
Engineered 6 0 0 2 2 1 4 9 2 2 8 4 0 2 3 11 2 3 2 9
type II + CAC
mean .75 2.25 1.88 .56 2.12
ngrd type I+ 7 1 0 0 4 2 4 6 4 3 5 3 0 2 3 11 1 5 2 8
icrofracture I
mean .12 1.75 1.50 2.56 2.06
microfracture 5 2 1 0 2 1 5 8 0 3 9 4 0 0 5 11 0 1 015
mean 0.50 2.19 2.06 2.69 .88
Untreated 0 12 [6 0 0 15 3 2 4 10 2 0 1 6 10 0 1 1 1
mean 2.56 2.17 1.67 2.53 2.83
Table 5-24. Pathologic changes in structures surrounding full-thickness
chondral articular cartilage defects in an adult canine model. Defects were
treated with collagen matrix implants and/or microfracture, or left
untreated. Data given as the number of observed grades by defect. 3= little
or no change, 2= slight change, 1= moderate change, 0= severe change. For
all categories except bone, separate grades were given to the two different
lateral edges. Mean values approximate the average of all observations. *6-
and 9-week data combined in 1.5 month EC group.
Series I: The results of the adjacent cartilage reflect the damage done in
suturing in the four implant groups. Untreated defects retain more safranin O
stain, as well as integrity of the superficial and deep adjacent cartilage relative
to the implant groups. However, cloning is more similar in all groups.
The grading of subchondral bone indicates that severe damage occurred only
in the defects receiving matrix implants. The untreated and fascia groups had
less bone damage, with untreated the only group with an average score
indicating only slight damage.
Series II: The most striking effect was that seen in the subchondral bone.
Approximately three quarters of the samples in each of the three treatment
groups had severe changes in the bone, while no untreated defects registered
this score.
In the adjacent cartilage, the two groups which received suturing registered
more changes in deep tissue integrity due to the presence of the suture tracks.
However, close to the defect site, the changes in safranin 0, cloning, and the
surface of the tissue were similar in all groups.
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5.4.4.1 Effects of unseeded type I matrix in chondral defects
All 4 week and 15-week defects containing fascia only or fascia-covered matrix
were observed histologically. Only 15-week defects were evaluated
quantitatively for tissue types (Table 5-20).
Histological observations showed wide variation in defect filling from sample to
sample. Fifteen-week samples appeared to be slightly more filled with repair
tissue than 4 week samples. At 15 weeks, matrix implanted samples showed a
trend toward more reparative tissue than fascia only controls (p<0.10). In
each group, several defects had almost no filling, while others were filled over
50% by repair tissue, but more fascia only defects were essentially unfilled.
The repair tissue was similar in all groups, with the vast majority fibrous in
nature. In each treatment group, in selected samples, small areas of
fibrocartilage, type 'c' or hyaline cartilage were seen, usually in the corners of
the defect next to the adjacent cartilage. These areas stained faintly with
safranin 0, indicating the presence of GAGs. However, even at 15 weeks,
hyaline and articular cartilages were essentially absent compared to controls.
At 4 weeks, tissue that was consistent with remodeling fascia was found in
several defects in both groups. It was not proven that this tissue was originally
fascia, however, in numerous studies in groups without fascia, no tissue similar
in appearance was seen. At 15 weeks, tissue that resembled fascia was only
seen in 1 of 6 defects in each group (with and without matrix). No matrix was
found even at 4 weeks.
As expected the fibrous tissue did not bond to the calcified cartilage (judged by
polarized light). Attachment -to adjacent cartilage was good in defects which
were filled, but the overall attachinent was low and there was no statistical
difference between groups. Still, some samples showed obvious clefts between
the adjacent cartilage and repair tissue.
Approximately three out of every four defects at each time showed at least one
break in the subchondral plate. The reactions in the subchondral bone varied,
with the most severe reactions found in the matrix implanted group. There
was no statistical difference in the amount of remaining intact calcified
cartilage. The presence of calcified cartilage, repair tissue, sutures, and fascia
in resorbed areas below the level of calcified cartilage in certain samples seem
to indicate a sudden collapse of a large area into the bone. In some cases there
was a clear distinction between fibrous tissue derived from the subchondral
area and fibrous tissue presumably from the joint space. In one case, the
subchondral material seemed to be displacing the overlying tissue.
141
5.4.4.2 Effect of unseeded type II matrix in microfracture defects
Micrographs of healing defects treated by microfracture alone and with
microfracture and engineered type II matrix are shown in Figures 5-27 and 5-
34. The calcified cartilage and subchondral plate were violated in all such
specimens, however the reaction in the bone of the matrix-implanted group
was much greater. Figure 5-34 shows a severe reaction in the matrix-implanted
group. The deeper portions of the defect contain more cartilaginous tissue
than the surface, staining at least lightly for safranin O throughout. Hyaline
cartilage is forming at the periphery of the defect above the small section of
calcified cartilage that has not resorbed.
More matrix implanted specimens were filled to the top of the defect, however
the trend toward more total filling was not found statistically significant
(p=0.20). Although the reparative tissue was predominantly fibrocartilage in
both groups, there was more safranin O and type II collagen staining in the
matrix implanted group. Two samples in each group had vessels forming in
the defect area.
The subchondral bone reaction was visually more severe in the matrix
implanted microfracture defects compared to the untreated defects. While
the corresponding amount of intact calcified cartilage was greater in the
microfracture only group, the difference was not found to be highly
statistically significant (p=0.17). While only one microfracture defect had at
least an intermediate amount of safranin O staining in remodeling bone below
the defect, most of the matrix implanted specimens had large subchondral
regions staining for safranin 0. Furthermore, while three of four microfracture
defects with significant bone remodeling contained newly vascularized tissue in
this region, only two of eight matrix implanted specimens had similar vessel
formation.
5.4.4.3 Effect of seeded type I matrix in chondral defects
Defects implanted with seeded type I matrices were more filled than defects
implanted with unseeded type I matrices. Statistically this difference in total
fill was not significant by t-test (p=0.37). Reparative tissue was fibrous and
fibrocartilaginous, and no vessels were seen in the defect area in either group
(although some new vessels were very close to the defect). The appearance of
the adjacent cartilage was similar, with both groups demonstrating damage
from suturing.
The reaction in the subchondral bone appeared slightly more severe with the
seeded implant group, although the amount of intact calcified cartilage could
not be distinguished statistically. In addition, there was more staining for
safranin O and type II collagen in the cell-seeded group. In each group, in one
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Figure 5-34. Light micrograph of a healing full-thickness chondral defect
treated with microfracture and unseeded type II collagen matrix in the dog
trochlear groove at 15 weeks (safranin O/fast green stain, 40 X). There is
severe subchondral bone remodeling in this defect, with cartilaginous tissue
staining for safranin O in deeper regions (arrow). The fibrocartilaginous
tissue in the defect stains for safranin O primarily in the corner. Near the
adjacent cartilage at the defect edge, near-hyaline tissue is forming.
Figure 5-35. Light micrograph of a healing full-thickness chondral defect
treated with CAC-seeded type II collagen matrix in the dog trochlear groove
at 15 weeks (safranin O/fast green stain, 40 X). There is severe subchondral
bone remodeling in this defect, with cartilaginous tissue staining for
safranin O in deeper regions (closed arrow). The adjacent cartilage is
severely damaged by suturing, with mechanical disruption and near
complete loss of safranin O staining (open arrow).
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of eight specimens newly formed vessels were found in the remodeling bone.
No differences in attachment or bonding could be distinguished.
5.4.4.4 Effect of implant chemistry in chondral defects
The appearances of defects implanted with seeded type I or type II collagen
matrices were very similar, with approximately the same total fill and tissue
profiles (predominantly fibrocartilage, Table 5-19). The type II group was
found to have better attachment to adjacent cartilage (p<0.03, two-tailed t-
test). One type II-implanted defect contained vessels at the very base of the
original defect.
The reaction in the underlying bone varied significantly across each group,
with slightly more reaction in the type II group. In the defects in which the
bone remodeling was most severe, there tended to be more subchondral
staining for safranin O and type II collagen in each group. Only one defect in
each group displayed newly formed vessels in the subchondral bone.
5.4.4.5 Comparison of cell source with type II matrices
For comparison with the microfracture plus type II matrix group (Figure 5-34),
a representative sample from the engineered, CAC-seeded type II matrix group
is depicted in Figure 5-35. The figure shows that in the CAC-treated group,
there is also an extensive reaction in the underlying bone in many samples. In
this case there is intense staining for safranin 0, mostly at the level of the
underlying bone, but extending somewhat into the defect area. However, this
finding was more consistent across the microfracture with matrix group. In
Figure 5-35, also note the damage in the adjacent cartilage from suturing
including mechanical disruption, tissue forming in the suture track, and near
complete loss of safranin O from the matrix.
In comparing the treatments involving implanted type II and different cell
sources (subchondral cells from microfracture vs. cultured autologous
chondrocytes in chondral defects), the microfracture defects (Table 5-20)
contained more reparative tissue (p=0.27). In each case, the predominant
tissue types filling the defect were fibrous in nature, with similar contributions
from all tissue types. The treatment with microfracture caused more damage
to the calcified cartilage layer, as evidenced by less remaining intact calcified
cartilage (p=0.15).
5.4.5 Comparison of all 15 week groups
Selected data from all canine groups at 15 weeks are presented for comparison
in Figures 5-36 and 5-37. Figure 5-36 plots total defect filling in decreasing
order and the corresponding percent of intact calcified cartilage. These data
have an inverse correlation with R2 = 0.61 (linear regression analysis, R = -
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Figure 5-36. Graph depicting the inverse relationship between total defect
filling and remaining intact calcified cartilage for 15 week canine
implant groups or controls. Linear regression analysis of correlation of
total filling with intact calcified cartilage: R 2=0.61
0.78). Note that the two points which appear to not fit the trend (CAC alone
and untreated defects) are two of three groups in which a matrix was not
implanted.
In Figure 5-37, the normalized contribution of tissue types for these same
groups are plotted. This graph shows clearly the inability of implant
treatments to match the contribution of hyaline cartilage found in CAC and
empty control defects. These same treatment groups exhibited the lowest
contributions to reparative tissue by fibrocartilage and fibrous tissue. These
same groups had a substantially more intact calcified cartilagcified cartilage layer (Figure 5-
36) and the least reaction in the subchondral bone, however the level of filling
was relatively low (Figure 5-36).
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Figure 5-37. Composition of reparative tissue in all groups at 15 weeks.
Mean contributions from each tissue type are normalized by the total
percent defect filling for the group. gFx=microfracture,
CAC=cultured autologous chondrocytes. type I and type II refer to
collagen matrices.
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6. Discussion
The novel findings of this work were as follows:
- This is the first work to develop a quantifiable adult canine model of a full-
thickness chondral articular cartilage defect, a defect that is being created
clinically in treating some cartilage lesions.
- The model was used to study the time course of healing, up to 18 months,
of defects treated with cultured autologous chondrocytes injected under
periosteum. Untreated controls were included at all times and periosteum
controls at selected times. The finding of no long-term effect differed from
previous studies. This was also the first work in any model to document
the nature of the initial appearance of a full-thickness chondral lesion.
- These are the first reports of implantation of a resorbable matrix (seeded or
unseeded) and of microfracture treatment applied to a full-thickness
chondral defect in an animal model.
- The use of an insoluble porous matrix made of predominantly type II
collagen has not been reported in previous work in tissue engineering of
articular cartilage. This construct generated several notable findings:
1) A difference in chondrocyte behavior in vitro in the type II material
versus one made of predominantly type I collagen.
2) The implantation of these matrices in the animal model increased
the amount of reparative tissue, albeit with less hyaline tissue at 15
weeks.
3) The implants of these matrices were associated with a biological
reactivity that caused resorption of the calcified cartilage and
underlying bone.
It is important to note that this work has not yet resulted in the regeneration
of articular cartilage. While limited areas of healing tissue appeared similar to
articular cartilage, the complete articular structure, from base to surface, was
not found. Furthermore, there was no demonstration that tissue which
histologically resembled articular cartilage was, in fact, biochemically and
biomechanically identical to normal tissue. On the positive side, engineered
matrices did result in increased amounts of reparative tissue relative to
untreated controls and sites treated with cultured autologous chondrocytes
alone. Longer term studies will be required to determine if this reparative
tissue matures to articular cartilage.
6.1 Type II collagen-GAG analogs of extracellular matrix
Although only the few constructs described in this thesis were extensively
studied, a wide range of pore sizes were produced in flat sheets of matrix by
varying the temperature of the freeze drier or freezing tray/mold. This is
consistent with previous work using the same equipment with type I collagen-
GAG matrices. It also appeared that several other variables could affect the
resultant pore structure, including slurry temperature, size of the mold,
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contact between the tray and shelf, and position within the freeze drier. Thus,
if a consistent pore structure is desired, care must be taken to ensure that all
processing conditions are exactly reproduced.
The lowest temperature obtainable in our freeze drier was approximately -45 0C.
In preparing matrices in sheets at a range of temperatures down to this level,
the lower limit on pore size for a sample large enough to be used in these
experiments (5 mm diameter) appeared to be approximately 50 Rm. Work
with type I collagen materials suggest that much pores as small as 5 gm can be
made in sheets under different freeze-drying conditions including much lower
temperatures (-200 0C) [41]. It is also known that pores as small as 5 gm in
type I matrices can be produced by lowering tubes (1.5 mm diameter) into
liquid-nitrogen cooled oil baths [30], and that the pore structure can be
modified by the rate of immersion and graft diameter [101, 102]. These
methods were not used with type II materials in this work, but could be used if
smaller pores were desired. However, because the minimum pore size used in
this work (27 jm) approaches the size of the a chondrocyte (approximately 15-
20 gm), it is not anticipated that smaller pores would allow cell penetration
into the material.
Type II matrices made in our laboratory grossly had physical properties similar
to those of type I matrices made under similar conditions. However, the
properties of the matrices in our lab appeared different from type II matrices
produced commercially from a similar starting material. The reasons for this
difference are unknown, as the processing conditions for the commercial
product were not revealed. Pore diameter analysis indicated that the pore
structure was more closely controlled in our laboratory than in the commercial
product.
6.2 In vitro experiments
6.2.1 Recommendations for seeding procedures
Several experimenters in our laboratory agreed that it was technically easier to
seed the type II matrices. Relative to the type I matrices, the type II matrices,
were, stiffer, collapsed less when wet, and were able to maintain an expanded
form when dried on filter paper. In contrast, it was difficult to dry the type I
matrices to the same degree due to the collapse of the matrix. The drier type
II matrices also appeared to absorb the cell suspension more readily.
Stiffer matrices, as evidenced by type II seeding vs. type I, were easier to seed.
Based on the results of the seeding experiments, the following were concluded:
- Seeding on both sides increased the number of cells in the matrix and
improved the distribution.
- Seeding on an agarose bed and drying the matrices on filter paper are both
recommended to increase the number of cells delivered to the matrix.
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- If it is possible to constrain the matrix laterally, this will also increase the
percentage of cells delivered to the matrix.
- The time at which the seeded constructs are added to medium is not
critical for the first few hours. It is recommended to add the matrices to
medium quickly (within one or two hours) to provide the cells with
nutrition. The finding of less washout of cells from the 6 hour sample
suggested that after several hours more cells may attach to the matrix and
reduce the washout effect. However, washout is only reduced from
approximately 30% to 12%, and leaving the matrices without a source of
nutrition for this long may cause cell death.
The result that the use of agarose improved seeding agreed with previous work
in which Louie seeded similar matrices with tenocytes [102]. Additional
methods which may improve seeding, such as agitation [35, 51], injection
[1911 and vacuum seeding [134, 186] were not studied in this work.
Modification of the matrix to be seeded with extracellular matrix components
or synthetic factors which may bind the cells has also been used in other work
to attempt to improve seeding with other cell types [84, 98] and chondrocytes
[170].
6.2.2 Matrix chemistry effects
There was a significant effect of the type of matrix used in the study on cell
morphology in matrices comprised primarily of type I and II collagen. This
study was repeated up to three weeks with similar results [130]. The majority
of cells in predominantly type II matrices were rounded, while those in
predominantly type I matrices were elongated.
This was the first study reporting the effect of insoluble matrices made of types
I and II collagen on chondrocytes in vitro. Because the constructs consisted of
least 90% collagen, it is likely that collagen type was a primary regulator of
chondrocytes. As early as the 1970's, it was demonstrated that type II collagen
could affect chondrocyte phenotype, at least in developing tissues [96]. More
recently that a type II collagen coating helped promote adult chondrocyte
attachment to synthetic polymers [170]. Another recent study directly
comparing the effects of types I and II collagen in soluble form indicated that
different collagen types had different effects on chondrocyte DNA and
proteoglycan synthesis in a specific culture system [149].
In the study by Qi et. al. [149], at least part of the collagen type effect could be
explained by matrix modulation of growth factor activity. Thus, although in
the present study the effect of growth factor modulation was not studied, it is
one possible mechanism for the effects seen. Another possible mechanism for
differential effects of collagen type is that of integrin binding. Tuckwell has
shown that integrins may react with different types of collagen [183]. The
149
differences in peptide sequences in the different type collagens can determine
which collagens act as ligands to specific integrins [181].
Furthermore, the effect of matrix chemistry may also depend on collagen
conformation. Two studies with type II collagen have shown such a difference.
Tuckwell found that different integrins mediated chondrosarcoma cell
attachment to type II collagen with intact native structure versus denatured
collagen [181]. This study was supported by of changes in chondrocyte
biosynthetic activity when cultured with solubilized intact versus denatured
type II collagen [149]. The change in the levels of collagen structure
encountered in the production of type I matrices has been extensively reviewed
by Yannas [199]. While the type I material has been shown to retain some
elements of native collagen banding (quaternary structure), the structure of
the type II material received from Geistlich Biomaterials has been shown to be
less organized [130]. This finding may explain some of the difference in
behavior between the materials in the present study.
However, it cannot be conclusively stated that only the collagen type was
responsible for the observed behavior, as there may have been other subtle
differences in matrix chemical or mechanical properties which could
contribute to these differences. Thus, a clear limitation of this work is the lack
of a complete biochemical analysis of the materials used to produce the
matrices. Other extracellular matrix components which have been implicated
in regulating chondrocyte behavior include proteoglycans [96] hyaluronic acid
[197] and link protein [148]. These reports indicated that several additional
factors, including concentration and molecular weight may be critical
determinants of cell behavior. In addition, the other extracellular matrix
components found in small quantities may have differential effects on
chondrocyte behavior. For example one study found that one purified,
component cartilage oligomeric matrix protein, promoted chondrocyte
attachment, while a second, thrombospondin 1, did not [43].
One known difference between the matrices in the present work was that of
glycosaminoglycan content. The type I material had 3 to 4 times as much
GAG as the type II material. Because there were differences in producing the
slurries, the GAG may also have been incorporated in different forms. It has
been shown in production of the type I material that the GAG is covalently
linked to the collagen by dehydrothermal treatment [199]. In the type II
material the state of the GAG was not studied. Many studies have
demonstrated effects of GAG-like substances on chondrocytes or, more
generally, the synovial environment [10, 11, 103, 114]. It is not known if the
GAG in the form or forms found in the present work may effect chondrocyte
behavior.
The findings of morphology in one study of type II materials (the comparison
with type I materials) did not match those in a second study of type II
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materials (comparison of varying pore size in type II materials). In the first
study, over 60% of cells in type II matrices were rounded even after as long as 2
weeks in culture. This result was duplicated by another experimenter in our
laboratory using the same materials [130]. In the second experiment, while
well over 90% of the cells were initially rounded, fewer than 40% remained
rounded at times from 1 day to 1 week. It should be first noted that caution
should be used in comparing in vitro experiments using different batches of
cells. Although the passage number was the same, there could have been
subtle differences in cell origin or culture conditions which altered the
phenotype of the cells. In addition, the type II matrices used in the study were
made by different processes, and may therefore have had subtle structural
differences. Because the first study was duplicated in one case with the same
material, but not in the second study with a different material, this is a strong
possibility. One possible mechanism may have been a change in collagen
conformation (banded vs. non-banded) from differences in processing.
Other differences in this series of experiments may not be completely due to
matrix chemistry (see discussion of matrix contraction, 6.2.5).
6.2.3 Effects of matrix pore structure
In this work, it appeared that the most important effect of the pore structure
of the matrix was in determining cell penetration into the matrix. Grossly,
surfaces with more open structures allowed more cells to penetrate into the
matrix. In surfaces with few pores, cells still managed to attach to the outer
layer. For relatively open pores, the pore diameter was grossly related to the
degree of penetration, with cells penetrating further into matrices with larger
pores. A pore diameter of at least 100 gm was needed to obtain fairly uniform
seeding throughout a 2-3 mm thick sample. This finding is in agreement with
the quantitative finding of Louie with tenocytes in type I collagen-GAG
matrices [102].
It is assumed that the principal mode of penetration in our system was
gravitational settling, where the cells are passive. This finding agrees with work
that examined distribution of passive particles injected into matrices of
varying pore size [191]. In the present work only after one week in culture was
there evidence of active cell migration into the construct.
The measured effects of the pore diameter of a matrix on cell behaviors in vitro
was limited. In type I matrix, there was an effect on cell morphology at three
hours, but not at one week. In type II matrix, there was no significant
difference in quantitative analyses at 1 day and 1 week, or in qualitative
analysis at three hours. It is more difficult to make conclusions about the pore
diameter effects on the proliferative and biosynthetic behaviors of these cells
because the assays included both cells within the pores and those in layers on
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the surface of the matrix. With many matrices exhibiting thick surface layers
of cells, the contribution of the cells within the pores was not known.
Previous analysis of the effect of pore size in tissue regeneration has
concentrated on in vivo experimentation [30, 93, 202]. Because in the current
work no differences were seen in vitro in the pore diameter range 50-250 Rm, it
is not believed that the pore diameter will be an important variable in vivo.
6.2.4 Effects of degree of cross-linking
There was a clear difference in the ability of matrices to resist degradation in
culture based on the degree of cross-linking to which they were exposed. This
is most meaningful to the surgeon or tissue engineer who is interested in
providing a construct that can be easily handled and transplanted from
culture to a biological recipient.
However, this experiment was not able to detect quantitative differences in cell
behavior based on degradation rate. While cell-breakdown products may affect
cell-behavior [149], it was not evident in this work. It is possible that such
products were not able to accumulate to significant enough levels in the
medium under the conditions of the current experiment.
In vivo, only one degree of cross-linking was used. It has been hypothesized
that the degradation rate of an implant, as controlled by the degree of cross-
linking, may be an important determinant in the biological activity [199].
Further work would be needed to determine whether the time course of healing
in the cartilage defects studied here could be altered by varying the degree of
cross-linking of the implants.
6.2.5 Matrix contraction
The observation of matrix contraction indicates that, when seeded into
matrices of either type I or II collagen, chondrocytes are capable of adopting a
contractile, or "myofibroblastic" phenotype [48, 163]. In one other study
reporting contraction of a collagen gel by chondrocytes, the chondrocytes were
described as "dedifferentiated" [143], also suggesting that in order for
chondrocytes to contract a matrix, they may have to undergo a change of
phenotype.
Little is known about chondrocytes contracting matrices. Most work in
contraction has focused on the behavior of fibroblasts in contracting collagen
gels or lattices. This work has suggested that collagen type may be one
mediator of cell contraction. Initially, one set of experiments using collagen
gels of differing collagen type showed differences in matrix contraction by
fibroblasts [44]. It should be noted that these experiments were not controlled
for the mechanical properties of the matrix (see below). Other studies which
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implicate integrins in contraction would support the hypothesis that a
difference in contraction is due to different integrin recognition by different
collagen types. These studies concluded that gel or lattice contraction was
mediated only by a subset of the chondrocyte integrins [66, 177], and that
integrin expression by the cells was in turn regulated by exposure to the matrix
[91, 1621.
But based on the present work, collagen type alone cannot be solely responsible
for contractile phenomena. In this work, two different type II matrices
behaved differently with respect to the ability of the chondrocytes to contract
the matrix. One explanation might be that these two observations were not
made in a single controlled experiment, and thus the number and nature of
the chondrocytes used may have varied somewhat. In addition, the matrices
were processed differently and may have had different conformations of
collagen. However, it is most likely that the differences in matrix shrinkage
were due to matrix stiffness. The type II Chondrocell matrices provided by
Geistlich were by far the stiffest matrices and showed the least shrinkage. In
contrast, type II (and type I) matrices produced in our laboratory were similar
to each other (both significantly softer than the Geistlich matrices), and
underwent comparable and significant shrinkage. This effect is currently
under investigation in our laboratory.
6.3 Animal model
This is the first use of a "full-thickness chondral" defect in the canine. It is
also the first work in any animal documenting the appearance of a lesion
made to the level of the calcified cartilage including scraping of the tidemark
to remove all non-calcified cartilage. Previous work in the rabbit did not
report such a study of the initial lesion [23, 64]. Because this type of defect is
prepared clinically to treat certain cartilage defects, there is a need to
determine more specifically the effects of creating this lesion.
6.3.1 Limitations of the model
The chondral defect applied in this work, which in some cases became
osteochondral over time, should be distinguished from more shallow defects in
which the bone is always preserved. Complete removal of cartilage may
subject the subchondral plate to mechanical forces high enough to cause
fractures during the healing period. In addition, it might be suspected that
the very thin calcified layer and limited subchondral plate in the canine are
more susceptible to damage at surgery. In our study, damage to the calcified
layer and reactions in the bone were not predictable, and significantly affected
the repair mechanisms of individual defects. These uncertainties in the
animal model raise questions about whether or not, and to what degree the
same events occur in clinical treatments
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It is not known how well the results in the canine predict those in the human.
It should first be noted that in current practice, in many, if not most, of the
clinical preparations of these defects, the subchondral bone is visibly violated
during the preparation of the defect [80, 120, 129]. This may be a reflection of
the use of the procedure on patients with chronic lesions who have already
experienced damage to the bone. Because this procedure is invasive, in a
clinical context it is being used under limited conditions that do not match
the idealized isolated chondral lesion in many cases.
Also, in this study the primary outcome variable was histology, whereas in
clinical work it is pain relief. In addition, the activity level and conditions of
loading can differ from the dog to the human. While it is hoped that the
canine model provides an accelerated reflection of healing in the human, there
is no assurance that this is the case. As with any animal model, the results
from this work should be interpreted with caution and efforts should be made
to verify them in humans.
6.3.2 Source of reparative tissue
The source of the cells involved in the observed healing is unknown. Possible
sources include the transplanted cells or periosteum, the adjacent cartilage,
the underlying bone, or the synovial environment, including bleeding into the
joint during surgery. The beta-galactosidase labeling demonstrated that
transplanted cells may be retained in this type of lesion. However, with the
autologous cell transplantation procedure, the participating surgeons felt that
it is likely that the number of these cells implanted and/or retained in the
lesion in the canine varied significantly from defect to defect due to variability
in surgical technique. Study of seeded matrices documented a low degree of
variability in the number of cells retained in such matrices after seeding (a
coefficient of variation of 4% in one such study, section 5.2.4.2), and suggested
that this is likely a more reproducible method of delivering cells to a chondral
defect.
In many defects, a contribution of healing tissue from the subchondral bone
was clearly established by the histological observation of breaks in the
subchondral plate. However, some defects, including several at 1.5 months
when communication with the underlying bone was most common, appeared
to fill without a break in the subchondral plate. This observation was based
on numerous (at least 8) sections from across the sample. It is possible that
fractures in the subchondral plate occurred in these defects, but were not
found due to insufficiently frequent sectioning, or because they had already
healed.
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While the depth of the lesion was well-documented in this work (section 5.3.1),
it is not know what contribution this made to the reparative response in the
calcified layer and bone. The resorption of large areas of calcified cartilage
and bone was important because it was correlated with increasing reparative
tissue, decreasing hyaline cartilage in the defect, and formation of vessels in
the defect area. Possible mechanisms for reaction in the calcified cartilage and
bone include:
1. Damage from the surgery (documented)
2. Activity of cells which enter the joint from damage in 1.
3. Mechanical forces in the joint
4. Other soluble factors in the joint
5. Reaction to the implanted matrix or tissue
6. Factors released by cells transplanted to the defect
In absence of any treatment, there is still damage to calcified cartilage and
associated response in the bone. Factors 1 through 4 may all contribute to this
process. We have most control over factors 1 and 2, direct consequences of the
damage done in surgery. With current mechanical methods of creating the
defect, at least slight damage to the calcified layer (i.e., microcracks) is
inevitable. In addition based on our analysis of acute defects, further damage
to the calcified layer occurred in up to one third of specimens. We do not
know to what degree this damage contributes to reaction in the bone, but it is
possible that even the slightest disturbance of the calcified layer, such as the
microfractures, may predispose the bone to resorptive processes.
Thus, the chondral defect applied in this work, which in some cases became
osteochondral over time, should be distinguished from more shallow defects in
which the bone is always preserved. In addition, it might be suspected that
the very thin calcified layer and limited subchondral plate in the canine are
more susceptible to damage at surgery. In our study, such processes were not
predictable, and significantly affected the repair mechanisms of individual
defects. These uncertainties in the animal model raise questions about
whether or not the same events occur in clinical treatments.
There is also indication that communication can occur in similar animal
models. An initial investigation of full-thickness chondral defects in the rabbit
femoral condyles suggested a similar degree of communication with the
subchondral bone as in our study [1]. Grande reported that in one of five
control defects in the rabbit patella evaluated at 6 weeks, there was a
subchondral fracture [64]. Thus, subchondral fractures and communication
may be a normal consequence of defects made by scraping to the level of the
calcified cartilage. The prevalence of fractures and the intensity of reactions in
the bone is unknown, but is likely to vary with many factors including species,
defect location, and post-operative motion and loading.
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The biological reaction in the bone varied considerably across the treatments
applied in this study. These experiments with matrix implants showed
increased reaction of the bone compared to autografts and control treatments.
Thus, there appeared to be a certain "biological activity" associated with the
implants. Furthermore, the degree of this activity appeared to vary. Because
of the limited histological results in the only other study which implanted a
matrix in this type of defect [23], it is not possible to make comparisons with
other implantable materials. This may have important implications for
treatment. If the calcified layer can reform and hyaline cartilage form in the
defect, this reactivity may be desirable. However, there was also evidence in
this work that greater communication allowed vessels to form in the defect,
and it was clear that hyaline cartilage formation was at least delayed, if not
prevented. Because implants were evaluated only at 15 weeks, it was not
known what the long-term effect would be. If this effect were found to inhibit
healing due to the increased reaction in the bone, a less-reactive matrix might
be chosen to better preserve the calcified layer.
6.3.3 Sources of variability
Variability in similar biological models with penetration of the bone is
common [24, 27]. This study was no exception, with some defects in a given
treatment group showing excellent healing, and others showing almost no
healing. Two major sources of this variability could be: 1) the state of the
calcified cartilage (whether broken and or healed, discussed above), and 2)
dislodgment of the graft or reparative tissue early in healing. The prevalence
of dislodgment of grafts is unknown. Study of several animals implanted with
matrix grafts for only 30 minutes established that the graft was not dislodged
in closing the joint or from minimal joint motion (greater than that assumed
to occur with the external fixation device). However, in defects which received
grafts, but later displayed minimal filling, the graft and/or reparative tissue
must have detached at some time during healing. This may have resulted
from early loss of the graft, or from incomplete bonding of reparative tissue
and loss with wearing away over time. In several defects viewed up to 15
weeks, histological observations were consistent with large pieces of reparative
tissue, in some cases nearly filling the defect, coming dislodged. While the
immediate effect may have resulted from tissue processing, this tissue was
clearly not well-bonded to the defect and may have been subject to similar
results from ongoing wearing in the joint.
Because the finding of an empty or nearly empty defect may have been
attributable to failure of the inherent reparative mechanism (as opposed to
the effectiveness of attaching the graft) all defects were included in reporting of
group totals for filling. While the variation is reflected in data through the
standard error of the mean, a more direct presentation of the number of
defects with minimal filling is included in Appendix M. To summarize, in
most groups the large majority of defects had greater than 20% filling. The
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one exception was the fascia group, in which four of six defects had less than
5% filling. The only other group in which more than one defect was found
with less than 10% filling was the 6 month untreated defects.
It should also be noted that because untreated defects showed some filling, the
finding of a filled defect does not prove that a graft was retained. With the
exception of the eight defects for beta-galactosidase labeling, no grafts in this
work were labeled to establish whether or not they became incorporated into
the reparative tissue.
Collectively, these results suggest that, with the exception of the fascia control
group, graft detachment probably did not frequently occur.
6.4 In vivo experiments
6.4.1 Phases of healing
Histological evaluation of chondral defects in canine articular cartilage over
time revealed phases of healing characterized by proliferation and remodeling,
comparable to those seen in the healing of other tissues [5, 36]. Through 6
months, significant portions of articular cartilage regenerated. In certain
defects, fibrous tissue was replaced by hyaline tissue and damage to the
subchondral bone was healed. However, by one year most samples appeared to
have entered a phase of degradation characterized by decreased safranin O
staining or fibrillated surfaces of reparative tissue, and by degenerative changes
in the adjacent cartilage. Due to the complexity of healing, several of the three
phases could occur simultaneously in close apposition to each other. The
overall process mirrors that found in osteochondral defects in articular
cartilage [168].
Several observations suggested a time dependent conversion or remodeling
(degradation followed by formation) of one tissue type to another: the
evolution of the tissue type profiles, and the histology which often showed
indistinct, mixed borders between otherwise distinct tissue types. It is likely
that reparative tissue can follow the regenerative sequence: fibrous tissue -
fibrocartilage - hyaline cartilage - articular cartilage. This would be one of few
examples in which an organized fibrous tissue is not a terminal scar, but
instead a precursor to another tissue type. Occurrence of the reverse
transitions were not certain, except for articular to hyaline. However, it is
strongly suspected that the transformation of hyaline cartilage to fibrocartilage
does occur, and that this is in fact the end point of healing. In some cases
hyaline cartilage appeared to degrade by fibrillation and gradual wearing away
(as in osteoarthritis), and there was also histological evidence at 18 months
that transitional tissue (specifically fibrocartilage) could replace hyaline
cartilage. If fibrocartilage is the terminal stage in repair, it would be the
cartilage analog to scarring in other tissues.
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Previous authors have also reported degradation following healing in various
models of cartilage defects [24, 124, 139, 168]. In our model, the initiating
event for degradation may have been a) opening of the joint b) the surgical
treatment to the defect (including suturing), or c) failure of immature
reparative tissue subjected to high biomechanical forces. Likely, all of these
factors were involved. Once initiated, the degradation appeared to encompass
the entire joint. Clearly, steps should be taken to prevent such occurrence.
Development of a less invasive, arthroscopic procedure is preferable to an open
surgery. In addition, an alternative method of graft fixation should be sought.
The idea that failure can be traced to breakdown of reparative tissue suggests
that long-term success in treating articular cartilage may require near perfect
regeneration in the remodeling phase and carefully controlled post-operative
care.
6.4.2 Microfracture
Although widely used clinically, this is the first report of microfracture in an
animal model. Several defects showed very good filling with limited bone
damage, while others had near complete resorption of the of the underlying
bone, similar to that seen often with collagen matrix implants. While the
filling was encouraging, no hyaline cartilage was found in the defects. Longer
term studies are necessary to establish the long term fate of healing in the
underlying bone and possible maturation of the reparative tissue.
6.4.3 Effect of matrices
This is the first study of the effect of a resorbable collagen matrix in either full-
thickness chondral defects or microfracture defects in any model. The only
other reported study of implants in full-thickness chondral defects involved
carbon fiber implants in the patella of a rabbit [23]. Thus, it is difficult to
compare the findings of this study to other published work. Many studies
have implanted matrices in osteochondral defects in several animal models
(Tables 2-1 and 2-2). These experiments may provide some basis for
comparison.
Implanted matrices had mixed effects on healing in this model. Both seeded
and unseeded matrices did increase the amount of reparative tissue relative to
control groups without matrices in both normal chondral defects, and those
treated with microfracture. The statistical significance of these findings was
only 0.10 < p < 0.20 due to large variability in the data. For the comparison of
microfracture with and without matrix, statistical significance is extremely
difficult to prove as the hypothetical limit of approximately 100% fill is
approached. The finding of increased filling when matrices are used is
consistent with the findings for a variety of matrices in osteochondral defects
[52, 53, 67, 93, 145, 172]. When used as a carrier for autologous cell
transplantation, the matrix delivers cells capable of participating in repair to
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the defect. However matrix effects are also found in unseeded matrices. In
this case, the matrix may perform one of several functions. First, the matrix
may serve as an attachment site and support for cells migrating into the defect
from the underlying bone, synovium, or adjacent cartilage. Second, the matrix
may regulate the effect of growth factors on the healing defect by binding or
inactivating them [81, 149]. Finally, the effect of the matrix may be indirect,
causing increased filling of the defect via increased resorption of the
underlying bone and the consequent flowing of undifferentiated mesenchymal
tissue into the defect. This mechanism is supported by the data from all of
the present experiments with matrices, in which the total filling of the defect
universally increased with the amount of damaged calcified cartilage.
On the other hand, the nature of this tissue at 15 weeks was less mature than
that found in untreated defects or autologous cell transplantation. It is
possible that this was also due to the greatly increased damage to the calcified
cartilage which prevented hyaline cartilage from forming. In the many defects
examined in this work, hyaline cartilage clearly formed preferentially on an
intact calcified cartilage layer. This suggests that the reformation of the
calcified layer and tidemark will be critical to regenerating articular cartilage.
It would be interesting to follow up these experiments at longer times to
determine whether a normal tidemark is reconstituted. It may also be
hypothesized that the biological activity of the implant will be critical in
determining how the matrix affects these processes in the bone. Similar
findings in the bone were not reported in work in similar defects (12 defects at
12 weeks) with carbon fiber matrices in the rabbit patella [23]. It is possible
that the animal species, defect location, and type of implant may all help
explain this difference.
The timing of the effects of the matrix is unknown. Both type I and type II
remnants were virtually completely degraded by 15 weeks (only a trace of a
large block-like type II matrix was found at 15 weeks). Presumably, once the
matrix is resorbed, it ceases to cause direct effects. However, the degree to
which the presence of the matrix has changed the cell populations, chemical
milieu, and resorption processes and mechanical integrity of the calcified layer
and underlying bone is unknown.
It is important to note that the composition of reparative tissues found filling
the defect from seeded type II matrices was similar in two separate trials with
separate sources of matrices and a slightly different seeding procedure.
Collagen matrices may have contributed to healing through two mechanisms.
First they provided a support to more consistently deliver cells to the defect
compared with autologous cell transplantation. Second, as discussed above,
they were associated with a biological activity in the subchondral bone that
created communication that can explain the high degree of filling found.
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6.4.4 Effect of cover materials
The effect of cover materials was not studied in a controlled manner in all
experiments. The cover controls included fascia at 15 weeks and periosteum at
1.5, 12, and 18 months. No controls for type II sponges or films were included
because of a need to limit the scope of the experiments.
All covers were resorbed or at least significantly remodeled within the first few
months. Type II collagen covers (compressed sponges or films) were resorbed
or remodeled to the point where the original tissue or material could not be
recognized at 15 weeks. Fascia was seen remodeling at 4 weeks, and may have
been evident at 15 weeks, although this was not proved. Periosteum could not
be distinguished clearly even at 6 weeks.
It is not certain to what extent the covers may have contributed to healing.
When used alone as a control, periosteum results mirrored those of periosteum
with transplanted CAC. However, the periosteum control was omitted at the
times when the CAC plus periosteum treatment had a measurable effect.
Periosteum has been used in previous work in full-thickness chondral defects
with methods similar to those in the present work. In the one study that used
periosteum controls [23], there was no indication that periosteum improved
healing. However, in a series of experiments in which periosteum was used in a
different manner, including osteochondral defects, reversed orientation of the
periosteum in the defect, and continuous passive postoperative motion, the
treatment was able to significantly improve healing [89, 127, 139, 140, 159].
Fascia may have hindered repair. First, many fascia-implanted control defects
were nearly empty. In addition, despite a substantially intact calcified
cartilage layer, there was almost no bonding to the defect base. Thus it is
appeared that fascia 1) did not stimulate repair, and 2) the fascia itself was
eventually detached from the defect due to its inability to integrate with the
surrounding structures.
6.4.5 Effect of autologous cultured chondrocytes
Based on comparison with periosteal controls at 1.5, 12, and 18 months, there
was no clear evidence in this work that cultured autologous chondrocytes
improved regeneration. However, at the intermediate times (3 and 6 months)
when the treatment was most effective, no periosteal controls were employed.
There did appear to be a benefit to the cell and periosteum treatment
compared with empty controls at these times. However, in the longer term
studies (12 and 18 months), the reparative tissue in all groups appeared
similar. One significant difference at these times was additional damage to the
adjacent cartilage in defects which were sutured (P and CAC groups).
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It is important to note that the earlier findings of filling of defects with hyaline
cartilage does not correlate with the long-term success (beyond 1 year). It is
likely that long-term success depends on many important factors, including a
higher degree of defect filling, formation of mature (hyaline) reparative tissue,
and complete integration with adjacent structure (both calcified cartilage and
adjacent cartilage). The findings of this study indicated that hyaline cartilage
forming in the defect readily bonded to calcified cartilage, but not always to
the adjacent cartilage. It may be necessary to involve growth factor or
enzymatic treatments in efforts to stimulate better integration of the
reparative tissue [78].
This experiment did not reach the same conclusions as some previous work
with respect to the effect of transplanted cells. Experiments in a rabbit model
showed a positive effect of CAC in the amounts and types of reparative tissue
forming up to one year [23]. In addition, the rabbit did not exhibit
generalized degradation in the treated defects at the 12-month time point.
Finally, significantly more spontaneous regeneration is reported in the canine
in this work than in previous work in the rabbit. While the rabbit response
could also be described by the phases of proliferation and remodeling, the time
course and intensity of each phase differed from the canine. The different
results from work in the rabbit and the dog indicate that the effect of the cells
may be sensitive to several variables including: a) species, b) subject age, c)
defect location (patella vs. trochlea), d) surgical skill in the treatment, and e)
post-operative animal activity.
The current canine results in the trochlear defect do not mirror clinical
experience in chondrocyte transplantation in other sites. Thus, while positive
clinical results of cell treatment in human subjects [22] warrants continued
investigation, it is not possible to conclusively attribute the promising effects
to the transplanted chondrocytes based on this study. The present results do,
however, suggest that the long-term performance in humans must be assessed
to determine the fate of the reparative tissue. Histological and biomechanical
analyses revealing normal or near normal articular cartilage structures and
properties would be of great value in confirming the efficacy of this novel and
promising procedure.
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7. Conclusions
The following are conclusions that relate to the hypotheses of this thesis and
can be drawn from the present work:
* The chemical composition of porous collagen-GAG matrices, made
principally of types I and II collagen, influences canine chondrocyte
morphology, proliferation, and accumulation of glycosaminoglycan in
culture; a greater percentage of cells in the type II collagen matrix display
a rounded morphology.
* The pore diameter of type I collagen-GAG matrix, when varied from 25 tm
to 85 tm, affects chondrocyte morphology 3 hours after seeding, but not
after one week. The pore diameter does not affect chondrocyte
proliferation or glycosaminoglycan accumulation.
* The pore diameter of type II collagen-GAG matrix, when varied in the range
of 50-250 Rpm, has only slight effects on chondrocyte morphology and
proliferation, and no effect on glycosaminoglycan synthesis or
accumulation for up to four weeks in culture.
* A canine model, using quantitative measures of defect filling by distinct
tissue types, can discriminate repair processes in the healing of full-
thickness chondral articular cartilage defects in the trochlea.
* Treatment of full-thickness chondral articular cartilage defects in the canine
trochlea with cultured autologous chondrocytes under a periosteal flap,
while increasing the amount of reparative tissue and hyaline cartilage at
three and six months relative to untreated controls, does not influence the
long-term healing of full-thickness chondral defects in this model (at 12
and 18 months).
* Relative to untreated controls, application of microfracture in treating full-
thickness chondral articular cartilage defects in the canine trochlea
increases the total amount of reparative tissue, but decreases the amount
of hyaline cartilage filling the defect at 15 weeks.
* In untreated, periosteum-treated, and CAC-treated defects, reparative tissue
follows similar trends in remodeling, beginning with predominantly fibrous
tissue (up to 1.5 months), progressing through a phase of maximum
hyaline cartilage filling (3 and 6 months), and tending toward
fibrocartilage by 18 months.
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* Relative to untreated controls, implantation of chondrocyte-seeded type I or
type II collagen-glycosaminoglycan matrices in full-thickness chondral
articular cartilage defects in the canine trochlea increases the total amount
of reparative tissue, but decreases the amount of hyaline cartilage filling
the defect at 15 weeks.
* The implantation of a porous type II collagen-GAG matrix in a
microfracture-treated full-thickness chondral articular cartilage defect in
the canine trochlea increases the total amount of reparative tissue, but not
the amount of hyaline cartilage filling the defect.
* In this defect model, there is an inverse correlation, by linear regression,
between total defect filling and the amount of calcified cartilage remaining
intact. This suggests that the primary means of filling of these defects is
from cells derived from the subchondral bone.
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8. Future work
The results from matrix implantation in the animal model at 15 weeks suggest
the need for follow-up studies at longer time periods. While total filling of
defects at this time was favorable, little hyaline cartilage existed at a time
when maximum hyaline cartilage as seen in untreated defects and defects
treated by cultured autolgous chondrocyte transplantation. In addition, more
severe reactions in the underlying bone were noted. It would be of great value
to determine the long-term result in these defects and to determine whether
the mechanism of perforation of the plate, with bone reaction and filling of the
defect, is consistent with long-term success in healing. Specifically, this future
work should answer the following questions: Will the subchondral plate and
tidemark reform? Will the reparative tissue remain in the defect? Will hyaline
cartilage form in the defect? Will the tissue be integrated with adjacent
structures? If the long-term result from perforation is poor, efforts should be
made to develop treatments which cause less reaction in the underlying bone.
This thesis did not study the effects of growth factors on healing. Future work
should investigate the contribution of growth factors in the healing process
and how the use of matrices may affect these processes. In addition, growth
factors should be investigated as an important component of tissue
engineering strategies, i.e., to augment treatments with cells and/or matrices.
Research should also continue to focus on which cell sources (i.e., transplanted
chondrocytes or periosteal cells, or cells supplied from the joint or underlying
bone) can be most useful in healing. In addition, there is a need to firmly
establish the conditions of the treatment (e.g., postoperative conditions such
as motion and loading) which may make the procedure more effective.
Because only one defect location was used in this study, it is not possible to
generalize to all defects. It would also be useful to determine the response of
defects in different locations, and whether they respond similarly to the same
treatments.
One means of improving the reparative process with cultured autologous
chondrocytes might focus more closely on the cells used for repair. In this
work, the articular cartilage was harvested without regard to the depth relative
the surface, and thus the origins of the cells that survived culture and
transplantation were not known. However, it is known that there can be
significant variations in chondrocyte activity with distance from the surface [8,
9]. Selective isolation of more active cells might improve repair.
Another important element not studied in this work is that of mechanical
properties of reparative tissue. It would especially be of interest to determine
if the reparative tissue described as hyaline or articular cartilage in this defect
has mechanical properties similar to normal cartilage. In addition, the
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mechanical properties of the reparative tissue in this work could be compared
to previous studies reporting the properties of tissue engineered cartilage.
This work indicated that significant damage to the adjacent cartilage occurred
in suturing the grafts or covers to the joint surface. This suggests the need to
identify an alternate means of fixing grafts to chondral defects. Several
adhesives have been used in work in cartilage in the past. Fibrin glue has been
used as a sealant in our canine model, and has been used to fix perichondrial
grafts in defects [74, 75, 121], although graft delamination sometimes occurs.
One study has suggested mussel adhesive protein a stronger alternative to
fibrin glue [147]. Most recently, the use of transglutaminase has been found
superior to fibrin for cartilage-cartilage bonding, and may be useful in fixing
collagen grafts [86]. It is likely that it is easier to fix a collagen matrix to the
calcified layer than creating a cartilage-cartilage bond, as glycosaminoglycan
chains which can detract from bonding are absent in the former case [86].
The present work touched on the gross and histological effects of the various
treatments on adjacent areas of the treated joint. In some cases, pathology
was noted. Thus, this work should be extended to determine if there are any
adverse effects on the biochemical or mechanical properties of other important
joint structures, and especially the opposing or uninvolved cartilage.
Future work may also investigate the development of a primate model. The
primary advantage will be in allowing arthroscopic investigations to be
performed. Because of the many adverse effects of open joint surgery, there is
a general trend in orthopedic surgery is to develop arthroscopic techniques
wherever possible. This is currently the case in autologous chondrocyte
transplantation, and it is desired to have a model that will be able to mimic
the clinical situation. In addition, arthroscopy can be used as a means of
multiple follow-ups on a single lesion, especially with the ongoing development
of new non-destructive arthroscopic testing methods. The primate model
would also have thicker cartilage and the cell biology may more closely
resemble that of human cartilage.
It is also important to determine if the defect response in the animal can be
used to predict the success of treatment of specific types of defects in the
human. For example, future work may be used to answer the following
questions: Is the clinical observation that CAC-treatment is more effective in
the femoral-tibial articulation than the patellar-trochlear articulation
mirrored in the canine? Can other conditions of treatment, such as patient
age, previous surgery, and relative joint stability be studied in the animal and
applied to the human?
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Further in vitro work may focus on two observations made in this study. First,
it would be of great interest to determine which elements of matrix chemistry
are responsible for the differences in chondrocyte behavior in matrices of
varying chemical composition. In addition, the mechanism of chondrocyte-
mediated contraction of sponges should be investigated.
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Appendices
Appendix A Methods of production of collagen-GAG matrices
Integra type I bovine tendon collagen (for matrices HB95-1 and all others)
1. Defrost wet tendon collagen (Integra Life Sciences, 2/2/95, 26.3% solids)
2. Cool blenders for 30 min. to 40C
3. Fill one blender with 600 ml of 0.05 M acetic acid
4. Weigh 13.69 g wet tendon collagen
5. Place collagen in blender
6. Blend for 90 minutes on high setting
7. Add 120 ml of chondroitin 6-sulfate (Sigma catalog # C-4384, St. Louis,
MO) solution over 15 minutes using peristaltic pump. (0.32 g C-6-S
in 120 ml 0.05M acetic acid)
8. Blend additional 90 min. on high
9. Pour out slurry and refrigerate in plastic storage bottle
10. De-gas in vacuum flask immediately before moving. Slurry is ready to
pour into freeze drying tray.
VirTis freeze drier protocol:
1. Set shelf temperature.
2. Turn on freeze and heat switches.
3. Turn on condenser switch. Condenser should reach -50 0 C before pulling
any vacuum.
4. Wait for shelf to cool to desired temperature.
5. Prepare tray with molds or dividers. Pre-cool freeze-drying tray if desired.
6. Add slurry to tray.
7. Wait until all slurry in tray is frozen.
8. Once frozen, turn on vacuum (make sure door is sealed). (Make sure
condenser is colder than -500C.)
9. Wait for vacuum to reach less than 200 mtorr. Set temperature to 00C
and leave overnight. Larger samples may need longer times to
completely sublimate.
10. Set temp to 200C and turn off freeze switch.
11. When sample reaches 20 0C, turn off heat, vacuum, and condenser. Release
vacuum and recover sample from chamber. Turn power off.
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Appendix B Description of pore characterization
Embedding and sectioning for pore analysis
1. Embed in JB-4 plastic (Appendix E).
2. Section to 5 pm on microtome and stain with aniline blue (Appendix F).
Pore Characterization Protocol
Capture Image:
1) Macintosh computer set up:
* Under the Apple menu, choose Control Panels, then Monitors.
* choose 32-bit addressing and 24-bit color
* turn off screen savers
2) Video camera set up
* Attach video camera to microscope
* Arrange sliding eyepiece selector knobs (at level of eyepieces) for TV:
- Left side slider in "out" position
- Right side slider in "middle" position
* Turn Gain and Offset knobs all the way down (counter clockwise)
* Turn on Hitachi video camera
3) Using the computer to capture the image:
* Several programs can be used: Scion Image, Ultimage, or Digit
* Using Scion Image 1.60c to grab video:
- Adjust light level on microscope so green light on Hitachi is on
- Choose Start capturing in the Special menu.
- Turn up gain and offset to get approximate picture on screen.
- Fine tune image and focus, then click on the image to freeze video.
- Save image by selecting Save as in the File menu.
- Use TIFF format. Each image file is about 325K.
Image Clean-Up:
1) Open Scion Image 1.60c and load image.
2) Ambiguous parts in the matrix need to be manually drawn in or deleted. It
is helpful to view the specimen under the microscope for reference points.
3) Additions can be made by clicking on the Pen Icon in the Tools box.
Double click on this same icon to change the pen width. Click on the Eraser
in the Tools box to make deletions. For more detailed modifications to the
image, it is suggested that you magnify the region of interest. To do this, select
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the Magnifying Glass in the Tools box. Then click on the appropriate area of
the image. To return to the original scale, select Unzoom in the Edit menu.
4) Click on Density Slice in the Options menu. This will highlight the non-
obvious matrix in red, in addition to some extraneous background. Areas that
are red should be manually filled in with the pen, unless of course it is not
matrix. It is not necessary to remove background noise at this point.
5) Click on Threshold in the Options menu. Click on Smooth or Sharpen
in the Process menu. If outcomes are not desirable, click on Undo in the
Edit menu. Do not overuse these techniques!
6) Click on Binary under the Process menu. Click on Make Binary. Click
on Erode which is underneath Binary in the Process menu. This is helpful in
systematically removing background pixels. Repeat if necessary.
7) When all modifications are complete, and you are satisfied with the image,
click on Apply LUT in the Process menu. This will provide an image of only
black and white (no gray) which will facilitate analysis. Save image with a
different filename in TIFF format. Be sure to indicate in the filename that this
is the final modified file. Quit Scion Image.
Pore Analysis:
1) Load Digit program 11-July -93 version. It will be necessary to install the
SoftwareFPU program in the control panel to run this program on a
PowerMacintosh. Failure to do so will result in a math coprocessor error.
2) Open final modified image file to be analyzed. Digit cannot be used to alter
the image.
3) Setting the Materials
Click on Materials in Options menu. The materials can either be
loaded from a saved file (if previously set), or edited on the spot. The
following are instructions for the correct settings for pore analysis:
Set the number of materials to 2.
The material to edit should be 1 (first material, or matrix). Click on Edit
Material.. Adjust to these settings:
Region number, solid = 1 Data source = pixel
Region number, void = 0 Threshold = gray level; low=0; high=100
Label = _matrix.
Click on Next Material . This is material 2 (pores). Adjust to these settings:
Region number, solid = 1 Data source = pixel
Region number, void = 0 Threshold = gray level; low=101; high=255
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Label = _pores
Click on Okay. Save this file (by clicking Save to File) if you wish to use
again.
4) Setting the Scale
Set Scale from the Options menu. Note that the "known distance" has
no units. You must know your units use them consistently (generally
microns). The microscope is calibrated as follows:
Objective magnification Known Distance (microns) Pixels
4x 4.15 1
10x 1.66 1
20x 0.83 1
40x 0.415 1
100x 0.166 1
5) Choosing the Region
Set the Region from the Options menu. A circular region of interest
must be used. Set by clicking Circle and dragging the mouse. If region drawn
is not acceptable, click on Clear, and repeat. Regions may be Saved. Click on
Close when done.
6) Click on Threshold in the View menu. Change high setting to 100.
7) Stereological Analysis
Click on Stereology in the Analyze menu. For analysis of matrix only,
set material number to 1. For analysis of pores only, set material number to 2.
For analysis of both materials, enter 0. The time of analysis will depend on the
size of the region and speed of the computer, and can be more than 30
minutes for a PowerMacintosh 7200/90 and a full screen region. Check box for
append results to existing file if you have already started a file (see below).
Click on Okay and either create a new stereology data file, or select the
stereology data file to append to. As soon as the file is opened or created, the
program will begin calculation (Apple watch icon appears on screen) and you
will not be able to work on the computer. Appearance of a blue elipse within
the yellow region circle indicates completion of calculation for material
number 1. The elipse indicates pore orientation (data for the elipse is
contained in the data file). Clicking anywhere on the screen will either a) start
analysis of the next material if there is more than one, or b) reset to the
original file and region if this is the last or only material. This data file can
later be viewed with Excel, but do not make any modifications to the
file. This will corrupt the file so that Digit will be unable to use it in attempts
to append later data.
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Notes on data output:
MIL=minimum intercept length and is taken as the pore size (Maximum and
Minimum estimates given)
Area Solid = Area of material reported
Area Total = Total area within region
Extent Anis = eccentricity of the blue elipse showing pore orientation. 0 means
isotropic, 1 means highly oriented in one direction
Estimating Pore Size with Eyepiece Grid
When using the grid eyepiece (10 x 10) in the microscope to estimate pore size,
use the following conversion:
Note: Microscope must NOT have photo cross-hairs engaged!!!
If using 4x objective, each square has length of 150 microns.
If using 10x objective, each square has length of 60 microns.
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Appendix C Cell isolation and seeding protocols
Isolation of chondrocytes
* Prepare 50 ml-tubes to store cartilage specimens: 40 ml of D-PBS + 0.4 ml
Pen./Strept. (100 U or gg/ml) + 0.2 ml fungizone. Weigh tube. Keep at 40C
if you expect a delay between harvest and processing the tissue. Digestion
should not start later than 4-6 hours after the harvest.
* Autoclave: cutting board, 3 petri dishes, 2 forceps, scalpel, spatula, ruler,
special blue tips (see below). (optimal forceps- 1 fine point curved, 1 micro
point straight)
* Prepare collagenase at 0.10 to 0.15% in DMEM/F12 The activity of
collagenase will vary. Generally try a bit higher concentration with lower
activity. At this time, we are using Sigma Collagenase, activity 370 U/mg.
This will take some playing depending on tissue and other, sometimes
unpredictable acts of the supernatural.
100 ml DMEM/F12
0.1 to 0.15 g collagenase
2 ml pen/stept (20,000 U or gg)
1 ml fungizone
Sterile filter complete solution through 45 gm corning filter system (cellulose
nitrate).
Store in T75 flask or sterile bottle or 50 ml tube.
* Retrieve tissue in sterile operation. Weigh tubes with tissue to get tissue
weight for future reference. Set up sterile area in hood with drape and
autoclaved stuff.
* Fill first petri dish with the specimen (dump in with PBS).
* Fill second petri dish with PBS (10 ml) for washing the specimen or placing
waste in.
* Fill third petri dish with about 20-30 ml of the collagenase-media solution.
* The cartilage chips are taken from the first dish, washed (dipped) in the
second dish (PBS), and than placed on the cutting board and manually diced
into pieces of the size 1xl mm (much easier to cut on board than in dish). If
pieces are very thin (as in thin cartilage shavings), they might not need to be
so small. Scoop or use forceps to move the small pieces into the third petri-
dish with collagenase.
* Transfer pieces plus collagenase to spinner flask. The following procedure has
been found to work well: Use 1000 gL micropipettor. Cut off end of sterile
blue to make large (about 5-6 mm) opening (best to prepare ahead of time
and autoclave). Use pipettor to suck up pieces and excess collagenase, and
squirt into spinner flask. Once pieces are gone, remove the rest of the
collagenase from the petri dish (by serological pipet). Add more collagenase
to spinner flask, washing down the arm of the flask. Must be enough
medium in spinner flask so that it will stir.
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* Put the spinning flask in the 370C incubator with the stir plate. Stir very
slowly, just enough to move the fluid. Digestion times can vary widely with
tissue type, size, and collagenase activity and concentration. Monitor as
needed- at least every few hours. At the end, just about everything should be
digested; only small remnants of adjacent tissue may remain. But don't
digest too long, because of the decreasing viability of the cells.
* Digested cartilage is filtered through nylon cell strainers from Falcon (70gm)
directly into 50 ml tubes. 2 methods may be used to get the solution from
the spinner flask to the cell strainers:
1) Pour directly out of spinner flask arm. Flame the opening from time to
time.
2) If not removing all of the contents of the spinner flask, remove what
you need with a 10 ml serological pipet. Pipet directly through the cell
strainers into the 50 ml tubes.
* Spin filtered solution at 1500 rpm for 10 minutes in centrifuge at room
temperature.
* Decant supernatant (via vacuum suction- be careful not to suck up cells) and
resuspend the pellet in 25 ml (total of all tubes from previous step) of
complete medium (or serum-supplemented PBS), then spin again at 1500 rpm
for 10 minutes. Do a total of two to three rinses.
* Before final spin, count cells in hemacytometer and determine viability
(Trypan blue staining)
* Resuspend final clean pellet in full culture media (5-10 ml usually works well)
(recount if desired).
* Put cells into a T25 or T75 flask (6.5 or 17 ml of media cell solution) and
incubate at 370 C in a humidified 5-10% C02 environment. T25: put about
5e5-1e6 cells. T75: put about 2-5e6 cells. Number of cells per flask depends
on cell type and expansion desired. For cells that don't like to attach or may
not be healthy, put more, as many may be lost. For chondrocytes, I would
put lots.
* Allow cells to attach before adding medium. This will depend a lot on cell
type and viability. For cells that may have been damaged in digestion or
don't like to attach (like chondrocytes), be patient. It is possible that only a
few out of many millions will attach. Wait to change medium and have
faith.
Cell-seeding protocols
1. Sterilizing/prewetting matrices: (all steps/instruments sterile)
A. Wet/sterilize with ethanol
- pour 70% ethanol into 85 mm petri dish (enough to cover matrices)
- add matrices by forceps
- squeeze out air bubbles with curved forceps (be careful not to tear
delicate matrices)
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- soak 10 min.
- squeeze out bubbles again before changing solution
B. Rinse out ethanol
- Remove all ethanol with pasteur pipette (if using vacuum suction,
take care not to suck up matrices). Tilt dish to allow last bits to
collect along edge.
- Add PBS to cover matrices
- Squeeze out air bubbles
- soak 5-10 min.
- squeeze out air bubbles
- REPEAT 4 more times with PBS
C. Pre-wet with medium
- Remove all PBS with pasteur pipette
- Add medium to cover matrices (can be complete or incomplete
medium)
- Squeeze out air bubbles- let medium penetrate matrix
- soak 5-10 min.
- squeeze out air bubbles
- REPEAT 1 more time with medium
- Cover and place matrices in medium in incubator until ready to seed
2. Collect cells.
- Follow protocol for cell passage/subculture to collect cells
- Count and resuspend in medium at 25 million/ml for seeding
- Store cell suspension in incubator until matrices are prepared
3. Seeding
- place sterile barrier in hood
- on barrier, spread out sterile filter papers for partially drying matrices
- with sterile forceps, remove matrices from pre-wetting petris
- drop matrices on filter papers and move or flip until "sufficiently" dry
- place matrices into agarose covered wells: center them, away from
walls
- remove suspension from incubator, resuspend with 1 ml pipette
- use micropipettor with extension for tips for aliquotting
- place aliquot of cell suspension (usually 32-40gl) on each matrix
- shake or resuspend cell suspension often during seeding
- allow several minutes for drop to settle into matrix
- flip matrix, placing again in center of well
- seed second side with drops from micropipettor
- place in incubator for 1 hour to allow cells to attach
- while seeded matrices are in incubator, prepare final plates with
medium and also place in incubator. 1.5 to 2 ml/24 well.
- with forceps, carefully move matrices from agarose to final wells
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Appendix D Protocols for biochemical assays
GAG assay
1. Prepare DMB stock solution:
32 mg 1,9-dimethylmethylene blue (DMB) dye
10 ml 100% ethanol
Mix gently with pipet (no vigorous shaking)
2. Prepare formic acid solution:
2 L distilled H20 (d H20)
4 ml 90% formic acid
pH to 3.5 with 10M NaOH
3. Prepare final DMB dye solution:
Combine DMB stock solution with formic acid solution
Store in dark bottle
Shelf life approximately 2 months
4. Assay:
Collagen samples must be digested by papain or protease
Vortex sample or mix completely
Add 100 Rl aliquot of sample to cuvette
Add 3 ml final DMB dye solution to cuvette. Mix.
Read immediately in spectrophotometer at 535 nm.
Read standards of shark chondroitin sulfate in dH20
DNA assay
1. Prepare TNE 10x buffer solution: (100 mM TRIS, 10 mM EDTA, 1.0 M NaC1)
800 ml dH20
3.7 g Disodium Ethylenediamine Tetraacetate (EDTA)
12.1 g TRIS
58.4 g NaCl
pH to 7.4 with concentrated HCI
dH20 to 1000 ml (approximately 165 ml)
store 40C
2. Prepare concentrated Hoechst dye stock solution: (1 mg/ml)
10 mg Hoechst dye #33258
10 ml dH20
Store 41C, shelf life: 6 months
Protect from light: fluorescent!
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3. On day of assay, prepare working solution of dye:
90 ml dH20 filtered through 0.45 m
10 ml TNE 10x buffer filtered through 0.45 gm
At latest possible time before working, add 100 pl concentrated Hoechst
dye stock solution (unfiltered- do not allow dye to bind to filter)
This concentration is good for reading DNA in final concentrations 10-
400 ng. Increase dye concentration for higher DNA concentration
4. Scale fluorimeter:
Warm up fluorimeter for 15 minutes
Prepare standards of calf thymus DNA
Zero with 2 ml working dye solution
Scale with calf thymus DNA, typically 250 ng
5. Assay:
Collagen samples must be digested by papain or protease and
freeze/thawed 3 times to lyse cells to release DNA
Centrifuge samples at 3000 rpm for 10 minutes (leaves DNA in solution
but pelletizes protein and collagen fibers)
Add 100 pl aliquot of sample (from supernatant only) to cuvette
Add 1.9 ml final working dye solution to cuvette. Mix.
Read immediately in flourometer
Papain digestion
1. Prepare stock solutions:
Monobasic stock: 6.9 g 0.5M NaH 2PO 4 in 100 ml dH20
Dibasic stock: 7.1 g 0.5M Na 2HPO 4 in 100 ml dH20
2. Prepare papain buffer:
2.46 ml dibasic stock solution
17.54 ml monobasic stock solution
80 ml dH 20
3. On day of digestion, complete papain buffer with:
87.82 mg L(+) - Cysteine HC1
186.12 mg Disodium Ethylenediamenetetraacetate (EDTA)
pH to 6.2 with 10M NaOH
4. Digestion:
Place specimen in 1.5 ml microcentrifuge tube
Add 1 ml complete papain buffer
Add 50 l papain. Vortex or mix thoroughly.
Float tubes in covered 65 0C bath overnight
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Appendix E Sample embedding and sectioning protocols
Decalcification:
Samples containing bone were first decalcified in 15% EDTA decalcifying
solution, pH 7.4. This solution was mixed as follows (makes =1800 ml):
- 1570 ml PBS (0.01 M phosphate buffer)
- 44 g NaOH (Fisher Scientific, Cat. #S-318, Fair Lawn, NJ)
- 270 g EDTA (Disodium Ethylenediamine Tetraacetate, Fisher Scientific, Cat.
#S311-3, Fair Lawn, NJ)
- =27 ml concentrated HC1
Instructions:
1) Make PBS, 10 mM. Either with dissolvable tablets (Sigma #P-4417, St. Louis,
MO. 1 tablet/200 ml dH20), or with packets (Sigma #P-3813, 1 packet/L
dH20).
2) Add NaOH. Dissolve completely. It is difficult to get EDTA into solution
without NaOH.
3) Add EDTA
4) pH adjustment to 7.4
Plastic embedding:
Embedding in plastic was performed using Polysciences JB-4 embedding kit
(Polysciences, Inc., Warrington, PA). This process included the following items:
- JB-4 embedding solution A (Cat. #0226A, Acrylic monomer n-Butoxyethanol)
- Catalyst (Cat. #02618, benzoyl peroxide, 70% wet).
- JB-4 embedding solution B (Cat. #0226B, N,N-Dimethylaniline
Poly [Ethyleneglycol]).
- Catalyzed solution A: dissolve 9 g catalyst in 1000 ml solution A.
I. Preparation. Samples should be decalcified and rinsed well of fixative with
water.
2. Dehydration.
A. Tissue specimens were dehydrated by machine (Tissue-Tek VIP 1000,
model 4617, Miles Scientific, Mishwaka, IN). In this experiment, the
following dehydration program (program #9) was used, with solutions
changed automatically as follows:
Solution Time Temperature
50% EtOH 1 hour room temp
70% EtOH 1 hour room temp
80% EtOH 1 hour room temp
95% EtOH 1 hour room temp
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95% EtOH
100% EtOH
100% EtOH
100% EtOH
1 hour
1 hour
1 hour
3 hour
room temp
room temp
room temp
room temp
B) Fragile collagen matrix samples were dehydrated by hand.
alcohol solutions were
Solution
distilled H20
distilled H20
distilled H20
50% EtOH
70% EtOH
80% EtOH
95% EtOH
95% EtOH
100% EtOH
100% EtOH
100% EtOH
(Dry, unused matrices were
at 40 C.
pipetted in and out of
Time
30
30
30
30
30
30
30
30
30
30
30
min-
min-
min-
min-
min-
min-
min-
min-
min-
min-
min-
1 hour
1 hour
1 hour
I hour
1 hour
1 hour
1 hour
1 hour
1 hour
1 hour
1 hour
placed directly in
24-well plates
Temperature
room temp
room temp
room temp
room
room
room
room
room
room
room
room
a
Water and
s follows:
temp
temp
temp
temp
temp
temp
temp
temp
100% alcohol). Leave overnight
3. Equilibration. Samples were stored in tissue cassettes and equilibrated
overnight at 40 C in a solution '50% ethanol/50% catalyzed JB-4 solution
A.
4. Vacuum infiltration. Under house vacuum, 40C, infiltrate in 100%
catalyzed JB-4 solution A, 1-4 days.
5. Embedding. Combine JB-4 catalyzed solution A : JB-4 solution B at a ratio
of 20:1. Mix well and pipet into plastic molds. Place samples face down in
plastic molds. Ensure that sample orientation is maintained. Solution
begins to harden in approximately 30 minutes. Before hardening
completed (careful- polymerization may progress rapidly once started),
place labeled metal embedding blocks in molds. Note: label should be
written in standard pencil marking only!
Paraffin embedding:
1. Samples should be decalcified and rinsed well of fixative, and placed in
plastic tissue cassettes (Tissue Tek unicassettes, #4170 or #4173, Miles, Inc.,
Elkhart, IN).
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2. Dehydration and infiltration.
A) Tissue specimens were dehydrated and infiltrated by machine (Tissue-
Tek VIP 1000, model 4617, Miles Scientific, Mishwaka, IN). In this experiment,
dehydration program #4 was used, with solutions changed automatically as
follows:
Solution
50% EtOH
70% EtOH
80% EtOH
95% EtOH
95% EtOH
100% EtOH
100% EtOH
100% EtOH
clearing solution
clearing solution
paraffin
paraffin
paraffin
Time
1 hour
1 hour
1 hour
1 hour
1 hour
1 hour
1 hour
1 hour
1 hour
1 hour
1 hour
30 min
30 min
Temperature
room temp
room temp
room temp
room temp
room temp
room temp
room temp
room temp
room temp
room temp
590C
590C
59 0C
Clearing solution: Americlear histology clearing solvent, Baxter Healthcare
Corp. #C4200-1, Deerfield, IL
Paraffin: Paraplast Cat. #8889-501006, melting temp 56 0C, Oxford Labware, St.
Louis, MO
B) Fragile collagen matrix samples were
alcohol solutions were pipetted in and out of
Solution
distilled H20
distilled H20
distilled H20
50% EtOH
70% EtOH
80% EtOH
95% EtOH
95% EtOH
100% EtOH
100% EtOH
100% EtOH
Time
min- 1 hour
min- I hour
min- 1 hour
min- 1 hour
min- 1 hour
min- 1 hour
min- 1 hour
min- 1 hour
min- 1 hour
min- 1 hour
min- 1 hour
dehydrated by hand. Water and
24-well plates as follows:
Temperature
room temp
room temp
room
room
room
room
room
room
room
room
room
temp
temp
temp
temp
temp
temp
temp
temp
temp
The matrices were then placed in tissue cassettes in clearing solution
(Americlear ) for 1 hour, then placed in molten paraffin to pre-infiltrate for a
minimum of 2 hours (as long as overnight) with 1-2 changes of solution.
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3. Embedding. Specimens were embed with the aid of Tissue-Tek II paraffin
embedding center, model 4603 (Lab-Tek Products, Westmont, IL). The
machine provided a molten source of paraffin and cooling plate. Paraffin
was placed in stainless steel molds of varying size, the specimen placed in
the mold, and the mold placed on a cooling plate. The tissue cassette was
placed on the mold and additional paraffin was added to affix the plastic
cassette to the mold.
Sectioning and storage:
Histological sections were cut on a microtome (Reichert-Jung model 2050
Supercut, Leica Instruments, Nussloch, Germany). Thickness were 7 gm for
paraffin sections and 5 pm for plastic. The sections were placed on glass slides
(Fisherbrand Superfrost Plus, Cat. #12-550-15, Fisher Scientific, Pittsburgh, PA)
for paraffin, and S/P Micro Slide, Baxter Scientific Cat. #M6156, McGraw Park, IL
for plastic). Slides with plastic sections were dried on a hot plate at low
temperature, then stored at room temperature. Paraffin slides were placed in
an oven at 500C to melt off excess paraffin overnight, then stored at 40 C.
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Appendix F Histological staining protocols
Note: Slides were coverslipped and sealed with Cytoseal 60 cell-mounting
medium (Stephens Scientific #8310-16, Riverdale, NJ).
Masson Trichrome Staining
Formalin-fixed, paraffin-embedded tissue
0. Deparaffinize and hydrate
Xylene: 2 x 5 min.
100% ethanol: 10-20 dips
100% ethanol: 10-20 dips
95% ethanol: 10-20 dips
80% ethanol: 10-20 dips
70% ethanol: 10-20 dips
dH 2 O: 10-20 dips
1. Mordant in Bouin's solution 1 hour at 560C or overnight at RT
2. Cool and wash in running water until yellow color disappears
3. Rinse in distilled water
4. Weigert's iron hematoxylin solution for 10 min. Wash in running water
10 min
5. Rinse in distilled water
6. Phosphomolybdic-phosphotungstic acid solution for 10 to 15 min.
Discard solution.
7. Aniline blue solution for 5 min. Save solution
8. Rinse in distilled water
9. Glacial acetic solution for 3 to 5 min. Discard solution
10. Dehydrate in 70, 80, 95, and 100% EtOH
11. Clear in xylene
12. Coverslip with Permount
Safranin O - Fast Green staining protocol
Formalin-fixed, paraffin-embedded tissue
Deparaffinize and hydrate
Xylene: 2 x 5 min.
100% ethanol: 10-20 dips
100% ethanol: 10-20 dips
95% ethanol: 10-20 dips
80% ethanol: 10-20 dips
70% ethanol: 10-20 dips
dH20: 10-20 dips
Safranin 0, 10 min (30 min for GMA sections)
Rinse with distilled water
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3. Counterstain with working solution Fast Green 10-15 sec
4. Rinse with distilled water
5. Dehydrate (70%-80%-95%-100% (x2)-xylene (x2))
6. Air dry sections
7. Coverslip with Permount
Solutions:
Safranin O
0.2 gm Safranin O
100 ml distilled water
1 ml glacial acetic acid
Stuck Fast Green- stock solution:
0.2 gm Fast Green
100 ml distilled water
1 ml glacial acetic acid
Fast Green working solution:
dilute stock solution 1:5 in distilled water
Hematoxylin and Eosin staining
Formalin-fixed, paraffin-embedded tissue
1. DEPARAFFINIZE AND REHYDRATE
Xylene: 2 x 5 min.
100% ethanol: 10-20 dips
100% ethanol: 10-20 dips
95% ethanol: 10-20 dips
80% ethanol: 10-20 dips
70% ethanol: 10-20 dips
dH20: 10-20 dips
2. Harris hematoxylin, 10 min.
3. Rinse in tap water, approx. 1 min. running or swishing until almost clear
4. Acid alcohol. Dip quickly 5-10 times. 20-30 sec total.
5. Rinse in tap water. Until foaming stops, maybe 30 sec.
6. Ammonia water. Quick dips (5 or so) until blue.
7. Rinse in tap water. About 1 min.
8. Eosin, 45 sec.
9. Rinse in tap water, 2 min.
10. DEHYDRATE
70% ethanol: 10-20 dips
80% ethanol: 10-20 dips
95% ethanol: 10-20 dips
100% ethanol: 10-20 dips
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100% ethanol: 10-20 dips
Xylene: 2 x 5 min.
11. Air dry, coverslip with Permount.
Solutions:
HEMATOXYLIN: Filter 200 ml of stock solution into staining dish. Sigma Harris
Hematoxylin Solution, Catalog HHS-128, Modified: Hematoxylin, 7.5 g/L;
sodium iodate, aluminum and ammonium sulfate, stabilizers and
preservative.
ACID ALCOHOL: 200 ml of 70% ethanol (in dH20) + 0.5 ml HC1
AMMONIA WATER: 200 ml dH20 + 5-10 drops ammonium hydroxide
pH should be roughly around 10.0 - use pH paper.
EOSIN: 100 ml stock solution + 100 ml dH20 + 1.0 ml glacial acetic acid
Sigma Eosin Y Solution Aqueous, catalog HT110-2-128.
Hematoxylin and Eosin staining
Formalin-fixed, plastic-embedded tissue
1. Dry slides
2. Harris hematoxylin, 60 min.
3. Rinse in tap water, approx. 1 min. running or swishing until almost clear
4. Acid alcohol. Dip quickly 5-10 times. 20-30 sec total.
5. Rinse in tap water. Until foaming stops, maybe 30 sec.
6. Ammonia water. Quick dips (5 or so) until blue.
7. Rinse in tap water. About 1 min.
8. Eosin, 5 min.
9. Rinse in tap water, 5 min.
10. Air dry, coverslip with Permount.
Aniline Blue Staining
Solution: 2.5 gm aniline blue
100 ml dH 20
2 ml glacial acetic acid
For GM A: 2-4 min. Rinse in alcohol
For paraffin: deparaffinize and hydrate. Stain 10 sec. Rehydrate and clear in
xylene.
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Appendix G Immunohistochemical staining protocols
Immunohistochemistry Supplies
Anti-Type II collagen antibody
clIcI (mouse anti-chick type II collagen monoclonal antibody)
Developmental Studies Hybridoma Bank
Iowa City, IA
Anti-type I antibody
Rabbit anti-human type I collagen
catalog #: IgG : D20111
Dr. Daniel Hartman
Institut Pasteur de Leon
Avenue Tony Garnier
69365 Leon CEDEX 7, France
011-33-72-73-43-25
FAX 011-33-78-61-05-03
Protease XIV (protease type XIV: Bacterial
Sigma cat # P 5147, St. Louis, MO
new supplier:
DMI
160c Larrabee Rd.
Westbrook, ME 04092
(207) 854-1163
FAX 207-854-8586
(pfs), also Pronase E)
DAB (3,3'-diaminobenzidene) KNOWN CARCINOGEN! HANDLE WITH
CARE! Sigma cat # D-5637, St. Louis, MO 63178
DTT (Diothiothreitol, (Cleland's reagent, DL-DTT), 99%)
Sigma cat # D 0632, St. Louis, MO
Iodoacetic Acid
Sigma cat # I 4386,
Horse serum
Sigma cat # H 0146,
Donkey serum
Sigma cat # D 9663,
Donkey anti-rabbit
Amersham catalog #:
St. Louis, MO
St. Louis, MO
St. Louis, MO
secondary antibody (biotinylated donkey anti-rabbit Ig)
RPN 1004, Arlington Heights, IL
Horse anti-mouse secondary antibody (biotinylated horse anti-mouse Ig)
Vector Laboratories catalog #: BA-2000, Burlingame, CA
ABC staining kit (Standard Vectastain ABC kit)
Vector Laboratories Catalog #: PK 4000, Burlingame, CA
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Control Tissue:
Chicken: Mayflower Poultry Co, Cambridge, MA
Bovine: Arena Brothers, Hopkinton, MA
TRIS (Tris[hydroxymethyl]aminomethane): 250 g white container from Sigma,
catalog # T-1378
Anti-Type I Collagen
Immunohistochemical Staining (ABC Method)
Rabbit anti-human type I from Daniel Hartman:
Handle all washes as gently as possible to preserve tissue adherence. Minimize
dipping.
Hydration (for paraffin sections)
1. Xylene, 2 X 2 min. Wipe off excess paraffin.
2. Alcohol: 100% -> 95% -> 80% -> 70%, 2 min each
3. Wash in TBS pH 7.4, 2 X 2 min. Wipe slides.
Blocking Serum (Donkey serum)
1. Dilute 1:20 in TBS pH 7.4
2. 30 min at RT
3. Do NOT wash slides (simply pipette off excess serum)
Primary Antibody (rabbit anti-human type I collagen IgG)
1. Dilution 1:50 in TBS pH 7.4
2. Incubate at RT x 60 min
3. Wash in TBS pH 7.4 2 X 2 min. Wipe slides.
Secondary Antibody (Donkey anti-rabbit IgG)
1. Dilution: 1:200 in TBS pH 7.4
2. 45 min at RT (*)
3. Wash in TBS pH 7.4 2 X 2 min. Wipe slides.
Endogenous peroxidase quench
1. 3% H202 in distilled water
2. 10 min at RT
3. Wash in TBS pH 7.4 2 X 2 min. Wipe slides.
ABC (Vectastain Labs)
1. Use pre-prepared ABC reagent (as outlined below (*))
2. 30 min at RT
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3. Wash in TBS pH 7.4 2 X 2 min. Wipe slides.
DAB
1. Prepare fresh DAB as outlined below (#)
2. 8 min at RT (or until dark)
3. Wash in TBS pH 7.4 2 X 2 min
Counterstain with Hematoxylin (paraffin protocol)
1. Hematoxylin for 10 min. Rinse thoroughly in water.
2. Dip in acid alcohol (5 sec). Rinse in water.
3. Dip in ammonia water (5 sec). Rinse in water.
Dehydrate and Mount (paraffin)
1. Alcohol: 70% -> 80% -> 95% -> 100%, 2 min each.
2. Xylene, 2 X 2 min. Let dry overnight.
3. Mount and coverslip.
(*) Make up ABC reagent at this point:
Add 1 drop reagent A to 5 ml of cold TRIS/HCI buffer (pH 7.6) and mix.
Add 1 drop reagent B and mix thoroughly. Allow to stand for 30 min at room
temperature before use.
(#) DAB reagent:
Add 100 gl of 30% hydrogen peroxide to 2.9 ml distilled water. Add 50
gl of this to a prepared solution of 2.5 mg DAB in 5 ml TRIS/HCI buffer (pH
7.6). Check the efficacy of this by adding one drop of this to one drop of ABC
reagent on a blank slide or coverslip.
Anti-type II
Immunohistochemical Staining (ABC Method):
Handle all washes as gently as possible to preserve tissue adherence. Minimize
dipping.
Hydration (for paraffin sections)
1. Xylene, 2 X 2 min. Wipe off excess paraffin.
2. Alcohol: 100% -> 95% -> 80% -> 70%, 2 min each
3. Wash in TBS pH 7.4, 2 X 2 min. Wipe slides.
Digestion:
1. Enzymatically digest specimens in protease type XIV (Sigma) 1.0 mg/ml
in TBS pH 7.4 for 60 min.
2. Wash in TBS pH 7.4 2 X 2 min. Wipe slides.
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Blocking Serum (Horse serum)
1. Dilute 1:20 in TBS pH 7.4
2. 30 min at RT
3. Do NOT wash slides (simply pipette off excess serum)
Primary Antibody (Mouse anti-chick type II collagen IgG)
1. Dilution 1:20 in TBS pH 7.4
2. Incubate at RT x 60 min or overnight at 40C in hydration chamber.
3. Wash in TBS pH 7.4 2 X 2 min. Wipe slides.
Secondary Antibody (Horse anti mouse)
1. Dilution: 1:200 in TBS pH 7.4
2. 45 min at RT (*)
3. Wash in TBS pH 7.4 2 X 2 min. Wipe slides.
Endogenous peroxidase quench
1. 3% H202 in distilled water
2. 10 min at RT
3. Wash in TBS pH 7.4 2 X 2 min. Wipe slides.
ABC (Vectastain Labs)
1. Use pre-prepared ABC reagent (as outlined below (*))
2. 30 min at RT
3. Wash in TBS pH 7.4 2 X 2 min. Wipe slides.
DAB
1. Prepare fresh DAB as outlined below (#)
2. 8 min at RT (or until dark)
3. Wash in TBS pH 7.4 2 X 2 min.
Counterstain with Hematoxylin (paraffin protocol)
1. Hematoxylin for 10 min. Rinse thoroughly in water.
2. Dip in acid alcohol (5 sec). Rinse in water.
3. Dip in ammonia water (5 sec). Rinse in water.
Dehydrate and Mount (paraffin)
1. Alcohol: 70% -> 80% -> 95% -> 100%, 2 min each.
2. Xylene, 2 X 2 min. Let dry overnight.
3. Mount and coverslip.
(*) Make up ABC reagent at this point:
Add 1 drop reagent A to 5 ml of cold TRIS/HC1 buffer (pH 7.6) and mix.
Add 1 drop reagent B and mix thoroughly. Allow to stand for 30 min at room
temperature before use.
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(#) DAB reagent:
Add 0.1 ml 30% hydrogen peroxide to 2.9 ml distilled water. Add 50gl
of this to a prepared solution of 2.5 mg DAB in 5 ml TRIS/HCI buffer (pH 7.6).
Check the efficacy of this by adding one drop of this to one drop of ABC
reagent on a blank slide or coverslip.
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Appendix H Methods of quantitative grading of art icular cartilage defects
Schematic guide to QUANTITATIVE grading of chondral
articular cartilage defects (acute and healing defects)
**All grading must be performed with a 1 Ox objective
without the photo knobs engaged
Schematic of normal articular cartilage
AC
cartilage marrow
spaces
subchondral Done plate
Normal appearance of a fresh chondral defect
Schematic of a fresh chondral defect showing how to define
the defect base, defect height, and the area of negative
, matrix flow
negative matrix flow
base
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Typical appearance of a healed defect filled with reparative tissue
Schemat ic of a healed chondral defect showing how t o define
the defect base, defect height, and the areas of
reparative tissue and matrix flow
corner I I corner
base
STEP 1: Grid placed outside defect to measure height
- measure height 10 small boxes from corner of defect
- here the height is about 8.5 boxes (then do other side-- 9 boxes)
I
corner
190
8 *
~-7 L -~C ~V ? TI - -- ~e
~55 ~T
STEP 2: begin sweeping grid across to measure defect base and repair
tissues (it may be easiest to do the base completely first, then go
back to do the repair tissues).
Here the grid covers:
- about 55 boxes of tissue (15 matrix flow and 40 repair tissue)
- exactly 10 boxes along the base of the defect
NOTE! The repair tissue can extend slightly outside the defect
area. as it does here
corner
II
II
STEP 2, CTD: Sweep to next spot (b), then continue to end (f).
(b) contains about 42 boxes of repair tissue
(f) contains 5 boxes of repair tissue, 5 boxes of flow
The base is 51 boxes
CI
.--..-- - -..-.-. . . ....
I I
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Measuring bonding of repair tissue to the calcified cartilage and apposition
of repair tissue to adjacent cartilage is next.
This schematic shows how you might look at a defect to determine bonding /
apposition. First, bonding to the CC is checked by polarized light. You can
make a mental picture like the schematic below.
Bonding to the adjacent cartilage is also measured. Rps and cracks (like
the one shown below do not count.
fibrous tissue or transition tissue- not bonded to base
/ crack between repair
hyaline tissue, bonded to base tissue and adjacent
cartilage
STEP 3:
- first,
- then
- here
Measuring bonding to the base
identify the bonded areas by polarized light (above)
sweep the grid across the bonded area to get a total:
the total = 37 (a=9, b=10, c=10, d=8)
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STEP 4: Judging tissue attachment is done by recording the amount height of
the repair tissue which is bonded to the adjacent cartilage.
On the left side, repair tissue goes to a height of 5.8 boxes. All is attached.
On the right side, the tissue goes all the way to the top (9 boxes vertically),
but 4.5 boxes are subtracted for the crack.
Total height attached: 5.8 + 4.5 = 10.3
This schematic can be used for the final quantitative step, grading
the amount of intact calcified cartilage.
In this example there has been some damage, as indicated:
corner fracture resorption
STEP 5: Measuring the intact calcified cartilage and subchondral plate
This is done by sweeping the grid across the intact sections as shown:
The total intact is 27 boxes (a= 10, b=5.5, c=10, d=1.5)
a1
F'I
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Power calculation
The number of animals to be used in each group was determined by a power
calculation. The procedure for a power calculation is an iterative one. Some
values must be based on hypothesized results or previous work. In our case, we
based the calculation on the results of our preliminary study of healing of
untreated and CAC-treated defects in our animal model.
Specifically, our calculation was based on our previous results for the most
important outcome variable, the combined amount of hyaline and articular
cartilage found in the defect site at the equivalent time period. These values
were 34.9 ± 16.1% for the CAC treated group, and 19.2 ± 13.0% for the empty
control (EC) group. We wished to detect differences approximately 50% greater
than that between these groups in order to identify a clinically meaningful
improvement. Thus, we required the minimum detectable difference between
groups to be 1.5 times that found previously, i.e. 1.5*(34.9-19.2) = 26.4%.
Assuming the same standard deviation found in the CAC treated group
(16.1%) for both groups, a power of 0.80 (P=0.20) and a level of significance,
a=0.05, n = 6 defects was required. Eight defects were chosen to provide a
margin of safety in the event of the loss of an animal or other pathology which
would prevent analysis of certain specimens.
The steps of the power calculation were as follows. This treatment assumes
that the experimenter is searching for the value of n2, the number of samples
in a treatment group, to allow detection of significant difference between the
treatment group and a control group. The case considered does not assume
that the sample numbers or variance in the control and treatment groups are
the same. It is assumed that if n2 is chosen for the treatment or experimental
group, than nl for the control group is the same, or is otherwise known.
1) Determine the desired or expected difference between sample means which
is the minimum you wish to detect between groups. This value will be based
on the best available information, such as that in the second paragraph above.
2) Guess the value of n2 needed for the experimental group.
3) If groups have different variances, calculate the pooled variance. The
pooled variance computed from the variances of each group is the best
estimate the variance of the entire population (eq. 1).
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Appendix I
2  2
2 V1dl +V2 S 2
equation 1: s2 =
S2 = variance
2
s, = pooled variance
v = degrees of freedom
subscripts: '1' or '2' refer to the two samples compared, here the control
(1) and experimental (2) groups. Note: v = n-1
4) Calculate the equivalent sample size, n. In order to compare the means of
the control and experimental groups, a single sample size, representative of
both groups, must be calculated (eq. 2).
2nln2
equation 2: n = 2n--n2
n, + n2
n = sample size
5) Given these values, equation 3 will calculate the minimum detectable
difference, 5, between the means of the two samples:
2s
equation 3: 6 2 -- P(ta(2), v + t(1), v)
n
6 = minimum detectable difference in means
ta(2),v = critical value of' t' for given parameters
a(2) = two - tailed probablility of significance a
pe() = one - tailed probablility of significance /
The power, 1-8, and the level of significance, a, are chosen by convention. If
the desired or expected difference in mean, as in step 1), is larger than 5, then
the calculation is repeated with smaller n2. If the desired difference is smaller
than 6, the calculation is repeated with larger n2. The iteration continues until
the critical n is determined.
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Elution of components of unseeded matrices in culture
In two sets of experiments with longer term cultures (at least 4 weeks),
measurements on unseeded matrices indicated the approximate rate at which
the matrix was degraded and components were eluted to the matrix. Both
experiments used type II collagen matrices which are known to contain both
GAG and DNA. Thus, the standard assays for DNA and GAG (section 4.2.2)
were used to monitor their loss over time in culture. These two series included
1) matrices of varying degree of cross-linking, and 2) matrices of varying pore
diameter. It should be noted that the values for DNA content include an
unknown background component due to interference by other matrix
molecules. Thus the absolute DNA values were not determined, and GAG/DNA
plots are not presented because they may not accurately indicate the true
ratio of GAG to DNA.
The results of the experiment where type II matrices were subjected to varying
degree of cross-linking are shown in Figures ApJ-l and ApJ-2. These matrices
were evaluated at 1 day, 4 weeks, and 6 weeks. The results of the experiment
in which type II matrices of varying pore diameter were cultured up to 4 weeks
are shown in Figures ApJ-3 and ApJ-4.
Matrices of varying degree of cross-linking: The results of the experiment where
type II matrices were subjected to varying degree of cross-linking are shown in
Figures ApJ-1 and ApJ-2. There was no statistical significance between 4-week
and 6-week values in either DNA or GAG content. Thus, most of these
components were lost over the first four weeks. Approximately half of the GAG
content in each DHT'd matrix was lost. Slightly more DNA and GAG were lost
from the 1-day DHT group vs. the 4-day DHT group. This effect of cross-linking
treatment was not highly significant by 2-way ANOVA (p=0.15 for DNA, p=0.38
for GAG). When UV cross-linked matrices were also evaluated at 6 weeks, the
three groups had the same amount of DNA, but differing amounts of GAG
(p=0.01, single factor ANOVA). The UV-cross-linked matrices had the least GAG
at 6 weeks.
Analysis of matrices of varying pore diameter: Biochemical assay of the DNA
and GAG contents of unseeded type II matrices of varying pore size show the
loss of the matrix to the medium over time (Figures ApJ-3 and ApJ-4). 2-way
ANOVA showed that the DNA content of unseeded matrices was significantly
dependent on both time (p<10-4) and pore size (p<10-7). The pore size effect
was evident as slightly less DNA in small pore matrices. The time effect was a
very slight decrease in DNA over time. This loss was most noticeable for the
small pore matrices. The loss of GAG from the matrices over time was much
more obvious. Both time and pore size effects were highly significant by 2-way
ANOVA (p values < 10-6). This loss had a similar profile in all three pore sizes,
but was slightly greater in the small pore matrices. These results showed that
the GAG was eluted from the matrix more rapidly than the DNA.
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Figure ApJ-1. DNA content of unseeded type II matrices of varying degree
of cross-linking with time in culture; n=3. Data given as mean ± SEM.
12.5
10
7.5
2.5
0
1 28 42
time (days)
Figure ApJ-2. GAG content of unseeded type II matrices of varying degree
of cross-linking with time in culture; n=3. Data given as mean ± SEM.
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Figure ApJ-3. DNA content of unseeded type II matrices of varying pore
size with time in culture; n=4. Data given as mean ± SEM.
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Figure ApJ-4. GAG content of unseeded type II matrices of varying pore
size with time in culture; n=4. Data given as mean ± SEM.
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Appendix K. Evaluation of relationship of proximal and distal defects
In this work, it was important to establish any relationship between the
proximal and distal defects. Two analyses were performed to this end:
1) A correlation analysis, to determine any positive or negative correlation
between the defects. Three separate analyses were performed, based on the
three series of animal experiments: series 1, untreated defects, periosteum, and
autologous cultured chondrocyte treatment (CAC); series 2, preliminary
implants of seeded and/or unseeded type I or II collagen; and series 3,
engineered type II collagen implants and microfracture. Within each series all
proximal and distal defects were grouped for all quantitative categories. A
correlation with linear regression was performed, and the coefficient of
determination (R2) obtained for all combinations of groups. The coefficients of
determination for the most important categories in healing in the three series
are reported in Table Appendix K-1:
series total fibrous fibro- hyaline + intact
(n) filling tissue cartilage articular calcified layer
1 (50) 0.03 (-) 0.04 (+) 0.06 (-) 0.42 (+) 0.10 (+)
2 (14) 0.15 (+) 0.01 (-) 0.06 (+) 0.03 (-) 0.02 (+)
3 (12) 0.08 (-) 0.03 (+) 0.14 (-) 0 0.18 (+)
Table Appendix K-1. Coefficients of determination from correlation analysis of
proximal vs. distal defects for selected categories from three series of
experiments in a canine model. The sign of the correlation is also given.
Defect locations were identical in all series. n = number of knees in which
comparison of proximal and distal defects was possible.
The coefficient of determination represents the portion of the value one
variable (distal data) which can be predicted by knowing values of the second
variable (proximal data). Thus, the results of this correlation indicate that
knowing the results of one defect in a knee gives very little information about
the other. This suggests that the two defect locations could be treated
independently. For this reason, the quantitative data for the animal series are
reported with each defect treated independently. In one case, that of hyaline
+ articular cartilage in the first series, this assumption is less substantially
justified. In this case, a fair portion of the data in one defect (42%) can be
predicted by the other. For this reason, in analyzing this data, a second
approach was added for completeness: the data from the proximal and distal
defects in each knee were averaged. This method results in the loss of some of
the information contained in the defects, but yields a more conservative value
for statistical significance. For completeness, the entire set of data, when
averaged by knee, is presented in Appendix L. Secondary statements of
statistical significance for the hyaline + articular category in the first series are
included in the main text for the data treated in this manner.
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2) The second evaluation was designed to determine if there were any
consistent differences between proximal and distal defects. This analysis
examined all quantitative categories including defect geometry, tissue types
filling the defect, attachment to adjacent structures, and the status of the
calcified cartilage. The difference in values for proximal and distal defects was
calculated and the resulting statistic compared to a value of zero by t-statistic
(one sample hypothesis). The same three series of animals as in the
correlation analysis were used in this manner. The results for selected
categories are presented in Table Appendix K-2.
series total fibrous fibro- hyaline + intact
(n) filling tissue cartilage articular calcified layer
1 >>0.5 <0.2 >0.2 >0.5 <0.1
(50) +1% -3% +1% -1% +9%
2 <0.1 <0.5 <0.2 >0.2 <0.5
(14) -20% -5% -12% -3% +8%
3 <0.2 <0.005 >0.5 >0.2 <0.05
(12) -27% -25% -3% +1% +23%
Table Appendix K-2. Significance level of difference in value of proximal vs.
distal defects for selected categories from three series of experiments in a
canine model. The absolute difference, proximal-distal (as a percentage of
the defect area or linear measure) is also given. Defect locations were
identical in all series. n = number of knees in which comparison of
proximal and distal defects was possible.
There were few differences in the first series of experiments, with only the
suggestion that the calcified layer was slightly more intact in the proximal
defects. The third series did show some differences in proximal and distal
defects: proximal defects had a substantially more intact subchondral plate
and less total filling. The extra tissue in distal defects was almost entirely
fibrous tissue. In the second series, the results were roughly similar although
the statistical significance and magnitude of the differences were lower. In
addition, in the second series, the additional tissue in the distal defects was
more fibrocartilage.
In most categories not presented, including matrix flow, integration with
adjacent cartilage, and bonding to the calcified cartilage, differences between
proximal and distal defects were not highly significant, and not consistent
among the three series. However, there was a consistent finding that proximal
defects were slightly larger than distal defects. The differences, as a percent of
total area were 6%, 1%, and 9% in the three series, with significance between
proximal and distal in each series ranging from p<0.1 to >>0.5.
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Appendix L Quantitative data for in vivo chondral defect experiments with data
averaged by knee
defect fibrous fibro- hyaline articular total matrix
time type (n) tissue cartilage cartilage cartilage bone filling flow
6 wk C (3) 24.5 ± 2.9 20.5 ± 2.1 3.1 ± 1.1 0 0 0 0 48.0 3.0 0.6 0.2
9wk C(6) 11.5 ±2.2 20.6 +9.2 5.2+ 1.6 0.6 0.4 0 +0 37.9 ± 7.9 4.7 ± 1.5
6&9 wk C (9) 15.8 ± 2.7 20.6 ± 6.0 4.5 ± 1.1 0.4 ± 0.3 0 ± 0 41.3 ± 5.4 3.3 ± 1.2
3mo C(5) 1.1 0.7 12.3 ± 4.2 14.4 +4.6 3.0 ± 1.8 0 +0 30.8 ± 8.8 1.6 ± 0.3
15 wk MF(4) 10.9 3.3 52.4 + 16.6 0.7 0.3 0 0 0 +0 64+ 13.7 1.8 ± 0.7
6mo C(3) 2.5+ 1.3 12.9 ± 5.4 10.0±+4.7 1.8 ± 1.3 0 0 37.1 ± 10.3 8.8 ± 4.4
12 mo C (4) 1.3 ± 0.9 17.2 ± 8.0 19 ± 3.7 3.7 ± 1.7 0.2 ± 0.2 41.4 ± 4.5 2.5 ± 1.1
18mo C(3) 8.4 +3.0 51.8 +8.4 9.6 +2.0 0+±0 5.8 ± 5.8 75.7 + 17.5 1.6 ± 0.5
Table 5-11a. Components
canine model. C =
microfracture.
a histological
of healing full-thickness chondral
untouched chondral defect. MF =
defects in an adult
chondral defect with
Values given as an areal percent of total defect area seen
cross-section from the center diameter of the defect, mean
SEM (data averaged by knee).
Integration with
adjacent AC
Bonding to
calcified cartilage
S
Intact
calcified cartilage
6 week chondral 0 0 6.3 ± 2.9 56.8 ± 18.6
9 week chondral 17.2 + 6.2 24.9 ± 8.5 62.5 ± 12.4
6 + 9 chondral 11.4 + 4.9 18.7 + 6.3 60.6 ± 9.7
3 months chondral 12.8 + 3.1 46.1 ± 15.6 94.9 ± 2.9
15 weeks microfracture 25.3 + 4.1 1.8 + 1 35.6 + 15.4
6 months chondral 13.2 + 4.5 39.5 ± 16.5 89.3 ± 8.7
12 months chondral 15.6 + 8.2 88.6 ± 9.7 92.3 ± 7.4
18 months chondral 24.6 + 9.1 40.7 ± 16.3 73.4 ± 12.9
Table 5-12a. Integration of reparative tissue and status of the underlying
calcified cartilage in healing full-thickness chondral defects in an adult
canine model. One group, as indicated, was treated with microfracture.
Values given as a linear percent of the length of the defect base or height, as
seen in a histological cross-section from the center diameter of the defect,
mean ± SEM (data averaged by knee).
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time defect type
time treat- Fibrous Transition Hyaline Articular Total matrix
(mo.) ment n Tissue Tissue Cartilage Cartilage Bone Repair flow
*EC 9 15.8 ± 2.7 20.6 ± 6.0 4.5 ± 1.1 0.4 ± 0.3 0 0 41.3 ± 5.4 3.3 ± 1.2
1.5 P 3 17.2 ± 5.4 33.9 ± 2.6 5.4 ± 3.8 0 0 0 0 56.5 ± 7.3 0.9 ± 0.5
CAC 6 10.6 + 4.8 15.2 + 6.7 10.4 ± 4.7 1.9 ± 1.8 0.1 ± 0.1 38.2 ± 9.2 1.5 ± 0.5
EC 5 1.1 ± 0.7 12.3 ± 4.2 14.4 ± 4.6 3.0 ± 1.8 0 0 30.8 ± 8.8 1.6 ± 0.3
3 P not studied
CAC 5 0.7 ± 0.5 12.5 ± 3.7 30.2 + 6.1 4.7 ± 3.6 0 0 48.1 ± 4.9 0.9 ± 0.2
EC 3 2.5 ± 1.3 12.9 ± 5.4 10.0 ± 4.7 1.8 ± 1.3 0 0 37.1 ± 10.3 8.8 ± 4.4
6 P not studied
CAC 3 6.1 ± 4.9 10.9 ± 5.9 18.7 ± 6.1 18.6 16.7 0 0 54.3 ± 15.3 1.3 ± 0.9
EC 4 1.3 ± 0.9 17.2 ± 8.0 19 ± 3.7 3.7 ± 1.7 0.2 ± 0.2 41.4 ± 4.5 2.5 + 1.1
12 P 3 2.2 ± 1.4 27.8 ± 13.6 14.7 ± 11.5 1.7 ± 1.7 1.6 ± 1.1 48 ± 10.5 2.7 ± 1.9
CAC 4 1.5 ± 0.9 19.1 ± 8.5 14.9 + 3.0 0.5 ± 0.3 0 ± 0 35.9 ± 10.3 2.8 ± 1.0
EC 3 8.4 ± 3.0 51.8 ± 8.4 9.6 + 2.0 0 ±0 5.8 ± 5.8 75.7 ± 17.5 1.6 ± 0.5
18 P 3 1.6 ± 0.8 41.4 ± 7.7 9.5 +2.2 0.4 ± 0.4 0 0 53 +5.8 2.1 ±0.6
CAC 4 2.5 ± 1 27.5 ± 7.5 12.9 ± 4.5 0.3 ± 0.3 2.7 ± 2.7 45.9 ± 8.0 1.7 ± 0.6
Table 5-14a. Components of healin
adult canine model. Defects are
g full-thickness chondral
untreated (EC), treated
defects in an
with periosteum
alone (P), or treated with periosteum and cultured autologous chondrocytes
(CAC). Values given as an areal percent of total defect area seen in a
histological cross-section from the center diameter of the defect, mean +
SEM (data averaged by knee). *1.5 month EC group includes both 6-week
and 9-week defects.
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Integration with
adjacent AC
-- p - -- S
Bonding to
calcified cartilage
Intact
calcified cartilage
*EC 11.4 + 4.9 18.7 + 6.3 60.6 ± 9.7
1.5 months P 8.3 + 5.4 27.3 ± 16.9 59.1 + 28.8
CAC 15.0 + 3.8 41.9 ± 13.5 79.3 ± 10.4
EC 12.8 + 3.1 46.1 ± 15.6 94.9 + 2.9
3 months P not studied
CAC 20.8 + 4.4 75.5 ± 14.8 96.4 ± 2.7
EC 13.2 + 4.5 39.5 ± 16.5 89.3 + 8.7
6 months P not studied
CAC 35.1 ± 5.5 87.4 ± 7.5 91.2 ± 7.6
EC 15.6 + 8.2 88.6 ± 9.7 92.3 + 7.4
12 months P 32.4 + 4.1 43.6 ± 28.7 65.1 + 17.9
CAC 21.2 + 4.5 60.1 ± 12.1 80.1 ± 11.1
EC 24.6 ± 9.1 40.7 ± 16.3 73.4 ± 12.9
18 months P 16.1 +7.4 46.7 ± 14.5 98.3 + 1.3
CAC 21.6 ± 5.2 59.3 ± 20.4 79.9 ± 15.4
5a. Integration of reparative tissue an
calcified cartilage in healing full-thickn
adult canine model. Defects are untrez
periosteum alone (P), or treated with
autologous chondrocytes (CAC). Values
the length of the defect base or height,
section from the center diameter of the
averaged by knee).
I status of the underlying
ess chondral defects in an
ated (EC), treated with
periosteum and cultured
given as a linear percent of
as seen in a histological cross-
defect, mean ± SEM (data
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time treatment
Table 5-1
Appendix M Description of defects with minimal filling
This table describes the number of defects which
data are given as the number of defects in each
percentage of total repair tissue, i.e. less than 5,
sectional area. Also recorded
(outside of those reported for
group. In the one experiment
times are also given.
had less than 20% filling. The
group with less than the given
10, 15 or 20% of the cross-
are the remaining low value for the group
<20%), and the absolute minimum value for
at multiple time points, the group totals for
filling remaining absolute
time group <5% <10% <15% <20% low % min %
15 wk CAC+typell 1/8 1/8 1/8 1/8 30 30
15 wk 4Fx+typell 0/8 0/8 0/8 0/8 48 48
15 wk 4Fx only 1/8 1/8 1/8 2/8 44 5
15 wk CaC 0/10 0/10 1/10 1/10 32 15
15 wk harvest 1/9 1/9 1/9 2/9 24 3
15 wk fascia 4/6 4/6 4/6 4/6 23 4
15 wk typel only 0/6 0/6 1/6 1/6 24 14
15 wk seededtypel 0/8 0/8 1/8 2/8 27 10
15 wk seeded typell 0/8 0/8 0/8 0/8 31 31
remaining absolute
<5% <10% <15% <20% low (%) min (%)
6wk untreated 0/6 0/6 0/6 0/6 35 35
9wk harvest 0/9 0/9 0/9 0/9 20 20
6 wk periosteum 1/6 1/6 1/6 1/6 33 4
6wk CAC 0/11 0/11 3/11 3/11 23 11
3 mo. harvest 1/9 1/9 1/9 2/9 24 3
3mo. CaC 0/10 0/10 1/10 1/10 32 15
6 mo. harvest 0/5 2/5 2/5 2/5 32 7
6 mo. CAC 0/6 0/6 0/6 0/6 20 20
12 mo. harvest 0/8 0/8 0/8 0/8 28 28
12 mo. periosteum 0/6 0/6 0/6 1/6 38 17
12 mo. CoC 0/8 0/8 1/8 2/8 20 13
18 mo. harvest 0/6 0/6 0/6 0/6 42 42
18 mo. periosteum 0/6 0/6 1/6 1/6 40 14
18 mo. CAC 0/8 0/8 0/8 1/8 27 16
qroup totals <5% <10% <15% <20%
harvest 1/43 3/43 3/43 4/43
periosteum 1/18 1/18 2/43 3/43
CAC 0/43 0/43 5/43 7/43
the
all
Figure ApM- 1. Number of defects in animal series with minimal filling with
reparative tissue. CAC=cultured autologous chondrocytes. Type I and II are
collagen matrices. kFx=microfracture. Harvest groups are empty control
defects. Remaining low is next lowest value above 20%.
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